Tehran University of Medical Sciences
| Farsi 
Print
Davood Beiki
Contact Information
http://tums.ac.ir/faculties/beikidav
Tel: 88633333
Fax: 88026905
Address: Research Center for Nuclear Medicine, Shariati Hospital, North Kargar Ave., 14117-13135 Tehran, Iran
Academic Rank
Professor
School
Medicine
Nuclear medicine
Hospital
Shariati
Nuclear medicine
Research Center
Research Institute for Nuclear Medicine
About
Dr. Davood Beiki acquired a PharmD in 1995 from the Tehran University of Medical Sciences (TUMS) and then finished a PhD in Radiopharmacy in 1999 from TUMS. He gained a postdoctoral training in Radiochemistry/Radiopharmacy at the University of Alberta in 2000. Dr. Beiki has obtained the honor of full professorship of TUMS since 2012. He has been involved in Research Center for Nuclear Medicine of TUMS as a Co-Founder and Vice-Chair since 2006 and as a chairman since 2023.
CV last edited on: 2023/26/02
1.
Radiochemistry/Radiopharmacy, University of Alberta, Edmonton, Canada, 1999- 2000
Thesis Title:1- Synthesis of 1-b-D-(5-deoxy-5-iodoarabinofuranosyl)-2-nitroimidazole (b-IAZA): a novel marker of tissue hypoxia., 2-Synthesis of b-azomycin nucleosides: 1-(b-D-2-iodo-2-deoxyarabinofuranosyl)-2-nitroimidazole, a novel marker of tissue hypoxia
Supervisor:Professor Leonard Wiebe
Postdoctoral fellowship
Radiochemistry/Radiopharmacy, University of Alberta, Edmonton, Canada, 1999- 2000
Thesis Title:1- Synthesis of 1-b-D-(5-deoxy-5-iodoarabinofuranosyl)-2-nitroimidazole (b-IAZA): a novel marker of tissue hypoxia., 2-Synthesis of b-azomycin nucleosides: 1-(b-D-2-iodo-2-deoxyarabinofuranosyl)-2-nitroimidazole, a novel marker of tissue hypoxia
Supervisor:Professor Leonard Wiebe
2.
Nuclear Pharmacy, TUMS/University of Alberta (Sandwich Program), Tehran/Edmonton, Iran/Canada, 1995-1999
Thesis Title:Tumor Imaging Agents: 1-Synthesis of tissue hypoxia Markers, 2- Radioiodination of antibodies
Ph.D
Nuclear Pharmacy, TUMS/University of Alberta (Sandwich Program), Tehran/Edmonton, Iran/Canada, 1995-1999
Thesis Title:Tumor Imaging Agents: 1-Synthesis of tissue hypoxia Markers, 2- Radioiodination of antibodies
3.
Doctor of Pharmacy , Tehran University of Medical Sciences, Tehran, Iran, 1989-1995
Thesis Title:Comparative bioavailability of two tablet formulations of dipyridamole in healthy male volunteers
Pharm D
Doctor of Pharmacy , Tehran University of Medical Sciences, Tehran, Iran, 1989-1995
Thesis Title:Comparative bioavailability of two tablet formulations of dipyridamole in healthy male volunteers
1.
English
2.
Persian - Farsi
1.
2005,
Razi Award for the foundations advocating medical sciences researches, Razi International Festival of Medical Sciences in Research, Tehran, Iran
2005,
2.
2005,
ARS Maurice H. Cottle Award, 51st Annual Meeting of the American Rhinologic Society, Los Angeles, California, USA
2005,
3.
2003,
Avicenna Award (Tehran University of Medical Sciences) for the young researcher, Tehran, Iran
2003,
4.
2003,
Razi Award for the young researcher in basic sciences, Razi International Festival of Medical Sciences in Research, Tehran, Iran
2003,
Scientific Position
1.
Research Center for Nuclear Medicine, Faculty of Medicine, Tehran University of Medical Sciences, Since 2012
Professor of Nuclear Pharmacy
Research Center for Nuclear Medicine, Faculty of Medicine, Tehran University of Medical Sciences, Since 2012
2.
Research Center for Nuclear Medicine, Faculty of Medicine, Tehran University of Medical Sciences, 2006-2011
Associate Professor of Nuclear Pharmacy
Research Center for Nuclear Medicine, Faculty of Medicine, Tehran University of Medical Sciences, 2006-2011
3.
Research Center for Nuclear Medicine, Faculty of Medicine, Tehran University of Medical Sciences, 2000-2005
Assistant Professor of Nuclear Pharmacy
Research Center for Nuclear Medicine, Faculty of Medicine, Tehran University of Medical Sciences, 2000-2005
Executive Position
1.
Department of Nuclear Medicine, Faculty of Medicine, Tehran University of Medical Sciences, 2001-2019
Deputy for Research
Department of Nuclear Medicine, Faculty of Medicine, Tehran University of Medical Sciences, 2001-2019
2.
Research Center for Nuclear Medicine, Tehran University of Medical Sciences, 2001-up to now
Co-Founder and Deputy President
Research Center for Nuclear Medicine, Tehran University of Medical Sciences, 2001-up to now
1.
Sabzevar University of Medical Sciences, Sabzevar, Iran, 15 May 2022, Learner
Advanced Search Techniques in Databases
Sabzevar University of Medical Sciences, Sabzevar, Iran, 15 May 2022, Learner
2.
Virtual University of Medical Sciences, Iran, 28 August 2021, Learner
Assessment and Evaluation in Medical Sciences
Virtual University of Medical Sciences, Iran, 28 August 2021, Learner
3.
Medical Ethics and History of Research Center, Tehran University of Medical Sciences, Tehran, Iran, 6 March 2021, Learner
Retraction
Medical Ethics and History of Research Center, Tehran University of Medical Sciences, Tehran, Iran, 6 March 2021, Learner
4.
Tehran University of Medical Sciences, Tehran, Iran, 22 February 2020, Learner
Regulations and Ethical Considerations in Animal Experiments
Tehran University of Medical Sciences, Tehran, Iran, 22 February 2020, Learner
5.
Education Development Center, TUMS, Tehran, Iran, 13 August 2020, Learner
Principles of teaching
Education Development Center, TUMS, Tehran, Iran, 13 August 2020, Learner
6.
Education Development Center, TUMS, Tehran, Iran, 26 August 2020, Learner
Student Evaluation and Online Assessment
Education Development Center, TUMS, Tehran, Iran, 26 August 2020, Learner
7.
Education Development Center, TUMS, Tehran, Iran, 7-8 July 2020, Learner
The Design and Implementation of Multiple Choice Questions (MCQs)
Education Development Center, TUMS, Tehran, Iran, 7-8 July 2020, Learner
8.
Virtual School, TUMS, Iran, 8 March 2017, Learner
Introduction to Research Ethics
Virtual School, TUMS, Iran, 8 March 2017, Learner
9.
Wolters Kluwer, Tehran, Iran, 16 November 2015, Learner
OvidSP Platform
Wolters Kluwer, Tehran, Iran, 16 November 2015, Learner
10.
Kowsar Academy, Tehran, Iran, 27 November 2014, Learner
Plagiarism Workshop
Kowsar Academy, Tehran, Iran, 27 November 2014, Learner
11.
Merck Serono Company, The Middle East and Near East Region, 19 December 2013, Learner
Clinical Research and Drug Safety
Merck Serono Company, The Middle East and Near East Region, 19 December 2013, Learner
12.
Iranian Blood Transfusion Organization, 31 October 2013, Learner
Workshop for Blood and Blood Component Handeling & Haemovigilance System
Iranian Blood Transfusion Organization, 31 October 2013, Learner
13.
Eczacibaci/Monrol Company, Turkey, 19-23 November 2012, Learner
Basic cGMP and Quality Control of 18F-FDG
Eczacibaci/Monrol Company, Turkey, 19-23 November 2012, Learner
14.
The Ministry of Health and Medical Education, Iran, 16 August 2012, Learner
Requirements for Board Exam forTeachers
The Ministry of Health and Medical Education, Iran, 16 August 2012, Learner
15.
The Ministry of Health and Medical Education, Iran, 1 February 2011, Learner
Workshop for Implementation of Relative Value of Health Services
The Ministry of Health and Medical Education, Iran, 1 February 2011, Learner
16.
Tehran University of Medical Sciences, Tehran, Iran, 16 January 2011, Learner
Open Journal Systems (OJS) - Workshop
Tehran University of Medical Sciences, Tehran, Iran, 16 January 2011, Learner
17.
Tehran University of Medical Sciences, Tehran, Iran, June 2007, 13 Lecturer
The Methods of Standard Setting
Tehran University of Medical Sciences, Tehran, Iran, June 2007, 13 Lecturer
18.
Tehran University of Medical Sciences, Tehran, Iran, 13 December 2006, Learner
Knowledge Translation & Utilization of Research Results
Tehran University of Medical Sciences, Tehran, Iran, 13 December 2006, Learner
19.
Faculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran, 30-31 May 2006, Learner
SPSS Software
Faculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran, 30-31 May 2006, Learner
20.
Tehran University of Medical Sciences, Tehran, Iran, 5 May 2006 , Learner
Exam Evaluating and Questions Preparation
Tehran University of Medical Sciences, Tehran, Iran, 5 May 2006 , Learner
21.
Atomic Energy Organization of Iran , Tehran, Iran, 11-15 March 2006, Learner
Radiopharmaceuticals Quality Control
Atomic Energy Organization of Iran , Tehran, Iran, 11-15 March 2006, Learner
22.
Faculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran, 22-23 December 2005, Learner
EndNote Software
Faculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran, 22-23 December 2005, Learner
23.
Faculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran, 18-20 September 2005, Learner
Reference Manager Software
Faculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran, 18-20 September 2005, Learner
24.
Faculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran, 23 February 2005, Learner
Scientific writing
Faculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran, 23 February 2005, Learner
25.
Institute of Public Health Researches, Tehran University of Medical Sciences, Tehran, Iran, 18-25 October, 2000, Learner
Research Methodology
Institute of Public Health Researches, Tehran University of Medical Sciences, Tehran, Iran, 18-25 October, 2000, Learner
26.
Radiation Control Committee, University of Alberta, Canada, 3-8 February 2000, Learner
Radiation Safety Course
Radiation Control Committee, University of Alberta, Canada, 3-8 February 2000, Learner
1.
Status: Completed, 2022
Evaluation of metabolically active non-abdominopelvic lymphadenopathy in FDG-PET/CT scan in patients with colorectal cancer
Status: Completed, 2022
2.
Status: Completed, 2022
Clinical benefit and quality of life assessment in patients with refractory thyroid cancer treated with sorafenib. A cohort study
Status: Completed, 2022
3.
Status: Completed, 2021
frequency of FDG avid thyroid nodules and comparison with cytohystopathologic findings in patients without known thyroid malignancy
Status: Completed, 2021
4.
Status: Completed, 2021
Comparative evaluation of 68Ga-PSMA PET/CT and 99mTc-PSMA SPECT/CT modalities in detection of tumoral lesions in patients with Castrate-resistant metastatic prostate cancer
Status: Completed, 2021
5.
Status: Completed, 2020
Diagnostic evaluation of active lesions by 68Ga-PSMA ligand PET/CT in patients with prostate cancer
Status: Completed, 2020
6.
Status: Completed, 2020
Biological evaluation and preclinical study of a 68Ga-labeled cyclic RGD peptide as an early diagnostic agent for overexpressed αvβ3 integrin receptors in non-small cell lung cancer
Status: Completed, 2020
7.
Status: Completed, 2019
Evaluation of FDG uptake in fatty liver in PET-CT scan and its impact on diagnostic acuracy of extrahepatic tumors assesment
Status: Completed, 2019
8.
Status: Completed, 2019
Synthesis, quality control and biodistribution study of radiolabeled somatostatin receptor antagonist for treatment of neuroendocrine tumors expressing the somatostatin receptor (SSTR)
Status: Completed, 2019
9.
Status: Completed, 2019
Synthesis, quality control and biodistribution study of 99mTc-labeled hexapeptide derivative in order to molecular imaging and diagnosis of β-amyloid plaques in Alzheimer’s disease
Status: Completed, 2019
10.
Status: Completed, 2019
Comparison of 68Ga-DOTATATE PET/CT, 99mTc-octreoscan SPECT/CT and CT-scan/MR imaging in the detection of tumoral lesions in neuroendocrine tumors
Status: Completed, 2019
11.
Status: Completed, 2019
Synthesis of anti-cancerous thiosemi- and semi-Cabazon ligands, radiolabeling with Ga-67, 68 and in-vivo evaluation in animal models
Status: Completed, 2019
12.
Status: Completed, 2018
Evaluating the correlation between myocardial perfusion deficit and types of anticonvulsant drugs in epileptic patients
Status: Completed, 2018
13.
Status: Completed, 2018
Preparation and optimizing recombinant complement receptor 2 to be labeled with radioisotope for ischemia reperfusion injury scintigraphy
Status: Completed, 2018
14.
Status: Completed, 2018
Preparation, quality control and biodistribution study of radiolabelled Bombesin nanoparticles for In Vivo Gastrin Releasing Peptide-Receptor Imaging
Status: Completed, 2018
15.
Status: Completed, 2017
Design, synthesis, radiolabeling and biological evaluation of a new peptide as PSMA imaging agent in prostate cancer
Status: Completed, 2017
16.
Status: Completed, 2017
Synthesis, radiolabeling, quality control and biological evaluation of LIKKPF peptide and its analogs with 18F-FDG for in vivo imaging of apoptosis
Status: Completed, 2017
17.
Status: Completed, 2017
Evaluation of 99mTc-alpha MSH in the diagnosis of primary and metastatic melanoma
Status: Completed, 2017
18.
Status: Completed, 2016
Comparison of sensitivity and specificity of Tc-99m somatostatin analogs (octreotide) and I-131 MIBG scintigraphies in diagnosis and localization of pheochromocytoma and neuroblastoma
Status: Completed, 2016
19.
Status: Completed, 2016
Assessment of lower limbs perfusion with 99mTc-MIBI in patients with intermediate pretest probability of coronary artery disease referred for myocardial perfusion imaging
Status: Completed, 2016
20.
Status: Completed, 2016
Efficacy of adding bone-seeking radiopharmaceuticals (samarium-153 or strantium-89)on local radiation in metstatic bone involvement
Status: Completed, 2016
21.
Status: Completed, 2015
Evaluation of post-thyroidectomy preablative thyroglobulin and anti-thyroglobulin level relation with radioiodine therapy response in patients with differentiated thyroid cancer
Status: Completed, 2015
22.
Status: Completed, 2015
Evaluation of 99mTc-TRODAT-1 SPECT in the diagnosis of Parkinson’s disease and its differentiation from other types of parkinsonism syndroms
Status: Completed, 2015
23.
Status: Completed, 2015
Assesseing the role of post-stress stunning in the diagnosis and risk stratification of patients with suspected CAD by gated SPECT MPI
Status: Completed, 2015
24.
Status: Completed, 2014
Synthesis, quality control and biodistribution study of 99mTc-labeled α-MSH derivative for diagnosis of melanoma
Status: Completed, 2014
25.
Status: Completed, 2013
The relationship between nephropathy in diabetes mellitus type 2 and severity and extent of myocardial ischemia and myocardial dysfunction
Status: Completed, 2013
26.
Status: Completed, 2013
The sensitivity and normalcy rate of myocardial perfusion scan using SPECT vs. SPECT-CT for the diagnosis of ischemic heart disease
Status: Completed, 2013
27.
Status: Completed, 2012
Evaluation of the quality of life in patients with differentiated thyroid carcinoma treated with radioiodine-131 in Dr. Sahriati hospital
Status: Completed, 2012
28.
Status: Completed, 2012
Evaluation of post-thyroidectomy preablative thyroglobulin and anti-thyroglobulin level relation with radioiodine therapy response in patients with differentiated thyroid cancer
Status: Completed, 2012
29.
Status: Completed, 2012
Radiolabeling, quality control and biological evaluation of non-peptide CRCR4 antagonists for targeted diagnosis and therapy of malignancies
Status: Completed, 2012
30.
Status: Completed, 2011
Comparison of radiosynovectomy efficacy with Re 188 sulfur colloid and Y-90 colloid in patient with chronic inflammatory knee joint disease
Status: Completed, 2011
31.
Status: Completed, 2011
The evaluation of Re-HEDP efficacy in metastatic bone pain pallation therapy
Status: Completed, 2011
32.
Status: Completed, 2011
Evaluation of 99mTc-bombesin in the diagnosis of breast cancer and its differentiation from benign lesions
Status: Completed, 2011
33.
Status: Completed, 2010
Compensation for collimator-detector blurring for brain SPECT resolution enhancement
Status: Completed, 2010
34.
Status: Completed, 2010
Salivary gland function evaluation after radioiodine therapy with doses equal or less than 100 mCi for either thyroid cancer or hyperthyroid state
Status: Completed, 2010
35.
Status: Completed, 2010
Cardiac perfusion changes in patients treated for breast cancer with radiation therapy
Status: Completed, 2010
36.
Status: Completed, 2010
Synthesis, quality control and biodistribution study of some 99mTc-labeled substance P derivatives for diagnosis of nerokinin receptor (NKr) expressing tumors
Status: Completed, 2010
37.
Status: Completed, 2009
The image quality and myocardial to visceral uptake ratio in myocardial perfusion scan using pharmacological stress with sub-maximal exercise in comparison with pharmacological stress alone.
Status: Completed, 2009
38.
Status: Completed, 2009
Evaluation of myocardial perfusion scintigraphy with Tc-99m sestamibi by ECG Gated SPECT method in determining one year prognosis of patients suspicious for coronary artery disease
Status: Completed, 2009
39.
Status: Completed, 2009
Evaluation of abormal findings in myocardial perfusion scan of asymptomatic diabetic patients
Status: Completed, 2009
40.
Status: Completed, 2009
Evaluation of Tc-99m Ubiquicidine in specific diagnosis of infection and differentiate it from noninfectional inflammations in diabetic patients foot ulcers
Status: Completed, 2009
41.
Status: Completed, 2009
Evaluation of Tc-99m Ubiquicidine in specific diagnosis of infection and differentiate it from noninfectional inflammations in orthopaedic infection
Status: Completed, 2009
42.
Status: Completed, 2009
Evaluation of different factors related to the patient or procedural techniques inducing reverse perfusion pattern in myocardial perfusion scan with Tc 99m MIBI
Status: Completed, 2009
43.
Status: Completed, 2008
Evaluation of the efficacy and complications of 153Sm-EDTMP in palliative therapy of multiple bone metastases
Status: Completed, 2008
44.
Status: Completed, 2007
Evaluation of short-term efficacy of I-131 re-treatment in patients with differentiated thyroid cancer who have undetectable stimulated serum Tg levels and positive whole body scan in thyroid bed after initial ablative therapy
Status: Completed, 2007
45.
Status: Completed, 2007
The value of myocardial perfusion and function assessment with 99mTc-MIBI Gated SPECT before and after low dose dobutamine in prediction of the perfusion and function improvement after revascularization
Status: Completed, 2007
46.
Status: Completed, 2007
Evaluation of the correlation between serum creatinin and GFR in acute renal necrosis in comparison with other causes of acute renal failure
Status: Completed, 2007
47.
Status: Completed, 2007
Evaluation of nasolacrimal duct obstruction associated with radioactive iodine therapy for thyroid carcinoma
Status: Completed, 2007
48.
Status: Completed, 2007
Evaluation of the effect of low dose dobutamine infusion on 99mTc-MIBI redistribution in patients with coronary artery disease using SPECT gamma camera
Status: Completed, 2007
49.
Status: Completed, 2007
Evaluation of protective effects of Hesperidin against genetic damage induced by 99mTechnetium-MIBI in human peripheral blood lymphocytes
Status: Completed, 2007
50.
Status: Completed, 2006
Evaluation of effectiveness of Vit E and Bethanechol for prevention of salivary gland dysfunction in thyroid cancer patients candidated for radioiodine therapy
Status: Completed, 2006
51.
Status: Completed, 2006
Evaluation of the effect of discontinuing beta-blocker drugs on dipyridamole myocardial perfusion imaging (DMPI) in patients who were on long-term beta-blocker therapy
Status: Completed, 2006
52.
Status: Completed, 2006
Agreement of two methods of planar and SPECT scintigraphy with Tc-99m RBC in detection of liver hemangioma
Status: Completed, 2006
53.
Status: Completed, 2006
Evaluation of diagnostic value of single injection-double acquisition gated SPECT imaging with low dose dobutamine-enhancement in comparison with conventional myocardial perfusion scan with 99m Tc-MIBI for diagnosis of myocardial perfusion abnormalities
Status: Completed, 2006
54.
Status: Completed, 2005
Comparison of myocardial perfusion between chemical warefare victims and normal individuals by SPECT
Status: Completed, 2005
55.
Status: Completed, 2005
The prevalence of increased gastric wall radiotracer uptake in Sestamibi myocardial perfusion SPECT and its association with symptoms of dyspepsia
Status: Completed, 2005
56.
Status: Completed, 2004
Assessment of different filters for reconstruction of the images in myocardial SPECT based upon image contrast and diagnostic value of scan for diagnosis of coronary artery disease
Status: Completed, 2004
57.
Status: Completed, 2004
ٍEvaluation of therapeutic efficacy of treatment with olanzapine and halopridol on regional cerebral blood flow messured by SPECT in patients with schizophrenia; correlating with the response to treatment
Status: Completed, 2004
58.
Status: Completed, 2004
Efficacy of 99mTc-Phytate for pre and intraoperative sentinel lymph node detection in the breast cancer
Status: Completed, 2004
59.
Status: Completed, 2004
Nuclear medicine cardiac SPECT and its denoising by Platelet-based Maximum Penalaized Likelihood Estimation (MPLE) method
Status: Completed, 2004
60.
Status: Completed, 2004
Value of Tc99m-MIBI scintigraphy in the diagnosis of multiple drug resistance in multiple myeloma patients
Status: Completed, 2004
61.
Status: Completed, 2004
Evaluation of diagnostic accuracy of myocardial perfusion scans with different patterns of interpretation in identification of coronary artery disease among patients with left bundle branch block
Status: Completed, 2004
62.
Status: Completed, 2004
Evaluation of the diagnostic accuracy of sentinel node biopsy (SLN) in staging of breast cancer with Lymph node dissection under guiding of scintigraphic probe using 99mTc-Sb2S2
Status: Completed, 2004
63.
Status: Completed, 2004
Bone SPECT value for differentiating malignant from benign lesions of vertebral column in patients with known primary malignancy
Status: Completed, 2004
64.
Status: Completed, 2004
Evaluation of relative occurrence of mother and fetus complications in women with differentiated thyroid carcinoma treated with radioactive iodine
Status: Completed, 2004
65.
Status: Completed, 2004
Myocardial perfusion scan role in evaluating Percutaneous Transluminal Coronary Angioplasty (PTCA) in patients with coronary artery disease
Status: Completed, 2004
66.
Status: Completed, 2003
Preparation of patients with thyroid cancer for I131 scintigraphy or therapy by 1-3 weeks of levothyroxine discontinuation or after total thyroidectomy
Status: Completed, 2003
67.
Status: Completed, 2003
Study of treatment of thyroid carcinoma using low 131I<1110MBq in comparison with that of routinly used high activity 131-I>3660MBq
Status: Completed, 2003
68.
Status: Completed, 2003
A Comparative study between Tc-EC 99m and 99m-TcMAG3 in evaluation of renal function in patients
Status: Completed, 2003
69.
Status: Completed, 2003
Evaluation of dacryoscintigraphy in the diagnosis of lacrimal apparatus obstruction
Status: Completed, 2003
70.
Status: Completed, 2003
Evaluation of the diagnostic value of erythrocyte sedimentation rate (ESR) and absolute neutrophil count in detection of pyelonephritis (based on the DMSA scan findings) in children with first time urinary tract infections
Status: Completed, 2003
71.
Status: Completed, 2003
Assessment of treatment requirement in patient with differentiated thyroid cancer and undetectable serum thyroglobulin and positive 131-I whole body scan only in thyroid bed
Status: Completed, 2003
Advisor/Consulter
1.
Post-treatment effect of levothyroxine on bone mineral density in patients with well-differentiated thyroid carcinoma
Mustafa Ahmed Al-Thabhawee,
MD, Nuclear Medicine Specialty, 2023 2.
A comparison of early imaging with traditional 68Ga-PSMA PET/CT imaging, for the diagnosis of local lymph node metastases and prostatic lesions based on delayed imaging after hydration and diuresis
Bahare Saidi,
MD, Nuclear Medicine Specialty, 2023 3.
Clinical benefit and quality of life assessment in radio-iodine refractory differentiated thyroid cancer patients receiving Sorafenib; A retrospective cohort study
Khatere Moharrami,
MD, Nuclear Medicine Specialty, 2022 4.
Preparation and biological and preclinical evaluation of hallow microcapsuls loaded by labeled doxorubicin with a positron emitter radioisotope and internal dosimetry calculations using Monte Carlo and MIRD
Samir Heidari,
Ph.D, Medical Physics, 2022 5.
Synthesis, quality control and biological evaluation of Gd-doped -silica-coated gold nanoclusters conjugated with aptamer AS1411 and rdiolabeled by 64Cu and 68Ga for multi modal imaging techniques of cancer tissue.
Atena Najdian,
Ph.D, Radiopharmacy, 2022 6.
Evaluation of metabolically active non-abdominopelvic lymphadenopathy in FDG-PET/CT scan in patients with colorectal cancer
Mahboobeh Ramezani,
MD, Nuclear Medicine Specialty, 2021 7.
frequency of FDG avid thyroid nodules and comparison with cytohystopathologic findings in patients without known thyroid malignancy
Nasibeh Mohseninia,
MD, Nuclear Medicine Specialty, 2021 8.
The role of whole body scan with technetium pertechnetate in the evaluation of thyroid remnant and metastasi the patients with differentiated thyroid carcinoma who underwent thyroidectomy
Sara Seyedinia,
MD, Nuclear Medicine Specialty, 2021 9.
Comparative evaluation of 68Ga-PSMA PET/CT and 99mTc-PSMA SPECT/CT modalities in detection of tumoral lesions in patients with Castrate-resistant metastatic prostate cancer
Niloufar Khademi,
MD, Nuclear Medicine Specialty, 2021 10.
Diagnostic evaluation of active lesions by 68Ga-PSMA ligand PET/CT in patients with prostate cancer
Sara Harsini,
MD, Nuclear Medicine Specialty, 2021 11.
Evaluation of octreoscan diagnostic precison in differentiated thyroid cancer patients with elevated thyroglobulin levels and negative I-131 whole body scans
Mahban Bastami,
MD, Nuclear Medicine Specialty, 2021 12.
Comparison of the 123I-SPECT / CT diagnostic value in patients with thyroid cancer after 131I therapy .demonstrating high follow up serum thyroglobulin levels
Aida Mohammadalipour,
MD, Nuclear Medicine Specialty, 2021 13.
Synthesis, quality control and biodistribution study of 99mTc-labeled hexapeptide derivative in order to molecular imaging and diagnosis of β-amyloid plaques in Alzheimer’s disease
Safura Jokar,
Ph.D, Radiopharmacy, 2021 14.
Determination of Diagnostic Agreement of Clinical Criterias in Evaluation of Takayasu's Arteritis Activity with FDGPET / CT Scan
Najmeh Karamzadeh,
MD, Nuclear Medicine Specialty, 2020 15.
Comparison of clinical interpretation with voxel based quantitative analysis in brain perfusion SPECT imaging for the evaluation of single-drug versus multi-drug treatment of patients with long term schizophrenia
Elnaz Jenabi,
MD, Nuclear Medicine Specialty, 2020 16.
Determining the effect of TSH stimulation on the detection of tumor lesions by FDG-PET / CT in patients with Differentiated Thyroid Carcinoma with Whole Body I-131 negative and increased Tg scan and comparison with patients without TSH stimulation
Fariba Ghorbani,
MD, Nuclear Medicine Specialty, 2020 17.
Molecular docking study, synthesis, radiolabeling and biological assessment of a novel integrin targeted peptide for lung tumor imaging and therapy
Nayanin Pirooynia,
Ph.D, Radiopharmacy, 2020 18.
Synthesis, quality control and biodistribution study of radiolabeled somatostatin receptor antagonist for treatment of neuroendocrine tumors expressing the somatostatin receptor (SSTR)
Hossein Behnammanesh,
Ph.D, Radiopharmacy, 2019 19.
Evaluation of FDG uptake in fatty liver in PET-CT scan and its impact on diagnostic acuracy of extrahepatic tumor assessment
Yeganeh Rahmani,
MD, Nuclear Medicine Specialty, 2019 20.
Evaluation of troDAT-scan in differentiation of lewy body dementia and alzheimer disease
Farzaneh Baseri,
MD, Nuclear Medicine Specialty, 2019 21.
Evaluation and comparison of 131I-MIBG and 68Ga-DOTATATE PET in patients with neuroendocrine tumors including neuroblastoma and pheochromocytoma
Pezhman Shahrokhi,
MD, Nuclear Medicine Specialty, 2019 22.
Preparation of radiolabeled bombesin nanoparticles for in vivo gastrin-Releasing peptide receptor imaging
Maliheh Hajiramezanali,
Ph.D, Radiopharmacy, 2019 23.
Atherogenic consequence of antiepileptic drugs: a study of myocardial perfusion with myocardial perfusion imaging
Zeinab Paymani,
MD, Nuclear Medicine Specialty, 2019 24.
Diagnostic efficiency of 68Ga-DOTATATE PET/CT as compared to conventional 99mTc-Octreotide SPECT/CT and morphologic modalities
Reyhaneh Manafi-Farid,
MD, Nuclear Medicine Specialty, 2019 25.
Synthesis of iron oxide PAMAM dendrimer coated nanoparticles, 68Ga radiolabeling, quality control and its biodistribution in normal and fibrosarcoma bearing rats and evaluating the images by PET-CT
Tinoosh Almasi,
Ph.D, Medical Physics, 2019 26.
Design, synthesis, radiolabeling and biological evaluation of a new peptide as PSMA imaging agent in prostate cancer
Mona Mosayebnia,
Ph.D, Radiopharmacy, 2018 27.
The value of 99mTc-α-MSH in diagnosis of primary and metastatic lesions of malignant melanoma
Rahman Etemadi,
MD, Nuclear Medicine Specialty, 2018 28.
Evaluation of relationship between 18F-FDG PET/CT findings in vertebral/hip bones and bone mineral density
Hamidreza Amini,
MD, Nuclear Medicine Specialty, 2018 29.
Comparison of radionuclide ventriculography using SPECT and planar techniques to evaluate LVEF in breast cancer patients during treatment with Trastuzumab
Hajar Alebooye,
MD, Nuclear Medicine Specialty, 2018 30.
Assessment of relationship between tumor markers level and FDG-PET/CT scan findings in colorectal carcinoma patients
Ali Kafshgar,
MD, Nuclear Medicine Specialty, 2017 31.
Assessment of correlation between gastric FDG uptake and 14C-UBT results
Fatemeh Farsyabi,
MD, Nuclear Medicine Specialty, 2017 32.
Assessment of relationship between thyroglobulin and thyroglobulin antibody levels and FDG-PET/CT scan findings in differentiated thyroid cancer patients
Hila Aghaei,
MD, Nuclear Medicine Specialty, 2017 33.
Assessment of lower limbs perfusion with 99mTc-MIBI in patients with intermediate pretest probability of coronary artery disease referred for myocardial perfusion imaging
Sanaz Katal,
MD, Nuclear Medicine Specialty, 2016 34.
Efficacy of adding bone-seeking radiopharmaceuticals (samarium-153 or strantium-89)on local radiation in metastatic bone involvement
Saeed Davoodian,
MD, Radiation Oncology Specialty, 2016 35.
Evaluation of delayed cardiac perfusion changes in patients with breast cancer treated by radiotherapy
Forough Kalantari,
MD, Nuclear Medicine Specialty, 2016 36.
Comparison of sensitivity and specificity of Tc-99m somatostatin analogs (octreotide) and I-131 MIBG scintigraphies in diagnosis and localization of pheochromocytoma and neuroblastoma
Arefeh Mirzabeigi,
MD, Nuclear Medicine Specialty, 2016 37.
Evaluation of correlative factors and patterns of FDG myocardial uptake in the patient's with malignancy
Bahar Mossess Ghafari,
MD, Nuclear Medicine Specialty, 2016 38.
Synthesis, radiolabeling, quality control and biological evaluation of LIKKPF peptide and its analogs with 18F-FDG for in vivo imaging of apoptosis
Sepideh Khoshbakht,
Ph.D, Radiopharmacy, 2016 39.
Evaluation of post-thyroidectomy preablative thyroglobulin and anti-thyroglobulin level relation with radioiodine therapy response in patients with differentiated thyroid cancer
Mohammad Reza Valipouri,
MD, Nuclear Medicine Specialty, 2015 40.
Novel combined agents for palliative treatment of bone pain
Hasan Ranjbar,
Ph.D, Physics- Medical Radiation, 2015 41.
Synthesis, quality control and biodistribution study of 99mTc-labeled α-MSH derivative for diagnosis of melanoma
Danial Shamshirian,
Ph.D, Radiopharmacy, 2015 42.
Assessment of post stress stunning in diagnosis and classification of patients with suspected CAD
Asghar Akbari,
MD, Nuclear Medicine Specialty, 2015 43.
Assessment of prognosis and prognostic factors in patients with lymph node involvement from differentiated thyroid carcinoma origin
Mehraneh Mostafavi,
MD, Nuclear Medicine Specialty, 2015 44.
Comparative evaluation of prognosis in patients with differentiated thyroid cancer based on elevated tg (>2ng/dl) and whole body scan findings after ablative therapy
Negar Ahmadpour,
MD, Nuclear Medicine Specialty, 2015 45.
Evaluation of prognosis and factors effective of pediatric patients(<18yr)with differentiated thyroid carcinoma
Masoomeh Havasi,
MD, Nuclear Medicine Specialty, 2015 46.
Evaluation of 99mTc-TRODAT-1 SPECT in the diagnosis of Parkinson’s disease and its differentiation from other types of parkinsonism syndroms
Atefeh Esmaeili,
MD, Nuclear Medicine Specialty, 2015 47.
Regulations and policies concerning the manufacture, preparation, importation, exportation, transportation and waste management of radiopharmaceuticals
Hesam Alibakhshi,
M.Sc, Pharmaceutical regulatory affairs/quality assurance, 2015 48.
Radiolabeling, quality control and biological evaluation of the AMD3100 as non-peptide CXCR4 antagonist for targeted diagnosis of related human malignancies and optimization of its synthesis
Ayuob Aghanejad,
Ph.D, Radiopharmacy, 2015 49.
Preparation and quality control of radio-labeled Porphyrin derivatives with radiolanthanides for therapeutic purposes
Nasim Vahidfar,
Ph.D, Radiopharmacy, 2014 50.
Evaluation of relationship between nephropathy and severity/extent of cardiac ischemia in type 2 diabetic patients by myocardial perfusion scan
Niloofar Tavakoli,
MD, Nuclear Medicine Speciality, 2014 51.
Evaluation of short-term efficacy of I-131 re-treatment in patients with differentiated thyroid cancer who have undetectable stimulated serum Tg levels and positive whole body scan in thyroid bed after initial ablative therapy
Somayeh Sahari,
MD, Nuclear Medicine Speciality, 2014 52.
Assessment of related factors in patients with CAD and mild to sever LV dysfunction by phase analysis of gated-SPECT myocardial perfusion imaging
Afsaneh Khorami,
MD, Nuclear Medicine Speciality, 2014 53.
Radiolabeling, quality control and biological evaluation of the AMD3100 as non-peptide CXCR4 antagonist for targeted diagnosis of related human malignancies and optimization of its synthesis
Ayoub Aghanezhad,
Ph.D, Radiopharmacy, 2014 54.
Production of a new peptide analog of neurotensin and lebeling it with 99mTc for detection of NT1 positive receptors
Nakisa Zarrabi,
Ph.D, Cell and Molecular Biology, 2013 55.
In vitro screening of new Triazol and Oxadiazole derivatives as benzodiazepine receptor agonists, using radioligand receptor binding assays
Fatemeh Ahmadi,
Ph.D, Radiopharmacy, 2013 56.
Evaluation of the sensitivity and normalcy rate of myocardial perfusion scan using SPECT vs. SPECT-CT for the diagnosis of ischemic heart disease
Arman Hasanzadeh,
MD, Nuclear Medicine Speciality, 2013 57.
The evaluation of Re-HEDP efficacy in metastatic bone pain pallation therapy
Maryam Tajik,
MD, Nuclear Medicine Speciality, 2012 58.
Cardiac perfusion changes in patients treated for breast cancer with radiation therapy
Hanieh Zamani,
MD, Nuclear Medicine Speciality, 2012 59.
Evaluation of the quality of life in patients with differentiated thyroid carcinoma treated with radioiodine-131
Seyed Kazem Razavi,
MD, Nuclear Medicine Speciality, 2012 60.
Synthesis, quality control and biodistribution study of some 99mTc-labeled substance P derivatives for diagnosis of nerokinin receptor (NKr) expressing tumors
Saeed Mozafari,
Ph.D, Radiopharmacy, 2012 61.
Evaluation of different factors related to the patient or procedural techniques inducing reverse perfusion pattern in myocardial perfusion scan with Tc 99m MIBI
Yalda salehi,
MD, Nuclear Medicine Speciality, 2011 62.
Protective effects of hesperidin against genotoxicity induced by 99mTc-MIBI in human cultured lymphocyte cells
Amirhossein Ahmadi,
Pharm D, Pharmacy, 2010 63.
Evaluation of the effect of concurrent submaximal exercise and pharmacologic stress on subdiaphragmatic activities in myocardial perfusion scan
Farahnaz Aghahosseini,
MD, Nuclear Medicine Speciality, 2010 64.
Salivary gland function evaluation after radioiodine therapy with doses equal or less than 100 mCi for either thyroid cancer or hyperthyroid state
Mohammad Karimi,
MD, Nuclear Medicine Speciality, 2010 65.
Evaluation of the effect of low dose dobutamine infusion on 99mTc-MIBI redistribution in patients with coronary artery disease using SPECT gamma camera
Zhila Mohseni,
Ph.D, Radiopharmacy, 2010 66.
Comparing the diagnostic sensitivity and specificity of cardiac perfusion imaging with 99mTc-MIBI in five defined protocols
Mahdi Haghighatafshar,
MD, Nuclear Medicine Speciality, 2010 67.
99mTc-Ubiquicidin [29–41], a Promising Radiopharmaceutical to Differentiate Orthopedic Implant Infections from Sterile Inflammation
Gholamali Yousefi,
MD, Nuclear Medicine Speciality, 2009 68.
Evaluation of 99mTc-Ubiquicidin 29–41 Scintigraphy in Differentiation of Bacterial Infection from Sterile Inflammation in Diabetic Foot
Mohammadreza Gharaei,
MD, Nuclear Medicine Speciality, 2009 69.
Evaluation of the efficacy and complications of 153Sm-EDTMP in palliative therapy of multiple bone metastases
Arash Keivan,
MD, Nuclear Medicine Speciality, 2009 70.
Evaluation of effectiveness of Vit E and Bethanechol for prevention of salivary gland dysfunction in thyroid cancer patients candidated for radioiodine therapy
Seyed Mohammad Abedi,
MD, Nuclear Medicine Speciality, 2008 71.
Evaluation of the correlation between serum creatinin and GFR in acute renal necrosis in comparison with other causes of acute renal failure
Alireza Emami-Ardekani,
MD, Nuclear Medicine Speciality, 2008 72.
Evaluation of nasolacrimal duct obstruction associated with radioactive iodine therapy for thyroid carcinoma
Saeed Farzanefar,
MD, Nuclear Medicine Speciality, 2008 73.
The value of myocardial perfusion and function assessment with 99mTc-MIBI Gated SPECT before and after low dose dobutamine in prediction of the perfusion and function improvement after revascularization
Morteza Bostani,
MD, Nuclear Medicine Speciality, 2008 74.
Evaluation of the clinical and laboratory findings in predicting of acute renal lesions by 99mTc-DMSA scan in children with first urinary tract infection
Amir Gholami,
MD, Nuclear Medicine Speciality, 2007 75.
Evaluation of scintigraphic patterns of bone metastases in patients with different types of cancers
MohammadBagher Khodaparast,
MD, Medical Doctor, 2007 76.
Evaluation of dacroscintigraphy in the diagnosis of lacrimal apparatus obstruction
Ali Gholamrezanezhad,
MD, Nuclear Medicine Speciality, 2006 77.
Evaluation of I-131 treatment in patients with differentiated thyroid cancer who have high levels of serum Anti-Tg and normal whole body scan
Mozhgan NazarAhari,
MD, Nuclear Medicine Speciality, 2006 78.
Evaluation of patients with differentiated thyroid cancer with elevated Anti-Tg level and its correlation with serum TG level and whole body scan with I-131
Sahar Mirpour,
MD, Nuclear Medicine Speciality, 2006 79.
Evaluation of adioiodine treatment complications to the mother and child in patients with differentiated thyroid carcinoma
Mahsa Hadifar,
MD, Medical Doctor, 2006 80.
The value of sentinel lymph node biopsy detected by lymphoscintigraphy with 99mTc-phytate and Blue dye technique in predicting pathological status of axillary lymph nodes in patients with breast cancer
Mohsen Arabi,
MD, Nuclear Medicine Speciality, 2005 81.
The effect of high-dose radioiodine treatment on lacrimal gland function in patients with differentiated thyroid carcinoma
Hossein Mirshekarpour,
MD, Nuclear Medicine Speciality, 2004 82.
Determination of the best time for sample collection during the 14C-urea breath test for the diagnosis of helicobacter pylori infection
Mohammad Hossein Al-Seyed Hossein,
Pharm D, Pharmacy, 2003 English
1.
Authors: Jokar S, Khazaei S, Gameshgoli XE, Khafaji M, Yarani B, Sharifzadeh M, Beiki D, Bavi O
English, Publisher: Exon Publications, 2020, Original
Amyloid β-targeted inhibitory peptides for Alzheimer’s disease: Current state and future perspectives. In: Alzheimer's disease: Drug discovery.2020; 51-68
Authors: Jokar S, Khazaei S, Gameshgoli XE, Khafaji M, Yarani B, Sharifzadeh M, Beiki D, Bavi O
English, Publisher: Exon Publications, 2020, Original
Farsi
1.
Authors: Beiki D,
Farsi, Publisher: TUMS, 2007, Original
Quality Control of Radiopharmaceuticals. In: Textbook of Nuclear Pharmacy. 2007; 195-235
Authors: Beiki D,
Farsi, Publisher: TUMS, 2007, Original
Papers
English
1.
Authors: Fallahi B, Moharrami K, Beiki D, Fard-Esfahani A, Alimoghaddam K, Eftekhari M,
Iran J Nucl Med, Vol.31, No.1, Year. 2023, Page:42-48,
Download
Clinical benefit and quality of life during low-dose sorafenib maintenance therapy in radioiodine refractory differentiated thyroid cancer patients: A historical cohort study
Authors: Fallahi B, Moharrami K, Beiki D, Fard-Esfahani A, Alimoghaddam K, Eftekhari M,
Iran J Nucl Med, Vol.31, No.1, Year. 2023, Page:42-48,
Download
2.
Authors: Hassanzadeh-Rad A, Kavosi H, Karamzade-Ziarati N, Fallahi B, Jamshidi AR, Emami-Ardekani A, Beiki D, Eftekhari M,
Iran J Nucl Med, Vol.31, No.1, Year. 2023, Page:11-19,
Download
Diagnostic agreement between clinical criteria and disease activity in Takayasu’s arteritis by 2-[18F]FDG PET-CT scan
Authors: Hassanzadeh-Rad A, Kavosi H, Karamzade-Ziarati N, Fallahi B, Jamshidi AR, Emami-Ardekani A, Beiki D, Eftekhari M,
Iran J Nucl Med, Vol.31, No.1, Year. 2023, Page:11-19,
Download
3.
Authors: Najdian A, Amanlou M, Beiki D, Bitarafan-Rajabi A, Mirzaei M, Shafiee Ardestani M,
Bioorg Chem, Vol.125, Year. 2022, Page:105827,
Amino-modified-silica-coated gadolinium-copper nanoclusters, conjugated to AS1411 aptamer and radiolabeled with technetium-99 m as a novel multimodal imaging agent
Authors: Najdian A, Amanlou M, Beiki D, Bitarafan-Rajabi A, Mirzaei M, Shafiee Ardestani M,
Bioorg Chem, Vol.125, Year. 2022, Page:105827,
4.
Authors: Heidari S, Akhlaghi M, Sadeghi M, Mokhtari Kheirabadi A, Beiki D, Emami-Ardekani A, Rouhollah A, Saeidzadeh P, Soleyman R,
J Drug Deliv Sci Technol, Vol.73, Year. 2022, Page:103477,
Development of 64Cu-DOX/DOX-loaded chitosan-BSA multilayered hollow microcapsules for selective lung drug delivery
Authors: Heidari S, Akhlaghi M, Sadeghi M, Mokhtari Kheirabadi A, Beiki D, Emami-Ardekani A, Rouhollah A, Saeidzadeh P, Soleyman R,
J Drug Deliv Sci Technol, Vol.73, Year. 2022, Page:103477,
5.
Authors: Al-Timimi A, Manafi-Farid R, Fallahi B, Beiki D, Askari E, Rezaei A, Adinehpour Z, Eftekhari M,
Iran J Nucl Med, Vol.30, No.2, Year. 2022, Page:115-121,
Download
Factors predicting the early biochemical response to [177Lu]Lu-PSMA therapy in patients with metastatic castration resistant prostate cancer
Authors: Al-Timimi A, Manafi-Farid R, Fallahi B, Beiki D, Askari E, Rezaei A, Adinehpour Z, Eftekhari M,
Iran J Nucl Med, Vol.30, No.2, Year. 2022, Page:115-121,
Download
6.
Authors: Rezaei Aghdam H, Bitarafan Rajabi A, Sadat Ebrahimi SE, Beiki D, Abdi KH, Mousavi Motlagh SS, Kiani Dehkordi B, Darbandi Azar A, Shafiee Ardestani M,
Journal of Nanomaterials, Vol.2022, No.Article ID 5737835 , Year. 2022, Page:1-9,
Download
18F-FDG microPET and MRI targeting breast cancer mouse model with designed synthesis nanoparticles
Authors: Rezaei Aghdam H, Bitarafan Rajabi A, Sadat Ebrahimi SE, Beiki D, Abdi KH, Mousavi Motlagh SS, Kiani Dehkordi B, Darbandi Azar A, Shafiee Ardestani M,
Journal of Nanomaterials, Vol.2022, No.Article ID 5737835 , Year. 2022, Page:1-9,
Download
7.
Authors: Emami-Ardekani A, Ghorbani-Nik F, Karamzade-Ziarati N, Manafi-Farid R, Fard-Esfahani A, Fallahi B, Beiki D, Salehi Y, Eftekhari M,
Iran J Nucl Med, Vol.30, No.2, Year. 2022, Page:88-95,
Download
Impact of TSH stimulation on 2-[18F]FDG PET/CT results in patients with papillary thyroid carcinoma presented with elevated serum thyroglobulin level and negative diagnostic iodine-131 whole-body scan
Authors: Emami-Ardekani A, Ghorbani-Nik F, Karamzade-Ziarati N, Manafi-Farid R, Fard-Esfahani A, Fallahi B, Beiki D, Salehi Y, Eftekhari M,
Iran J Nucl Med, Vol.30, No.2, Year. 2022, Page:88-95,
Download
8.
Authors: Haghighi F, Manafi-Farid R, Emami-Ardekani A, Beiki D,
Iran J Nucl Med, Vol.30, No.1, Year. 2022, Page:72-75,
Download
Disseminated thoracoabdominal splenosis mimicking metastatic disease: A case of colorectal cancer
Authors: Haghighi F, Manafi-Farid R, Emami-Ardekani A, Beiki D,
Iran J Nucl Med, Vol.30, No.1, Year. 2022, Page:72-75,
Download
9.
Authors: Harsini S, Fallahi B, Karamzade-Ziarati N, Amini E, Emami-Ardekani A, Fard-Esfahani A, Kardoust Parizi M, Farzanefar S, Beiki D,
Asia Ocean J Nucl Med Biol, Vol.9, No.2, Year. 2021, Page:101-110,
Download
A Prospective Study on [68Ga]-PSMA PET/CT Imaging in Newly Diagnosed Intermediate- and High-Risk Prostate Cancer
Authors: Harsini S, Fallahi B, Karamzade-Ziarati N, Amini E, Emami-Ardekani A, Fard-Esfahani A, Kardoust Parizi M, Farzanefar S, Beiki D,
Asia Ocean J Nucl Med Biol, Vol.9, No.2, Year. 2021, Page:101-110,
Download
10.
Authors: Fallahi B, Khademi N, Karamzade-Ziarati N, Fard-Esfahani A, Emami-Ardekani A, Farzanefar S, Eftekhari M, Beiki D,
Clin Nucl Med, Vol.46, No.2, Year. 2021, Page:e68-e74,
Download
99mTc-PSMA SPECT/CT Versus 68Ga-PSMA PET/CT in the Evaluation of Metastatic Prostate Cancer
Authors: Fallahi B, Khademi N, Karamzade-Ziarati N, Fard-Esfahani A, Emami-Ardekani A, Farzanefar S, Eftekhari M, Beiki D,
Clin Nucl Med, Vol.46, No.2, Year. 2021, Page:e68-e74,
Download
11.
Authors: Fard-Esfahani A, Saidi B, Emami-Ardekani A, Fallahi B, Beiki D, Mirshahvalad SA, Eftekhari M,
Iran J Nucl Med, Vol.29, No.2, Year. 2021, Page:97-103,
Download
Adrenal lesions: Common findings and pitfalls on 18F-FDG PET/CT
Authors: Fard-Esfahani A, Saidi B, Emami-Ardekani A, Fallahi B, Beiki D, Mirshahvalad SA, Eftekhari M,
Iran J Nucl Med, Vol.29, No.2, Year. 2021, Page:97-103,
Download
12.
Authors: Almasi T, Gholipour N, Akhlaghi M, Mokhrari Kheirabadi A, Mazidi SM, Hosseini SH, Geramifar P, Beiki D, Rostampour N, Shahbazi Gahrouei D,
Int J Polym Mater, Vol.70, No.15, Year. 2021, Page:1077-1089,
Development of Ga-68 radiolabeled DOTA functionalized and acetylated PAMAM dendrimer-coated iron oxide nanoparticles as PET/MR dual-modal imaging agent
Authors: Almasi T, Gholipour N, Akhlaghi M, Mokhrari Kheirabadi A, Mazidi SM, Hosseini SH, Geramifar P, Beiki D, Rostampour N, Shahbazi Gahrouei D,
Int J Polym Mater, Vol.70, No.15, Year. 2021, Page:1077-1089,
13.
Authors: Jokar S, Behnammanesh H, Erfani M, Sharifzadeh M, Gholami M, Sabzevari O, Amini M, Geramifar P, Hajiramazanali M, Beiki D,
Bioorg Chem, Vol.99, Year. 2020, Page:103857,
Synthesis, biological evaluation and preclinical study of a novel 99mTc-peptide: A targeting probe of amyloid-beta plaques as a possible diagnostic agent for Alzheimer's disease
Authors: Jokar S, Behnammanesh H, Erfani M, Sharifzadeh M, Gholami M, Sabzevari O, Amini M, Geramifar P, Hajiramazanali M, Beiki D,
Bioorg Chem, Vol.99, Year. 2020, Page:103857,
14.
Authors: Jokar S, Erfani M, Bavi O, Khazaei S, Sharifzadeh M, Hajiramazanali M, Beiki D, Shamloo A,
Bioorg Chem, Vol.102, Year. 2020, Page:104050,
Design of peptide-based inhibitor agent against amyloid-β aggregation: Molecular docking, synthesis and in vitro evaluation
Authors: Jokar S, Erfani M, Bavi O, Khazaei S, Sharifzadeh M, Hajiramazanali M, Beiki D, Shamloo A,
Bioorg Chem, Vol.102, Year. 2020, Page:104050,
15.
Authors: Pirooznia N, Abdi K, Beiki D, Emami F, Arab SS, Sabzevari O, Soltani-Gooshkhaneh S,
Bioorg Chem, Vol.102, Year. 2020, Page:104100,
177Lu-labeled cyclic RGD peptide as an imaging and targeted radionuclide therapeutic agent in non-small cell lung cancer: biological evaluation and preclinical study
Authors: Pirooznia N, Abdi K, Beiki D, Emami F, Arab SS, Sabzevari O, Soltani-Gooshkhaneh S,
Bioorg Chem, Vol.102, Year. 2020, Page:104100,
16.
Authors: Mosayebnia M, Hajimahdi Z, Beiki D, Rezaeianpour M, Hajiramezanali M, Geramifar P, Sabzevari O, Amini M, Hatamabadi D, Shahhosseini S,
Bioorg Chem, Vol.99, Year. 2020, Page:103743,
Download
Design, synthesis, radiolabeling and biological evaluation of new urea-based peptides targeting prostate specific membrane antigen
Authors: Mosayebnia M, Hajimahdi Z, Beiki D, Rezaeianpour M, Hajiramezanali M, Geramifar P, Sabzevari O, Amini M, Hatamabadi D, Shahhosseini S,
Bioorg Chem, Vol.99, Year. 2020, Page:103743,
Download
17.
Authors: Pirooznia N, Abdi K, Beiki D, Emami F, Arab SS, Sabzevari O, Pakdin-Parizi Z, Geramifar P, Ghassemi Tabassi E,
Contrast Media Mol Imaging, Vol.2020, Year. 2020, Page:8421657,
Radiosynthesis, biological evaluation and preclinical study of a 68Ga-labeled cyclic RGD peptide as an early diagnostic agent for overexpressed avß3 integrin receptors in non-small cell lung cancer
Authors: Pirooznia N, Abdi K, Beiki D, Emami F, Arab SS, Sabzevari O, Pakdin-Parizi Z, Geramifar P, Ghassemi Tabassi E,
Contrast Media Mol Imaging, Vol.2020, Year. 2020, Page:8421657,
18.
Authors: Fard-Esfahani A, Valipouri MR, Harsini S, Beiki D, Emami-Ardekani A, Fallahi B, Eftekhari M,
Iran J Nucl Med, Vol.28, No.1, Year. 2020, Page:14-20,
Download
68Ga-DOTATATE PET/CT compared with 131I-MIBG SPECT/CT in the evaluation of neural crest tumors
Authors: Fard-Esfahani A, Valipouri MR, Harsini S, Beiki D, Emami-Ardekani A, Fallahi B, Eftekhari M,
Iran J Nucl Med, Vol.28, No.1, Year. 2020, Page:14-20,
Download
19.
Authors: Behnammanesh H, Erfani M, Hajiramazanali M, Jokar S, Geramifar P, Sabzevari O, Amini M, Mazidi M, Beiki D,
Asia Ocean J Nucl Med Biol, Vol.8, No.2, Year. 2020, Page:109-115,
Download
Preclinical study of a new 177Lu-labeled somatostatin receptor antagonist in HT-29 human colorectal cancer cells
Authors: Behnammanesh H, Erfani M, Hajiramazanali M, Jokar S, Geramifar P, Sabzevari O, Amini M, Mazidi M, Beiki D,
Asia Ocean J Nucl Med Biol, Vol.8, No.2, Year. 2020, Page:109-115,
Download
20.
Authors: Gholipour N, Akhlaghi M, Mokhtari Kheirabadi A, Geramifar P, Beiki D,
Int J Biol Macromol, Vol.138, Year. 2020, Page:932-941,
Development of Ga-68 labeled, biotinylated thiosemicarbazone dextran-coated iron oxide nanoparticles as multimodal PET/MRI probe
Authors: Gholipour N, Akhlaghi M, Mokhtari Kheirabadi A, Geramifar P, Beiki D,
Int J Biol Macromol, Vol.138, Year. 2020, Page:932-941,
21.
Authors: Fard-Esfahani A, Valipouri MR, Harsini S, Beiki D, Emami-Ardekani A, Fallahi B, Eftekhari M,
Iran J Nucl Med, Vol.28, No.1, Year. 2020, Page:14-20,
Download
Predictors of success of the ablative/therapeutic radioiodine (131I) in differentiated thyroid cancer
Authors: Fard-Esfahani A, Valipouri MR, Harsini S, Beiki D, Emami-Ardekani A, Fallahi B, Eftekhari M,
Iran J Nucl Med, Vol.28, No.1, Year. 2020, Page:14-20,
Download
22.
Authors: Shahrokhi P, Emami-Ardekani A, Harsini S, Eftekhari M, Fard-Esfahani A, Fallahi B, Karamzade Ziarati N, Akhlaghi M, Farzanefar S, Hashemi Taheri AP, Beiki D,
Asia Ocean J Nucl Med Biol, Vol.8, No.1, Year. 2020, Page:8-17,
Download
68Ga-DOTATATE PET/CT compared with 131I-MIBG SPECT/CT in the evaluation of neural crest tumors
Authors: Shahrokhi P, Emami-Ardekani A, Harsini S, Eftekhari M, Fard-Esfahani A, Fallahi B, Karamzade Ziarati N, Akhlaghi M, Farzanefar S, Hashemi Taheri AP, Beiki D,
Asia Ocean J Nucl Med Biol, Vol.8, No.1, Year. 2020, Page:8-17,
Download
23.
Authors: Behnammanesh H, Jokar S, Erfani M, Geramifar P, Sabzevari O, Amini M, Mazidi SM, Hajiramazanali M, Beiki D,
Bioorg Chem, Vol.94, Year. 2020, Page:103381,
Design, preparation and biological evaluation of a 177Lu-labeled somatostatin receptor antagonist for targeted therapy of neuroendocrine tumors
Authors: Behnammanesh H, Jokar S, Erfani M, Geramifar P, Sabzevari O, Amini M, Mazidi SM, Hajiramazanali M, Beiki D,
Bioorg Chem, Vol.94, Year. 2020, Page:103381,
24.
Authors: Jokar S, Khazaei S, Behnammanesh H, Shamloo A, Erfani M, Beiki D, Bavi O,
Biophys Rev, Vol.11, No.6, Year. 2019, Page:901-925,
Download
Recent advances in the design and applications of amyloid-β peptide aggregation inhibitors for Alzheimer’s disease therapy
Authors: Jokar S, Khazaei S, Behnammanesh H, Shamloo A, Erfani M, Beiki D, Bavi O,
Biophys Rev, Vol.11, No.6, Year. 2019, Page:901-925,
Download
25.
Authors: Hajiramezanali M, Atyabi F, Mosayebnia M, Akhlaghi M, Geramifar P, Jalilian AR, Mazidi SM, Yousefnia H, Shahhosseini S, Beiki D,
Int J Nanomed, Vol.14, Year. 2019, Page:2591-2605,
68Ga-radiolabeled bombesin-conjugated to trimethyl chitosan-coated superparamagnetic nanoparticles for molecular imaging: preparation, characterization and biological evaluation
Authors: Hajiramezanali M, Atyabi F, Mosayebnia M, Akhlaghi M, Geramifar P, Jalilian AR, Mazidi SM, Yousefnia H, Shahhosseini S, Beiki D,
Int J Nanomed, Vol.14, Year. 2019, Page:2591-2605,
26.
Authors: Fard-Esfahani A, Beiki D, Harsini S, Emami-Ardekani A, Fallahi B, Eftekhari M,
Iran J Nucl Med, Vol.27, No.2, Year. 2019, Page:142-145,
Absent radiotracer uptake in thyroid gland in parathyroid scintigraphy with 99mTc-MIBI: A case report
Authors: Fard-Esfahani A, Beiki D, Harsini S, Emami-Ardekani A, Fallahi B, Eftekhari M,
Iran J Nucl Med, Vol.27, No.2, Year. 2019, Page:142-145,
27.
Authors: Fallahi B, Manafi-Farid R, Eftekhari M, Fard-Esfahani A, Geramifar P, Akhlaghi M, Hashemi Taheri AP, Beiki D,
Asia Ocean J Nucl Med Biol, Vol.7, No.2, Year. 2019, Page:129-140,
Download
Diagnostic efficiency of 68Ga-DOTATATE PET/CT as compared to 99mTc-Octreotide SPECT/CT and conventional morphologic modalities in neuroendocrine tumors
Authors: Fallahi B, Manafi-Farid R, Eftekhari M, Fard-Esfahani A, Geramifar P, Akhlaghi M, Hashemi Taheri AP, Beiki D,
Asia Ocean J Nucl Med Biol, Vol.7, No.2, Year. 2019, Page:129-140,
Download
28.
Authors: Khoshbakht S, Beiki D, Geramifar P, Kobarfard F, Sabzevari O, Amini M, Bolourchian N, Shamshirian D, Shahhosseini S,
Cancer Biother Radiopharm, Vol.34, No.5, Year. 2019, Page:271-279,
Design, synthesis, radiolabeling, and biologic evaluation of three 18F-FDG-radiolabeled targeting peptides for the imaging of apoptosis
Authors: Khoshbakht S, Beiki D, Geramifar P, Kobarfard F, Sabzevari O, Amini M, Bolourchian N, Shamshirian D, Shahhosseini S,
Cancer Biother Radiopharm, Vol.34, No.5, Year. 2019, Page:271-279,
29.
Authors: Gholipour N, Akhlaghi M, Mokhtari Kheirabadi A, Fasihi Ramandi M, Farashahi A, Beiki D, jalilian AR,
Radiochim Acta, Vol.107, No.3, Year. 2019, Page:233-242,
Download
Development of a novel 68Ga-dextran carboxylate derivative for blood pool imaging
Authors: Gholipour N, Akhlaghi M, Mokhtari Kheirabadi A, Fasihi Ramandi M, Farashahi A, Beiki D, jalilian AR,
Radiochim Acta, Vol.107, No.3, Year. 2019, Page:233-242,
Download
30.
Authors: Almasi T, Jabbari K, Gholipour N, Mokhtari Kheirabadi A, Beiki D, Shahrokhi P, Akhlaghi M,
Int J Biol Macromol, Vol.125, Year. 2019, Page:915-21,
Synthesis, characterization, and in vitro and in vivo 68Ga radiolabeling of thiosemicarbazone Schiff base derived from dialdehyde dextran as a promising blood pool imaging agent
Authors: Almasi T, Jabbari K, Gholipour N, Mokhtari Kheirabadi A, Beiki D, Shahrokhi P, Akhlaghi M,
Int J Biol Macromol, Vol.125, Year. 2019, Page:915-21,
31.
Authors: Eftekhari M, Abbasi A, Tarafdari A, Emami-Ardekani A, Farzanefar S, Kalantari F, Fallahi B, Fard-Esfahani A, Beiki D, Naseri M, Saghari M,
J Med Imaging Health Inform, Vol.8, No.9, Year. 2018, Page:1844-49,
Automated interpretation of myocardial perfusion images with multilayer perceptron network as a decision support system
Authors: Eftekhari M, Abbasi A, Tarafdari A, Emami-Ardekani A, Farzanefar S, Kalantari F, Fallahi B, Fard-Esfahani A, Beiki D, Naseri M, Saghari M,
J Med Imaging Health Inform, Vol.8, No.9, Year. 2018, Page:1844-49,
32.
Authors: Fallahi B, Beiki D, Salehi Y, Salehi Y, Emami-Ardekani A, Fard-Esfahani A, Aghahosseini F, Eftekhari M,
Iran J Nucl Med, Vol.26, No.2, Year. 2018, Page:105-111,
Benefits of combined pharmacologic and submaximal exercise stress on Sub-diaphragmatic activity in myocardial perfusion scintigraphy
Authors: Fallahi B, Beiki D, Salehi Y, Salehi Y, Emami-Ardekani A, Fard-Esfahani A, Aghahosseini F, Eftekhari M,
Iran J Nucl Med, Vol.26, No.2, Year. 2018, Page:105-111,
33.
Authors: Mosayebnia M, Rezaeianpour S, Rikhtechi P, Hajimahdi Z, Beiki D, Kobarfard F, Sabzevari O, Amini M, Abdi K, Shahhosseini S,
Iran J Pharm Res, Vol.17, No.3, Year. 2018, Page:917-26,
Download
Novel and efficient method for solid phase synthesis of urea-containing peptides targeting prostate specific membrane antigen (PSMA) in comparison with current methods
Authors: Mosayebnia M, Rezaeianpour S, Rikhtechi P, Hajimahdi Z, Beiki D, Kobarfard F, Sabzevari O, Amini M, Abdi K, Shahhosseini S,
Iran J Pharm Res, Vol.17, No.3, Year. 2018, Page:917-26,
Download
34.
Authors: Emami-Ardekani A, Mirzabeigi A, Fard-Esfahani A, Fallahi B, Beiki D, Hasanzadeh A, Geramifar P, Eftekhari M,
Iran J Nucl Med, Vol.26, No.2, Year. 2018, Page:68-75,
Comparing diagnostic performance of 131I-metaiodobenzylguanidine (131I-MIBG) and 99mTc-hydrazinonicotinyl-Tyr3-Octreotide (99mTc-HYNIC-TOC) in diagnosis and localization of pheochromocytoma and neuroblastoma
Authors: Emami-Ardekani A, Mirzabeigi A, Fard-Esfahani A, Fallahi B, Beiki D, Hasanzadeh A, Geramifar P, Eftekhari M,
Iran J Nucl Med, Vol.26, No.2, Year. 2018, Page:68-75,
35.
Authors: Farzanefar S, Etemadi R, Shirkhoda M, Mahmoodzadeh H, Erfani M, Fallahi B, Abbasi M, Ayati N, Hassanzadeh-Rad A, Eftekhari M, Beiki D,
Asia Ocean J Nucl Med Biol, Vol.6, No.2, Year. 2018, Page:155-60,
Download
The value of Technetium-99m labeled alpha-Melanocyte-Stimulating Hormone (99mTc-α-MSH) in diagnosis of primary and metastatic lesions of malignant melanoma
Authors: Farzanefar S, Etemadi R, Shirkhoda M, Mahmoodzadeh H, Erfani M, Fallahi B, Abbasi M, Ayati N, Hassanzadeh-Rad A, Eftekhari M, Beiki D,
Asia Ocean J Nucl Med Biol, Vol.6, No.2, Year. 2018, Page:155-60,
Download
36.
Authors: Beiki D,
Iran J Nucl Med, Vol.26, No.1, Year. 2018,
A quarter of a century with Iranian Journal of Nuclear Medicine
Authors: Beiki D,
Iran J Nucl Med, Vol.26, No.1, Year. 2018,
37.
Authors: Zolghadri S, Naderi M, Yousefnia H, Alirezapour A, Beiki D,
Asia Ocean J Nucl Med Biol, Vol.6, No.1, Year. 2018, Page:41-49,
Download
Evaluation of the possible utilization of 68Ga-DOTATOC in diagnosis of adenocarcinoma breast cancer
Authors: Zolghadri S, Naderi M, Yousefnia H, Alirezapour A, Beiki D,
Asia Ocean J Nucl Med Biol, Vol.6, No.1, Year. 2018, Page:41-49,
Download
38.
Authors: Shanehsazzadeh S, Jalilian AR, Lahooti A, Geramifar P, Beiki D, Yousefnia H, Rabiee A, Mazidi M, Mirshojaei SF, Maus S,
Iran J Pharm Res, Vol.16, No.4, Year. 2017, Page:1415-23,
Download
Preclinical evaluation of 68Ga-MAA from commercial available 99mTc-MAA
Authors: Shanehsazzadeh S, Jalilian AR, Lahooti A, Geramifar P, Beiki D, Yousefnia H, Rabiee A, Mazidi M, Mirshojaei SF, Maus S,
Iran J Pharm Res, Vol.16, No.4, Year. 2017, Page:1415-23,
Download
39.
Authors: Mottaghitalab F, Kiani M, Farokhi M, Kundu SC, Reis RL, Gholami M, Bardania H, Dinarvand R, Geramifar P, Beiki D, Atyabi F,
ACS Appl Mater Interfaces, Vol.9, No.37, Year. 2017, Page:31600-31611,
Targeted delivery system based on gemcitabine loaded silk fibroin nanoparticles for lung cancer therapy
Authors: Mottaghitalab F, Kiani M, Farokhi M, Kundu SC, Reis RL, Gholami M, Bardania H, Dinarvand R, Geramifar P, Beiki D, Atyabi F,
ACS Appl Mater Interfaces, Vol.9, No.37, Year. 2017, Page:31600-31611,
40.
Authors: Sharifi M, Yousefnia H, Bahrami-Samani A, Jalilian AR, Zolghadri S, Alirezapour B, Geramifar P, Maus S, Beiki D,
Radiochimica Acta, Vol.105, No.5, Year. 2017, Page:399-408,
Download
Optimized production, quality control, biological evaluation and PET/CT imaging of 68Ga-PSMA-617 in breast adenocarcinoma model
Authors: Sharifi M, Yousefnia H, Bahrami-Samani A, Jalilian AR, Zolghadri S, Alirezapour B, Geramifar P, Maus S, Beiki D,
Radiochimica Acta, Vol.105, No.5, Year. 2017, Page:399-408,
Download
41.
Authors: Kumar P, Roselt P, Reischl G, Cullinane C, Beiki D, Ehrlichmann W, Binns D, Naimi E, Yang J, Hicks R, Machulla HJ, Wiebe LI,
Curr Radiopharm, Vol.10, No.2, Year. 2017, Page:93-101,
Download
β-[18F]Fluoro Azomycin Arabinoside (β-[18F]FAZA): Synthesis, radiofluorination and preliminary PET imaging of murine A431 tumors
Authors: Kumar P, Roselt P, Reischl G, Cullinane C, Beiki D, Ehrlichmann W, Binns D, Naimi E, Yang J, Hicks R, Machulla HJ, Wiebe LI,
Curr Radiopharm, Vol.10, No.2, Year. 2017, Page:93-101,
Download
42.
Authors: Eftekhari M, Kalantari F, Emami-Ardekani A, Amini H, Fard-Esfahani A, Fallahi B, Beiki D, Farzanefar S, Kalantari E, Hasanzadeh-Rad A, Abbasi M,
Iran J Nucl Med, Vol.25, No.Suppl 1, Year. 2017, Page:21-25,
Download
Radiation induced myocardial perfusion abnormalities in patients with left breast cancer: A prospective study with short and long term follow up
Authors: Eftekhari M, Kalantari F, Emami-Ardekani A, Amini H, Fard-Esfahani A, Fallahi B, Beiki D, Farzanefar S, Kalantari E, Hasanzadeh-Rad A, Abbasi M,
Iran J Nucl Med, Vol.25, No.Suppl 1, Year. 2017, Page:21-25,
Download
43.
Authors: Fallahi B, Moasses-Ghafari B, Fard-Esfahani A, Geramifar P, Beiki D, Emami-Ardekani A, Eftekhari M,
Iran J Nucl Med, Vol.25, No.Suppl 1, Year. 2017, Page:52-61,
Download
Factors influencing the pattern and intensity of myocardial 18F-FDG uptake in oncologic PET-CT imaging
Authors: Fallahi B, Moasses-Ghafari B, Fard-Esfahani A, Geramifar P, Beiki D, Emami-Ardekani A, Eftekhari M,
Iran J Nucl Med, Vol.25, No.Suppl 1, Year. 2017, Page:52-61,
Download
44.
Authors: Gholipour N, Akhlaghi M, Mokhtari Kheirabadi A, Beiki D, Geramifar P, Yousefnia H, Mazidi M,
J Radioanal Nucl Chem, Year. 2017, Page:doi: 10.1007/s10967-016-5164-z,
Download
Chelator-free radiolabeling of dextran with 68Ga for PET studies
Authors: Gholipour N, Akhlaghi M, Mokhtari Kheirabadi A, Beiki D, Geramifar P, Yousefnia H, Mazidi M,
J Radioanal Nucl Chem, Year. 2017, Page:doi: 10.1007/s10967-016-5164-z,
Download
45.
Authors: Farzanefar S, Abbasi M, Beiki D,
Iran J Nucl Med, Vol.25, No.1, Year. 2017, Page:77-80,
Download
Sentinel lymph node biopsy correctly predicts regional lymph node recurrence in trunk malignant melanoma with multiple drainage basins
Authors: Farzanefar S, Abbasi M, Beiki D,
Iran J Nucl Med, Vol.25, No.1, Year. 2017, Page:77-80,
Download
46.
Authors: Fallahi B, Beiki D, Salehi Y, Emami-Ardekani A, Fard-Esfahani A, Aghahosseini F, Haghighatafshar M, Eftekhari M,
Nucl Med Commun, Vol.38, No.1, Year. 2017, Page:15-20,
Download
Reverse perfusion pattern in myocardial perfusion imaging using technetium-99m-sestamibi in patients with intermediate risk for coronary artery disease in relation to the time of acquisition and intensity of visceral uptake as artifactual causes
Authors: Fallahi B, Beiki D, Salehi Y, Emami-Ardekani A, Fard-Esfahani A, Aghahosseini F, Haghighatafshar M, Eftekhari M,
Nucl Med Commun, Vol.38, No.1, Year. 2017, Page:15-20,
Download
47.
Authors: Fallahi B, Fard-Esfahani A, Emami-Ardekani A, Sahari S, Beiki D, Hassanzadeh-Rad A, Abedi SM, Geramifar P, Eftekhari M,
Iran J Nucl Med, Vol.25, No.1, Year. 2017, Page:51-59,
Download
How to manage patients with undetectable thyroglobulin but thyroid residue after radioiodine ablative therapy in differentiated thyroid carcinoma, retreatment or observation
Authors: Fallahi B, Fard-Esfahani A, Emami-Ardekani A, Sahari S, Beiki D, Hassanzadeh-Rad A, Abedi SM, Geramifar P, Eftekhari M,
Iran J Nucl Med, Vol.25, No.1, Year. 2017, Page:51-59,
Download
48.
Authors: Ranjbar H, Bahrami-Samani A, Beiki D, Ghannadi-Maragheh M,
Iran J Nucl Med, Vol.25, No.1, Year. 2017, Page:11-16,
Download
Development of 153Sm/177Lu-EDTMP as a possible therapeutic complex
Authors: Ranjbar H, Bahrami-Samani A, Beiki D, Ghannadi-Maragheh M,
Iran J Nucl Med, Vol.25, No.1, Year. 2017, Page:11-16,
Download
49.
Authors: Sharifi M, Yousefnia H, Zolghadri S, Bahrami-Samani A, Naderi M, Jalilian AR, Geramifar P, Beiki D,
Nucl Sci Tech, Vol.27, No.6:142, Year. 2016,
Download
Preparation and biodistribution assessment of 68Ga-DKFZ-PSMA-617 for PET prostate cancer imaging
Authors: Sharifi M, Yousefnia H, Zolghadri S, Bahrami-Samani A, Naderi M, Jalilian AR, Geramifar P, Beiki D,
Nucl Sci Tech, Vol.27, No.6:142, Year. 2016,
Download
50.
Authors: Shamshirian D, Erfani M, Beiki D, Hajiramazanali M, Fallahi B,
Iran J Pharm Res, Vol.15, No.3, Year. 2016, Page:349-360,
Download
A 99mTc-tricine-HYNIC-labeled peptide targeting the melanocortin-1 receptor for melanoma imaging
Authors: Shamshirian D, Erfani M, Beiki D, Hajiramazanali M, Fallahi B,
Iran J Pharm Res, Vol.15, No.3, Year. 2016, Page:349-360,
Download
51.
Authors: Khoshbakht S, Beiki D, Geramifar P, Kobarfard F, Sabzevari O, Amini M, Shahhosseini S,
J Radioanal Nucl Chem, Vol.310, Year. 2016, Page:413-421,
Download
18FDG-labeled LIKKPF: a PET tracer for apoptosis imaging
Authors: Khoshbakht S, Beiki D, Geramifar P, Kobarfard F, Sabzevari O, Amini M, Shahhosseini S,
J Radioanal Nucl Chem, Vol.310, Year. 2016, Page:413-421,
Download
52.
Authors: Jalilian AR, Beiki D,
Iran J Pharm Res, Vol.15, No.3, Year. 2016, Page:257-259,
Download
The present status of radiopharmaceuticals in the country
Authors: Jalilian AR, Beiki D,
Iran J Pharm Res, Vol.15, No.3, Year. 2016, Page:257-259,
Download
53.
Authors: Fard-Esfahani A, Marzban M, Emami-Ardekani A, Hassanzadeh-Rad A, Fallahi B, Beiki D, Geramifar P, Eftekhari M,
Iran J Nucl Med, Vol.24, No.2, Year. 2016, Page:146-148,
Download
Spinal cord metastasis from testicular seminoma detected by F-18 FDG PET/CT study prior to neurological symptoms: An unusual presentation
Authors: Fard-Esfahani A, Marzban M, Emami-Ardekani A, Hassanzadeh-Rad A, Fallahi B, Beiki D, Geramifar P, Eftekhari M,
Iran J Nucl Med, Vol.24, No.2, Year. 2016, Page:146-148,
Download
54.
Authors: Mirzaei A, Jalilian AR, Akhlaghi M, Beiki D,
Curr Radiopharm, Year. 2016, Page: [Epub ahead of print],
Download
Production of 68Ga-citrate based on a SnO2 generator for short-term turpentine oil-induced inflammation imaging in rats
Authors: Mirzaei A, Jalilian AR, Akhlaghi M, Beiki D,
Curr Radiopharm, Year. 2016, Page: [Epub ahead of print],
Download
55.
Authors: Katal S, Hassanzadeh-Rad A, Eftekhari M, Fard-Esfahani A, Beiki D, Fallahi B, Emami-Ardekani A, Abbasi M,
Iran J Nucl Med, Vol.24, No.2, Year. 2016, Page:120-128,
Download
Two-day stress-rest lower limbs perfusion scan in patients referred for myocardial perfusion imaging
Authors: Katal S, Hassanzadeh-Rad A, Eftekhari M, Fard-Esfahani A, Beiki D, Fallahi B, Emami-Ardekani A, Abbasi M,
Iran J Nucl Med, Vol.24, No.2, Year. 2016, Page:120-128,
Download
56.
Authors: Jalilian AR, Beiki D, Hassanzadeh-Rad A, Eftekhari A, Geramifar P, Eftekhari M,
Semin Nucl Med, Vol.46, No.4, Year. 2016, Page:340-358,
Download
Production and clinical applications of radiopharmaceuticals and medical radioisotopes in Iran
Authors: Jalilian AR, Beiki D, Hassanzadeh-Rad A, Eftekhari A, Geramifar P, Eftekhari M,
Semin Nucl Med, Vol.46, No.4, Year. 2016, Page:340-358,
Download
57.
Authors: Fallahi B, Esmaeili A, Beiki D, Oveisgharan S, Noorollahi-Moghaddam H, Erfani M, Tafakhori A, Rohani M, Fard-Esfahani A, Emami-Ardekani A, Geramifar P, Eftekhari M,
Ann Nucl Med, Vol.30, No.2, Year. 2016, Page:153-62,
Download
Evaluation of 99mTc-TRODAT-1 SPECT in the diagnosis of Parkinson’s disease versus other progressive movement disorders
Authors: Fallahi B, Esmaeili A, Beiki D, Oveisgharan S, Noorollahi-Moghaddam H, Erfani M, Tafakhori A, Rohani M, Fard-Esfahani A, Emami-Ardekani A, Geramifar P, Eftekhari M,
Ann Nucl Med, Vol.30, No.2, Year. 2016, Page:153-62,
Download
58.
Authors: Razavi Ratki SK, Fallahi B, Namiranian N, Emami-Ardekani A, Saghari M, Mirabzadeh A, Fard-Esfahani A, Beiki D, Eftekhari M, Pooyafard F,
Iran J Nucl Med, Vol.24, No.2, Year. 2016, Page:92-97,
Download
Factors affecting the quality of life of well-differentiated thyroid carcinoma patients: A cross-sectional study on 435 Iranian patients
Authors: Razavi Ratki SK, Fallahi B, Namiranian N, Emami-Ardekani A, Saghari M, Mirabzadeh A, Fard-Esfahani A, Beiki D, Eftekhari M, Pooyafard F,
Iran J Nucl Med, Vol.24, No.2, Year. 2016, Page:92-97,
Download
59.
Authors: Khoshbakht S, Beiki D, Geramifar P, Kobarfard F, Sabzevari O, Amini M, Mehrnejad F, Shahhosseini S,
Iran J Pharm Res, Vol.15, No.2, Year. 2016, Page:415-424,
Download
Synthesis, radiolabeling, and biological evaluation of peptide LIKKPF functionalized with HYNIC as apoptosis imaging agent
Authors: Khoshbakht S, Beiki D, Geramifar P, Kobarfard F, Sabzevari O, Amini M, Mehrnejad F, Shahhosseini S,
Iran J Pharm Res, Vol.15, No.2, Year. 2016, Page:415-424,
Download
60.
Authors: Mirzaei A, Jalilian AR, Shabani G, Mazidi M, Akhlaghi M, Beiki D,
J Radioanal Nucl Chem, Vol.307, Year. 2016, Page:725-732,
Download
Development of 68Ga Ethyl Cysteinate Dimer for PET studies
Authors: Mirzaei A, Jalilian AR, Shabani G, Mazidi M, Akhlaghi M, Beiki D,
J Radioanal Nucl Chem, Vol.307, Year. 2016, Page:725-732,
Download
61.
Authors: Aghanejad A, Jalilian AR, Maus S, Yousefnia H, Geramifar P, Beiki D,
Iran J Nucl Med, Vol.24, No.1, Year. 2016, Page:29-36,
Download
Optimized production and quality control of 68Ga-DOTATATE
Authors: Aghanejad A, Jalilian AR, Maus S, Yousefnia H, Geramifar P, Beiki D,
Iran J Nucl Med, Vol.24, No.1, Year. 2016, Page:29-36,
Download
62.
Authors: Khoshbakht S, Kobarfard F, Beiki D, Sabzevari O, Amini M, Mehrnejad F, Tabib K, Shahhosseini S,
J Radioanal Nucl Chem, Vol.307, Year. 2016, Page:1125-34,
Download
HYNIC a bifunctional prosthetic group for the labelling of peptides with 99m Tc and 18 FDG
Authors: Khoshbakht S, Kobarfard F, Beiki D, Sabzevari O, Amini M, Mehrnejad F, Tabib K, Shahhosseini S,
J Radioanal Nucl Chem, Vol.307, Year. 2016, Page:1125-34,
Download
63.
Authors: Aghanejad A, Jalilian AR, Bolourinovin F, Mirzaee A, Abdi K, Erfani M, Beiki D, Maus S, Khalaj A,
Recent Patents and Topics on Imaging, Vol.5, No.1, Year. 2015, Page:26-30,
Download
Preparation and Quality Control of 111In-Plerixafor for Chemokine Receptor CXCR4
Authors: Aghanejad A, Jalilian AR, Bolourinovin F, Mirzaee A, Abdi K, Erfani M, Beiki D, Maus S, Khalaj A,
Recent Patents and Topics on Imaging, Vol.5, No.1, Year. 2015, Page:26-30,
Download
64.
Authors: Emami-Ardekani A, Esteghamati A, Farzanefar S, Abousaidi M, Abbasi M, Abdollahi S, Fallahi B, Beiki D, Fard-Esfahani A, Nakhjavani M, Eftekhari M,
Ann Nucl Med, Vol.29, No.8, Year. 2015, Page:740-4,
Download
Folate therapy improves the stress-to-rest mean LV volume ratio in myocardial perfusion imaging in patients with diabetes
Authors: Emami-Ardekani A, Esteghamati A, Farzanefar S, Abousaidi M, Abbasi M, Abdollahi S, Fallahi B, Beiki D, Fard-Esfahani A, Nakhjavani M, Eftekhari M,
Ann Nucl Med, Vol.29, No.8, Year. 2015, Page:740-4,
Download
65.
Authors: Shamshirian D, Erfani M, Beiki D, Fallahi B, Shafiei M,
Ann Nucl Med, Vol.29, Year. 2015, Page:709-20,
Download
Development of a 99mTc-labeled lactam bridge-cyclized alpha- MSH derivative peptide as a possible single photon imaging agent for melanoma tumors
Authors: Shamshirian D, Erfani M, Beiki D, Fallahi B, Shafiei M,
Ann Nucl Med, Vol.29, Year. 2015, Page:709-20,
Download
66.
Authors: Mirzaei A, Jalilian AR, Aghanejad A, Mazidi M, Yousefnia H, Shabani G, Ardaneh K, Geramifar P, Beiki D,
Nucl Med Mol Imaging, Vol.49, Year. 2015, Page:208-216,
Download
Preparation and evaluation of 68Ga-ECC as a PET renal imaging agent
Authors: Mirzaei A, Jalilian AR, Aghanejad A, Mazidi M, Yousefnia H, Shabani G, Ardaneh K, Geramifar P, Beiki D,
Nucl Med Mol Imaging, Vol.49, Year. 2015, Page:208-216,
Download
67.
Authors: Vahidfar S, Jalilian AR, Fazaeli Y, Bahrami-Samani A, Beiki D, Khalaj A,
Iran J Nucl Med, Vol.23, No.2, Year. 2015, Page:65-72,
Download
Preparation of a 153Sm-5,10,15,20-tetrakis(4-methoxyphenyl) porphyrin complex as a possible therapeutic agent
Authors: Vahidfar S, Jalilian AR, Fazaeli Y, Bahrami-Samani A, Beiki D, Khalaj A,
Iran J Nucl Med, Vol.23, No.2, Year. 2015, Page:65-72,
Download
68.
Authors: Mirzaei A, Jalilian AR, Badbarin A, Mazidi M, Morshojaei F, Geramifar P, Beiki D,
Ann Nucl Med, Vol.29, No.6, Year. 2015, Page:506-511,
Download
Optimized production and quality control of 68Ga-EDTMP for small clinical trials
Authors: Mirzaei A, Jalilian AR, Badbarin A, Mazidi M, Morshojaei F, Geramifar P, Beiki D,
Ann Nucl Med, Vol.29, No.6, Year. 2015, Page:506-511,
Download
69.
Authors: Beiki D, Karami F, Fallahi B, Kaviani A, Harirchi I, Omranipour R, Erfani M, f Farzanefar S, Fard-Esfahani A, Emami-Ardekani A, Saghari M, Eftekhari M,
Iran J Nucl Med, Vol.23, No.2, Year. 2015, Page:103-107,
Download
Evaluation of a new 99mTc-Bombesin analog in differentiation of malignant from benign breast tumors
Authors: Beiki D, Karami F, Fallahi B, Kaviani A, Harirchi I, Omranipour R, Erfani M, f Farzanefar S, Fard-Esfahani A, Emami-Ardekani A, Saghari M, Eftekhari M,
Iran J Nucl Med, Vol.23, No.2, Year. 2015, Page:103-107,
Download
70.
Authors: Chavoshi M, Fard-Esfahani A, Fallahi B, Emami-Ardekani A, Beiki D, Hassanzadeh-Rad A, Eftekhari M,
Indian J Nucl Med, Vol.30, No.3, Year. 2015, Page:233-238,
Download
Assessment of prognostic value of semiquantitative parameters on gated single photon emission computed tomography myocardial perfusion scintigraphy in a large middle eastern population
Authors: Chavoshi M, Fard-Esfahani A, Fallahi B, Emami-Ardekani A, Beiki D, Hassanzadeh-Rad A, Eftekhari M,
Indian J Nucl Med, Vol.30, No.3, Year. 2015, Page:233-238,
Download
71.
Authors: Ranjbar S, Ghannadi-Maragheh M, Bahrami-Samani A, Beiki D,
Radiat Phys Chem, Vol.108, Year. 2015, Page:60-64,
Download
Dosimetric evaluation of 153Sm-EDTMP, 177Lu-EDTMP and 166Ho-EDTMP for systemic radiation therapy: Influence of type and energy of radiation and half life of radionuclides
Authors: Ranjbar S, Ghannadi-Maragheh M, Bahrami-Samani A, Beiki D,
Radiat Phys Chem, Vol.108, Year. 2015, Page:60-64,
Download
72.
Authors: Beiki D, Tajik M, Haddad P, Fallahi B, Arefpour AM, Mirzaei H, Fard-Esfahani A, Emami-Ardekani A, Eftekhari M,
Iran J Nucl Med, Vol.23, No.1, Year. 2015, Page:44-48,
Download
Effectiveness and complications of 188Re-HEDP in palliative treatment of diffuse skeletal metastases
Authors: Beiki D, Tajik M, Haddad P, Fallahi B, Arefpour AM, Mirzaei H, Fard-Esfahani A, Emami-Ardekani A, Eftekhari M,
Iran J Nucl Med, Vol.23, No.1, Year. 2015, Page:44-48,
Download
73.
Authors: Eftekhari M, Anbiaei R, Zamani H, Fallahi B, Beiki D, Ameri A, Emami-Ardekani A, Fard-Esfahani A, Gholamrezanezhad A, Razavi Ratki SK, Momen Roknabadi A,
Asia Ocean J Nucl Med Biol, Vol.3, No.1, Year. 2015, Page:3-9,
Download
Radiation-induced myocardial perfusion abnormalities in breast cancer patients following external beam radiation therapy
Authors: Eftekhari M, Anbiaei R, Zamani H, Fallahi B, Beiki D, Ameri A, Emami-Ardekani A, Fard-Esfahani A, Gholamrezanezhad A, Razavi Ratki SK, Momen Roknabadi A,
Asia Ocean J Nucl Med Biol, Vol.3, No.1, Year. 2015, Page:3-9,
Download
74.
Authors: Aghanejad A, Jalilian AR, Bahrami-Samani A, Beiki D, Maus S, khalaj A,
Iran J Nucl Med, Vol.23, No.1, Year. 2015, Page:36-43,
Download
Preparation and preliminary biological evaluation of [153Sm] samarium AMD3100; towards a possible therapeutic chemokine receptor CXCR4 targeting complex
Authors: Aghanejad A, Jalilian AR, Bahrami-Samani A, Beiki D, Maus S, khalaj A,
Iran J Nucl Med, Vol.23, No.1, Year. 2015, Page:36-43,
Download
75.
Authors: Mozafari S, Erfani M, Beiki D, Johari Daha F, Kobarfard F, Balalaie S, Fallahi B,
Iran J Pharm Res, Vol.14, No.1, Year. 2015, Page:97-110,
Download
Synthesis and preliminary evaluation of a new 99mTc labeled substance P analogue as a potential tumor imaging agent
Authors: Mozafari S, Erfani M, Beiki D, Johari Daha F, Kobarfard F, Balalaie S, Fallahi B,
Iran J Pharm Res, Vol.14, No.1, Year. 2015, Page:97-110,
Download
76.
Authors: Ranjbar S, Bahrami-Samani A, Beiki D, Shirvani-Arani S, Ghannadi-Maragheh M,
J Radioanal Nucl Chem, Vol.303, No.1, Year. 2015, Page:71-79,
Download
Evaluation of 153Sm/177Lu-EDTMP mixture in wild-type rodents as a novel combined palliative treatment of bone pain agent
Authors: Ranjbar S, Bahrami-Samani A, Beiki D, Shirvani-Arani S, Ghannadi-Maragheh M,
J Radioanal Nucl Chem, Vol.303, No.1, Year. 2015, Page:71-79,
Download
77.
Authors: Salehi Y, Fard-Esfahani A, Fallahi B, Aghahosseini F, Beiki D, Emami-Ardekani A, Fard-Esfahani P, Ansari M, Eftekhari M,
Iran J Nucl Med, Vol.23, No.1, Year. 2015, Page:27-35,
Download
The myocardial perfusion scintigraphy in asymptomatic diabetic patients
Authors: Salehi Y, Fard-Esfahani A, Fallahi B, Aghahosseini F, Beiki D, Emami-Ardekani A, Fard-Esfahani P, Ansari M, Eftekhari M,
Iran J Nucl Med, Vol.23, No.1, Year. 2015, Page:27-35,
Download
78.
Authors: Fard-Esfahani A, Fallahi B, Karimi M, Beiki D, Saghari M, Emami-Ardekani A, Fard-Esfahani P, Ansari M, Eftekhari M,
Iran J Nucl Med, Vol.23, No.1, Year. 2015, Page:1-7,
Download
Changes in salivary gland function following radioiodine therapy of thyroid diseases: A comparison of high-dose therapy for thyroid cancer and low-dose therapy for benign thyroid disease
Authors: Fard-Esfahani A, Fallahi B, Karimi M, Beiki D, Saghari M, Emami-Ardekani A, Fard-Esfahani P, Ansari M, Eftekhari M,
Iran J Nucl Med, Vol.23, No.1, Year. 2015, Page:1-7,
Download
79.
Authors: Hamidieh AA, Beiki D, Paragomi P, Fallahi B, Behfar M, Fard-Esfahani A, Hosseini AS, Shamshiri A, Eftekhari M, Ghavamzadeh A,
Pediatr Transplant, Vol.18, No.5, Year. 2014, Page:510-517,
Download
The potential role of pretransplant MIBG diagnostic scintigraphy in targeted administration of 131 I-MIBG accompanied by ASCT for high-risk and relapsed neuroblastoma: A pilot study
Authors: Hamidieh AA, Beiki D, Paragomi P, Fallahi B, Behfar M, Fard-Esfahani A, Hosseini AS, Shamshiri A, Eftekhari M, Ghavamzadeh A,
Pediatr Transplant, Vol.18, No.5, Year. 2014, Page:510-517,
Download
80.
Authors: Fard-Esfahani A, Emami-Ardekani A, Fallahi B, Fard-Esfahani P, Beiki D, Hassanzadeh-Rad A, Eftekhari M,
Nucl Med Commun, Vol.35, No.8, Year. 2014, Page:808-817,
Download
Adverse effects of radioactive iodine-131 treatment for differentiated thyroid carcinoma
Authors: Fard-Esfahani A, Emami-Ardekani A, Fallahi B, Fard-Esfahani P, Beiki D, Hassanzadeh-Rad A, Eftekhari M,
Nucl Med Commun, Vol.35, No.8, Year. 2014, Page:808-817,
Download
81.
Authors: Vahidfar N, Jalilian AR, Fazaeli Y, Aghanejad A, Bahrami-Samani A, Alirezapoor B, Erfani M, Beiki D, Khalaj A,
Radiochimica Acta, Vol.102, No.7, Year. 2014, Page:659-668,
Download
Development of radiolanthanide labeled porphyrin complexes as possible therapeutic agents in beast carcinoma xenografts
Authors: Vahidfar N, Jalilian AR, Fazaeli Y, Aghanejad A, Bahrami-Samani A, Alirezapoor B, Erfani M, Beiki D, Khalaj A,
Radiochimica Acta, Vol.102, No.7, Year. 2014, Page:659-668,
Download
82.
Authors: Fallahi B, Fard-Esfahani A, Hassanzadeh-Rad A, Emami-Ardekani A, Beiki D, Eftekhari M,
Iran J Nucl Med, Vol.22, No.2, Year. 2014, Page:51-56,
Download
Comparison of transient ischemic dilation ratios in SPECT and SPECT-CT myocardial perfusion imaging in the low pre-test probability group
Authors: Fallahi B, Fard-Esfahani A, Hassanzadeh-Rad A, Emami-Ardekani A, Beiki D, Eftekhari M,
Iran J Nucl Med, Vol.22, No.2, Year. 2014, Page:51-56,
Download
83.
Authors: Vahidfar N, Jalilian AR, Fazaeli Y, Bahrami-Samani A, Beiki D, khalaj A,
J Radioanal Nucl Chem, Vol.301, No.1, Year. 2014, Page:269-276,
Download
Radiosynthesis and biological evaluation of 166Ho labeled methoxylated porphyrins as possible therapeutic agents
Authors: Vahidfar N, Jalilian AR, Fazaeli Y, Bahrami-Samani A, Beiki D, khalaj A,
J Radioanal Nucl Chem, Vol.301, No.1, Year. 2014, Page:269-276,
Download
84.
Authors: Zarrabi Ahrabi N, Erfani M, Parivar K, Beiki D, Jalilian AR,
J Radioanal Nucl Chem, Vol.299, Year. 2014, Page:461-469,
Download
Preparation and evaluation of a new neurotensin analog labeled with 99mTc for targeted imaging of neurotensin receptor positive tumors
Authors: Zarrabi Ahrabi N, Erfani M, Parivar K, Beiki D, Jalilian AR,
J Radioanal Nucl Chem, Vol.299, Year. 2014, Page:461-469,
Download
85.
Authors: Emami-Ardekani A, Fallahi B, Amini M, Fard-Esfahani A, Beiki D, Farzanefar S, Abbasi M, Sadeghian L, Eftekhari M, Saghari M,
Iran J Nucl Med, Vol.22, No.1, Year. 2014, Page:23-28,
Download
Accuracy of modification of diet for renal disease and Cockcroft-Gault equations as compared to the radioisotope double sample method: A study in patients with acute renal failure
Authors: Emami-Ardekani A, Fallahi B, Amini M, Fard-Esfahani A, Beiki D, Farzanefar S, Abbasi M, Sadeghian L, Eftekhari M, Saghari M,
Iran J Nucl Med, Vol.22, No.1, Year. 2014, Page:23-28,
Download
86.
Authors: Ahmadi F, Dabirian S, Faizi M, Tabatabai SA, Beiki D, Shahhosseini,
Iran J Pharm Res, Vol.13, Year. 2014, Page:79-86,
Download
Optimum conditions of radioligand receptor binding assay of ligands of benzodiazepine receptors
Authors: Ahmadi F, Dabirian S, Faizi M, Tabatabai SA, Beiki D, Shahhosseini,
Iran J Pharm Res, Vol.13, Year. 2014, Page:79-86,
Download
87.
Authors: Aghanejad A, Jalilian AR, Fazaeli Y, Alirezapoor B, Pouladi M, Beiki D, Maus S, Khalaj A,
Scientia Pharmaceutica, Vol.82, Year. 2014, Page:29-42,
Download
Synthesis and Evaluation of [67Ga]-AMD3100; a novel imaging agent for targeting chemokine receptor CXCR4
Authors: Aghanejad A, Jalilian AR, Fazaeli Y, Alirezapoor B, Pouladi M, Beiki D, Maus S, Khalaj A,
Scientia Pharmaceutica, Vol.82, Year. 2014, Page:29-42,
Download
88.
Authors: Aghanejad A, Jalilian AR, Fazaeli Y, Beiki D, Fateh B, khalaj A,
J Radioanal Nucl Chem, Vol.299, Year. 2014, Page:1635-1644,
Download
Radiosynthesis and biodistribution studies of [62Zn/62Cu]-Plerixafor complex as a novel in vivo PET generator for chemokine receptor imaging
Authors: Aghanejad A, Jalilian AR, Fazaeli Y, Beiki D, Fateh B, khalaj A,
J Radioanal Nucl Chem, Vol.299, Year. 2014, Page:1635-1644,
Download
89.
Authors: Ahmadi F, Faizi M, Tabatabai SM, Beiki D, Shahhosseini S,
Nucl Med Biol, Vol.40, No.7, Year. 2013, Page:896-900,
Download
Comparison [3H]-flumazenil binding parameters in rat cortical membrane using different separation methods, filtration and centrifugation
Authors: Ahmadi F, Faizi M, Tabatabai SM, Beiki D, Shahhosseini S,
Nucl Med Biol, Vol.40, No.7, Year. 2013, Page:896-900,
Download
90.
Authors: Fallahi B, Beiki D, Abedi SM, Saghari M, Fard-Esfahani A, Akhzari F, Mokarami B, Eftekhari M,
Nucl Med Commun, Vol.34, No.8, Year. 2013, Page:777-786,
Download
Does vitamin E protect salivary glands from I-131 radiation damage in patients with thyroid cancer
Authors: Fallahi B, Beiki D, Abedi SM, Saghari M, Fard-Esfahani A, Akhzari F, Mokarami B, Eftekhari M,
Nucl Med Commun, Vol.34, No.8, Year. 2013, Page:777-786,
Download
91.
Authors: Beiki D, Yousefi G, Fallahi B, Tahmasebi MN, Gholamrezanezhad A, Fard-Esfahani A, Erfani M, Eftekhari M,
Iran J Pharm Res, Vol.12, No.2, Year. 2013, Page:347-353,
Download
99mTc-Ubiquicidin [29–41], a promising radiopharmaceutical to differentiate orthopedic implant infections from sterile inflammation
Authors: Beiki D, Yousefi G, Fallahi B, Tahmasebi MN, Gholamrezanezhad A, Fard-Esfahani A, Erfani M, Eftekhari M,
Iran J Pharm Res, Vol.12, No.2, Year. 2013, Page:347-353,
Download
92.
Authors: Beiki D, Haddad P, Fallahi B, Keyvan A, Gholamrezanezhad A, Mirzaei H, Saghari M, Amouzegar-Hashemi F, Kazemian A, Fard-Esfahani A, Eftekhari M,
Iran J Nucl Med, Vol.21, No.1, Year. 2013, Page:26-32,
Download
Effectiveness and complications of 153Sm-EDTMP in palliative treatment of diffuse skeletal metastases
Authors: Beiki D, Haddad P, Fallahi B, Keyvan A, Gholamrezanezhad A, Mirzaei H, Saghari M, Amouzegar-Hashemi F, Kazemian A, Fard-Esfahani A, Eftekhari M,
Iran J Nucl Med, Vol.21, No.1, Year. 2013, Page:26-32,
Download
93.
Authors: Fallahi B, Beiki D, Akbarpour S, Gholamrezanezhad A, Fard-Esfahani A, Akhzari F, Izadyar S, Esmaeli J, Saghari M, Eftekhari M,
DARU Journal of Pharmaceutical Sciences, Vol.21, No.1, Year. 2013,
Download
Withholding or continuing beta-blocker treatment before dipyridamole myocardial perfusion imaging for the diagnosis of coronary artery disease? a randomized clinical trial
Authors: Fallahi B, Beiki D, Akbarpour S, Gholamrezanezhad A, Fard-Esfahani A, Akhzari F, Izadyar S, Esmaeli J, Saghari M, Eftekhari M,
DARU Journal of Pharmaceutical Sciences, Vol.21, No.1, Year. 2013,
Download
94.
Authors: Vahidfar N, Jalilian AR, Fazaeli Y, Bahrami-Samani A, Beiki D, khalaj A,
J Radioanal Nucl Chem , Vol.295, Year. 2013, Page:979-986,
Download
Development and evaluation of a 166holmium labelled porphyrin complex as a possible therapeutic agent
Authors: Vahidfar N, Jalilian AR, Fazaeli Y, Bahrami-Samani A, Beiki D, khalaj A,
J Radioanal Nucl Chem , Vol.295, Year. 2013, Page:979-986,
Download
95.
Authors: Fard-Esfahani A, Fallahi B, Mirpour S, Gholamrezanezhad A, Abdi E, Karimi M, Beiki D, Emami-Ardekani A, Akhzari F, Ansari M, Eftekhari M,
Iran J Nucl Med, Vol.20, No.2, Year. 2012, Page:20-24,
Download
Evaluation of myocardial perfusion and function after kidney transplantation by Gated SPECT myocardial perfusion scintigraphy
Authors: Fard-Esfahani A, Fallahi B, Mirpour S, Gholamrezanezhad A, Abdi E, Karimi M, Beiki D, Emami-Ardekani A, Akhzari F, Ansari M, Eftekhari M,
Iran J Nucl Med, Vol.20, No.2, Year. 2012, Page:20-24,
Download
96.
Authors: Fard-Esfahani A, Farzanefar S, Fallahi B, Beiki D, Saghari M, Emami-Ardekani A, Majdi M, Eftekhari M,
Nucl Med Commun , Vol.33, No.10, Year. 2012, Page:1077-80,
Download
Nasolacrimal duct obstruction as a complication of iodine-131 therapy in patients with thyroid cancer
Authors: Fard-Esfahani A, Farzanefar S, Fallahi B, Beiki D, Saghari M, Emami-Ardekani A, Majdi M, Eftekhari M,
Nucl Med Commun , Vol.33, No.10, Year. 2012, Page:1077-80,
Download
97.
Authors: Kalantari F, Rajabi H, Ay MR, Razavi-Ratki SK, Fard-Esfahani A, Beiki D, Eftekhari M, Fallahi B, Sadeghian L, Emami-Ardekani A,
Hell J Nucl Med , Vol.15, No.2, Year. 2012, Page:92-97,
Download
The influence of resolusion recovery by using collimator detector response during 3D OSEM image reconstruction on 99mTc-ECD brain SPET images
Authors: Kalantari F, Rajabi H, Ay MR, Razavi-Ratki SK, Fard-Esfahani A, Beiki D, Eftekhari M, Fallahi B, Sadeghian L, Emami-Ardekani A,
Hell J Nucl Med , Vol.15, No.2, Year. 2012, Page:92-97,
Download
98.
Authors: Fallahi B, Beiki D, Takavar A, Fard-Esfahani A, Ansari Gilani K, Saghari M, Eftekhari M,
Nucl Med Commun , Vol.33, No.3, Year. 2012, Number of Page:275-282
Download
Low versus high radioiodine dose in postoperative ablation of residual thyroid tissue in patients with differentiated thyroid carcinoma: a large randomized clinical trial
Authors: Fallahi B, Beiki D, Takavar A, Fard-Esfahani A, Ansari Gilani K, Saghari M, Eftekhari M,
Nucl Med Commun , Vol.33, No.3, Year. 2012, Number of Page:275-282
Download
99.
Authors: Ansari-Gilani K, Gholamrezanezhad A, Beiki D, Mirpour S, Modaresi Esfeh J,
Clin Nucl Med, Vol.36, No.12, Year. 2011, Page:1086-91,
Download
Renal axis deviation in urinary tract abnormalities of children: the role of renal scintigraphy
Authors: Ansari-Gilani K, Gholamrezanezhad A, Beiki D, Mirpour S, Modaresi Esfeh J,
Clin Nucl Med, Vol.36, No.12, Year. 2011, Page:1086-91,
Download
100.
Authors: Fallahi B, Beiki D, Khodaparast MB, Gholamrezanezhad A, Fard-Esfahani A, Eftekhari M,
Iran J Nucl Med , Vol.19, No.1, Year. 2011, Page:52-58,
Download
Additive clinical value of bone scintigraphy in patients with malignant tumors with absence of localized bone pain: A report on most common sex-related cancers
Authors: Fallahi B, Beiki D, Khodaparast MB, Gholamrezanezhad A, Fard-Esfahani A, Eftekhari M,
Iran J Nucl Med , Vol.19, No.1, Year. 2011, Page:52-58,
Download
101.
Authors: Mehrazin M, Nezameddini-Kachooei SA, Fallahi B, Derakhshan MK, Beiki D, Ghodsi SM, Assadi M, Pooyafard F, Eftekhari M,
Hell J Nucl Med , Vol.14, No.3, Year. 2011, Page:243-250,
Download
Prospective evaluation of technetium-99m ECD SPET in mild traumatic brain injury for the prediction of sustained neuropsychological sequels
Authors: Mehrazin M, Nezameddini-Kachooei SA, Fallahi B, Derakhshan MK, Beiki D, Ghodsi SM, Assadi M, Pooyafard F, Eftekhari M,
Hell J Nucl Med , Vol.14, No.3, Year. 2011, Page:243-250,
Download
102.
Authors: Eftekhari M, Fard-Esfahani A, Haghighatafshar M, Keyvan A, Beiki D, Aghahosseini F, Emami-Ardekani A, Saghari M,
Iran J Nucl Med , Vol.18, No.2, Year. 2010, Page:56-59,
Download
Bone scan with incidental visualization of the entire colon
Authors: Eftekhari M, Fard-Esfahani A, Haghighatafshar M, Keyvan A, Beiki D, Aghahosseini F, Emami-Ardekani A, Saghari M,
Iran J Nucl Med , Vol.18, No.2, Year. 2010, Page:56-59,
Download
103.
Authors: Fard-Esfahani A, Beiki D, Fallahi B, Mohajeri-Tehrani MR, Gharaie MR, Rouhipour N, Dehghanian M, Saghari M, Emami-Ardekani A, Eftekhari M,
Iran J Nucl Med , Vol.18, No.2, Year. 2010, Page:20-28,
Download
Evaluation of 99mTc-Ubiquicidin 29–41 scintigraphy in differentiation of bacterial infection from sterile inflammation in diabetic foot
Authors: Fard-Esfahani A, Beiki D, Fallahi B, Mohajeri-Tehrani MR, Gharaie MR, Rouhipour N, Dehghanian M, Saghari M, Emami-Ardekani A, Eftekhari M,
Iran J Nucl Med , Vol.18, No.2, Year. 2010, Page:20-28,
Download
104.
Authors: Fallahi B, Beiki D, Fard-Esfahani A, Akbarpour S, Abolhassani A, Dabbagh Kakhki VR, Eftekhari M,
Hell J Nucl Med , Vol.13, No.3, Year. 2010, Page:246-252,
Download
The additive value of transient left ventricular dilation using two-day dipyridamole 99mTc-MIBI SPECT for screening coronary artery disease in patients with otherwise normal myocardial perfusion: a comparison between diabetic and non-diabetic cases
Authors: Fallahi B, Beiki D, Fard-Esfahani A, Akbarpour S, Abolhassani A, Dabbagh Kakhki VR, Eftekhari M,
Hell J Nucl Med , Vol.13, No.3, Year. 2010, Page:246-252,
Download
105.
Authors: Haghighatafshar M, Fard-Esfahani A, Karami F, Saghari M, Fallahi B, Beiki D, Aghahosseini F, Eftekhari M,
Iran J Nucl Med , Vol.18, No.1, Year. 2010, Page:57-61,
Download
McCune-Albright syndrome: Report of a case
Authors: Haghighatafshar M, Fard-Esfahani A, Karami F, Saghari M, Fallahi B, Beiki D, Aghahosseini F, Eftekhari M,
Iran J Nucl Med , Vol.18, No.1, Year. 2010, Page:57-61,
Download
106.
Authors: Esfahani AF, Chavoshi M, Noorani MH, Saghari M, Eftekhari M, Beiki D, Beiki D, Fallahi B, Assadi M,
J Med Case Reports , Vol.4, Year. 2010, Page:323,
Download
Successful application of technetium-99m-labeled octreotide acetate scintigraphy in the detection of ectopic adrenocorticotropin-producing bronchial carcinoid lung tumor: a case report
Authors: Esfahani AF, Chavoshi M, Noorani MH, Saghari M, Eftekhari M, Beiki D, Beiki D, Fallahi B, Assadi M,
J Med Case Reports , Vol.4, Year. 2010, Page:323,
Download
107.
Authors: Fard-Esfahani A, Fallahi B, Mohagheghi A, Assadi M, Beiki D, Eftekhari M, Saghari M, Takavar A,
Iran J Nucl Med , Vol.18, No.1, Year. 2010, Page:7-13,
Download
The value of myocardial perfusion imaging with Tc-99m MIBI for the prediction of perfusion improvement after percutaneous transluminal coronary angioplasty
Authors: Fard-Esfahani A, Fallahi B, Mohagheghi A, Assadi M, Beiki D, Eftekhari M, Saghari M, Takavar A,
Iran J Nucl Med , Vol.18, No.1, Year. 2010, Page:7-13,
Download
108.
Authors: Beiki D, Fallahi B, Mohseni M, Khalaj A, Fard-Esfahani A, Eftekhari M,
Nuklearmedizin, Vol.49, No.1, Year. 2010, Page:19-27,
Download
Initial and delayed stress phase imaging in a single-injection double-acquisition SPECT: The potential value of early 99mTc-MIBI redistribution in assessment of myocardial perfusion reversibility in patients with coronary artery disease
Authors: Beiki D, Fallahi B, Mohseni M, Khalaj A, Fard-Esfahani A, Eftekhari M,
Nuklearmedizin, Vol.49, No.1, Year. 2010, Page:19-27,
Download
109.
Authors: Hosseinimehr SJ, Beiki D, Kebriaeezadeh A, Khalaj A, Pirali Hamedani M, Akhlaghpoor S, Esmaeili H, Barazesh A,
Iran J Radiat Res , Vol.7, No.2, Year. 2009, Page:91-96,
Download
Synthesis and radioprotective study of novel amino-alkyldithiocarbamic acid derivatives against γ-irradiation in mice
Authors: Hosseinimehr SJ, Beiki D, Kebriaeezadeh A, Khalaj A, Pirali Hamedani M, Akhlaghpoor S, Esmaeili H, Barazesh A,
Iran J Radiat Res , Vol.7, No.2, Year. 2009, Page:91-96,
Download
110.
Authors: Fallahi B, Beiki D, Mousavi SA, Gholamrezanezhad A, Eftekhari M, Fard-Esfahani A, Alimoghadam K, Mirpour S, Skandarian A, Saghari M,
Hell J Nucl Med, Vol.12, No.3, Year. 2009, Page:255-259,
Download
99mTc-MIBI whole body scintigraphy and P-glycoprotein for the prediction of multiple drug resistance for the prediction of multiple drug resistance
Authors: Fallahi B, Beiki D, Mousavi SA, Gholamrezanezhad A, Eftekhari M, Fard-Esfahani A, Alimoghadam K, Mirpour S, Skandarian A, Saghari M,
Hell J Nucl Med, Vol.12, No.3, Year. 2009, Page:255-259,
Download
111.
Authors: Fard-Esfahani A, Chavoshi M, Eftekhari M, Fallahi B, Beiki D, Saghari M,
Iran J Nucl Med , Vol.17, No.1, Year. 2009, Page:57-60,
Download
Giant cavernous hemangioma on Tc-99m RBC scan
Authors: Fard-Esfahani A, Chavoshi M, Eftekhari M, Fallahi B, Beiki D, Saghari M,
Iran J Nucl Med , Vol.17, No.1, Year. 2009, Page:57-60,
Download
112.
Authors: Ansari Gilani K, Modaresi Esfeh J, Gholamrezanezhad A, Gholami A, Mamishi S, Eftekhari M, Beiki D, Fard-Esfahani A, Fallahi B, Anvari A,
Int Urol Nephrol , Vol.42, No.4, Year. 2009, Page:1041-1047,
Download
Predictors of abnormal renal cortical scintigraphy in children with first urinary tract infection: the importance of time factor
Authors: Ansari Gilani K, Modaresi Esfeh J, Gholamrezanezhad A, Gholami A, Mamishi S, Eftekhari M, Beiki D, Fard-Esfahani A, Fallahi B, Anvari A,
Int Urol Nephrol , Vol.42, No.4, Year. 2009, Page:1041-1047,
Download
113.
Authors: Fard-Esfahani A, Assadi M, Saghari M, Mohagheghie A, Fallahi B, Eftekhari M, Beiki D, Takavar A, Nabipour I, Ebrahimi A, Izadyar S, Ansari-Gilani K,
Hell J Cardiol , Vol.50, No.5, Year. 2009, Page:396-401,
Download
The role of myocardial perfusion imaging in the evaluation of patients undergoing percutaneous transluminal coronary angioplasty
Authors: Fard-Esfahani A, Assadi M, Saghari M, Mohagheghie A, Fallahi B, Eftekhari M, Beiki D, Takavar A, Nabipour I, Ebrahimi A, Izadyar S, Ansari-Gilani K,
Hell J Cardiol , Vol.50, No.5, Year. 2009, Page:396-401,
Download
114.
Authors: Eftekhari M, Beiki D, Fallahi B, Arabi M, Memari F, Gholamrezanezhad A, Esmaeili J, Akhzari F, Fard-Esfahani A,
DARU Journal of Pharmaceutical Sciences, Vol.17, No.2, Year. 2009, Page:83-87,
Download
Assessment the diagnostic accuracy of sentinel lymph nodes lymphoscintigraphy using Technetium-99m phytate in breast cancer
Authors: Eftekhari M, Beiki D, Fallahi B, Arabi M, Memari F, Gholamrezanezhad A, Esmaeili J, Akhzari F, Fard-Esfahani A,
DARU Journal of Pharmaceutical Sciences, Vol.17, No.2, Year. 2009, Page:83-87,
Download
115.
Authors: Fallahi B, Beiki D, Eftekhari M, Ansari Gilani K, Fard-Esfahani A, Gholamrezanezhad A, Yamini Sharif A, Ansari M, Saghari M,
Hell J Nucl Med , Vol.12, No.2, Year. 2009, Page:132-137,
Download
High accuracy of myocardial perfusion imaging in patients with left bundle branch block: comparison of four interpretation approaches
Authors: Fallahi B, Beiki D, Eftekhari M, Ansari Gilani K, Fard-Esfahani A, Gholamrezanezhad A, Yamini Sharif A, Ansari M, Saghari M,
Hell J Nucl Med , Vol.12, No.2, Year. 2009, Page:132-137,
Download
116.
Authors: Fard-Esfahani A, Hadifar M, Fallahi B, Beiki D, Eftekhari M, Saghari M, Takavar A,
Hell J Nucl Med , Vol.12, No.1, Year. 2009, Page:37-40,
Download
Radioiodine treatment complications to the mother and child in patients with differentiated thyroid carcinoma
Authors: Fard-Esfahani A, Hadifar M, Fallahi B, Beiki D, Eftekhari M, Saghari M, Takavar A,
Hell J Nucl Med , Vol.12, No.1, Year. 2009, Page:37-40,
Download
117.
Authors: Hosseinimehr SJ, Ahmadi A, Beiki D, Mahmoudzadeh A, Babaei M, Habibi E,
Genet Mol Res , Vol.8, No.3, Year. 2009, Page:923-928,
Download
The radiotracer 99mTc-MIBI is not genotoxic for human peripheral blood lymphocytes
Authors: Hosseinimehr SJ, Ahmadi A, Beiki D, Mahmoudzadeh A, Babaei M, Habibi E,
Genet Mol Res , Vol.8, No.3, Year. 2009, Page:923-928,
Download
118.
Authors: Hosseinimehr SJ, Ahmadi A, Beiki D, HabibiE, Mahmoudzadeh A,
Nucl Med Biol , No.36, Year. 2009, Page:863-867,
Download
Protective effects of hesperidin against genotoxicity induced by 99mTc-MIBI in human cultured lymphocyte cells
Authors: Hosseinimehr SJ, Ahmadi A, Beiki D, HabibiE, Mahmoudzadeh A,
Nucl Med Biol , No.36, Year. 2009, Page:863-867,
Download
119.
Authors: Fallahi B, Bostani M, Ansari Gilani K, Beiki D, Gholamrezanezhad A,
J Med Case Reports , Vol.3, Year. 2009, Page:7759,
Download
Manifestations of Ollier's disease in a 21-years old man: a case report
Authors: Fallahi B, Bostani M, Ansari Gilani K, Beiki D, Gholamrezanezhad A,
J Med Case Reports , Vol.3, Year. 2009, Page:7759,
Download
120.
Authors: Fard-Esfahani A, Gholamrezanezhad A, Mirpour S, Tari AS, Saghari M, Beiki D, Sichani BF, Eftekhari M,
Orbit, Vol.27, No.4, Year. 2008, Page:237-241,
Download
Assessment of the accuracy of lacrimal scintigraphy based on a prospective analysis of patients' symptomatology
Authors: Fard-Esfahani A, Gholamrezanezhad A, Mirpour S, Tari AS, Saghari M, Beiki D, Sichani BF, Eftekhari M,
Orbit, Vol.27, No.4, Year. 2008, Page:237-241,
Download
121.
Authors: Eftekhari M, Asadollahi A, Beiki D, Izadyar S, Gholamrezanezhad A, Assadi M, Fard-Esfahani A, Fallahi B, Takavar A, Saghari M,
Hell J Nucl Med , Vol.11, No.3, Year. 2008, Page:160-163,
Download
The long term effect of levothyroxine on bone mineral density in patients with well differentiated thyroid carcinoma after treatment
Authors: Eftekhari M, Asadollahi A, Beiki D, Izadyar S, Gholamrezanezhad A, Assadi M, Fard-Esfahani A, Fallahi B, Takavar A, Saghari M,
Hell J Nucl Med , Vol.11, No.3, Year. 2008, Page:160-163,
Download
122.
Authors: Fallahi B, Beiki D, Gholamrezanezhad A, Mahmoudian B, Ansari Gilani K, Eftekhari M, Fard-Esfahani A, Mohseni Z, Saghari M,
Int J Cardiovasc Imaging , Vol.24, No.8, Year. 2008, Page:825-835,
Download
Single Tc-99m Sestamibi injection, double acquisition gated SPECT after stress and during low-dose dobutamine infusion: a new suggested protocol for evaluation of myocardial perfusion
Authors: Fallahi B, Beiki D, Gholamrezanezhad A, Mahmoudian B, Ansari Gilani K, Eftekhari M, Fard-Esfahani A, Mohseni Z, Saghari M,
Int J Cardiovasc Imaging , Vol.24, No.8, Year. 2008, Page:825-835,
Download
123.
Authors: Pooyafard F, Fallahi B, Assadi SM, Amini H, Beiki D, Fard-Esfahani A, Rahiminezhad F, Shahmansouri N, Mohammadi MR,
Iran J Nucl Med , Vol.16, No.1, Year. 2008, Page:43-51,
Download
The pattern of brain perfusion SPECT in non-medicated schizophrenic patients
Authors: Pooyafard F, Fallahi B, Assadi SM, Amini H, Beiki D, Fard-Esfahani A, Rahiminezhad F, Shahmansouri N, Mohammadi MR,
Iran J Nucl Med , Vol.16, No.1, Year. 2008, Page:43-51,
Download
124.
Authors: Beiki D, Eftekhari M, Gheisari F, Hozhabrosadati M, Fard-Esfahani A, Takavar A, Gholamrezanezhad A, Saghari M, Ansari Gilani K,
DARU, Vol.16, No.1, Year. 2008, Page:41-46,
Download
Comparative scintigraphic study of renal function with 99mTc-Mercaptoacetyl-triglycine and 99mTc-Ethylenedicysteine
Authors: Beiki D, Eftekhari M, Gheisari F, Hozhabrosadati M, Fard-Esfahani A, Takavar A, Gholamrezanezhad A, Saghari M, Ansari Gilani K,
DARU, Vol.16, No.1, Year. 2008, Page:41-46,
Download
125.
Authors: Gholamrezanezhad A, Fard-Esfahani A, Sadeghi-Tari A, Mirpour S, Saghari M, Eftekhari M, Fallahi B, Beiki D, Poormoslemi A, Tarbiat A,
Orbit, Vol.26, No.4, Year. 2007, Page:229-235,
Download
Quantitative assessment of dacryoscintigraphic images in the evaluation of epiphora
Authors: Gholamrezanezhad A, Fard-Esfahani A, Sadeghi-Tari A, Mirpour S, Saghari M, Eftekhari M, Fallahi B, Beiki D, Poormoslemi A, Tarbiat A,
Orbit, Vol.26, No.4, Year. 2007, Page:229-235,
Download
126.
Authors: Fard-Esfahani A, Mirshekarpour H, Fallahi B, Eftekhari M, Saghari M, Beiki D, Ansari-Gilani K, Takavar A,
Clin Nucl Med , Vol.32, No.9, Year. 2007, Page:696-699,
Download
The effect of high-dose radioiodine treatment on lacrimal gland function in patients with differentiated thyroid carcinoma
Authors: Fard-Esfahani A, Mirshekarpour H, Fallahi B, Eftekhari M, Saghari M, Beiki D, Ansari-Gilani K, Takavar A,
Clin Nucl Med , Vol.32, No.9, Year. 2007, Page:696-699,
Download
127.
Authors: Gholamrezanezhad A, Saghari M, Mirpour S, Beiki D, Javan S, Abdollahzadeh J,
Endokrynol Pol / Polish J Endocrinol, Vol.58, No.2, Year. 2007, Page:100-104,
Download
On-levothyroxine measurement of thyroglobulin is not a reliable test for the follow-up of patients at high risk for remnant/recurrent differentiated thyroid carcinoma
Authors: Gholamrezanezhad A, Saghari M, Mirpour S, Beiki D, Javan S, Abdollahzadeh J,
Endokrynol Pol / Polish J Endocrinol, Vol.58, No.2, Year. 2007, Page:100-104,
Download
128.
Authors: Gholamrezanezhad A, Mirpour S, Esfahani AF, Saghari M, Mirpour K, Beiki D, Soheilifar M,
Nucl Med Commun, Vol.28, No.1, Year. 2007, Page:41-48,
Download
A correlative study comparing current different methods of calculating left ventricular ejection fraction
Authors: Gholamrezanezhad A, Mirpour S, Esfahani AF, Saghari M, Mirpour K, Beiki D, Soheilifar M,
Nucl Med Commun, Vol.28, No.1, Year. 2007, Page:41-48,
Download
129.
Authors: Fard-Esfahani A, Haddad P, Modares Mosalla MM, Fallahi B, Eftekhari M, Saghari M, Beiki D, Takavar A,
Cancer Bulletin , Vol.1, No.2, Year. 2006, Page:65-76,
Download
Efficacy of pilocarpine for the prevention of radiation induced xerostomia evaluated by semi-quantitative 99mTc-pertechnetate scanning in a randomized trial
Authors: Fard-Esfahani A, Haddad P, Modares Mosalla MM, Fallahi B, Eftekhari M, Saghari M, Beiki D, Takavar A,
Cancer Bulletin , Vol.1, No.2, Year. 2006, Page:65-76,
Download
130.
Authors: Eftekhari M, Gholamrezanezhad A, Izadyar S, Esmaili J, Mirpour S, Saghari M, Fard-Esfahani A, Fallahi Sichani B, Beiki D,
Iran J Nucl Med , Vol.14, No.1, Year. 2006, Page:21-25,
Download
Catheter related artifacts on bone scanes: report of two cases
Authors: Eftekhari M, Gholamrezanezhad A, Izadyar S, Esmaili J, Mirpour S, Saghari M, Fard-Esfahani A, Fallahi Sichani B, Beiki D,
Iran J Nucl Med , Vol.14, No.1, Year. 2006, Page:21-25,
Download
131.
Authors: Eftekhari M, Assadi M, Kazemi M, Saghari M, Mojtahedi A, Fard-Esfahani A, Sichani BF, Beiki D,
Am J Rhinol , Vol.20, No.6, Year. 2006, Page:577-81,
Download
Brain perfusion single photon emission computed tomography findings in patients with posttraumatic anosmia and comparison with radiological imaging
Authors: Eftekhari M, Assadi M, Kazemi M, Saghari M, Mojtahedi A, Fard-Esfahani A, Sichani BF, Beiki D,
Am J Rhinol , Vol.20, No.6, Year. 2006, Page:577-81,
Download
132.
Authors: Fallahi B, Beiki D, Assadi M, Fard-Esfahani A,
Hell J Nucl Med , Vol.9, No.2, Year. 2006, Page:106-108,
Download
Thallium-201 single photon emission tomography after injecting an antimuscarinic agent compared with computed tomography for the diagnosis of recurrent colorectal cancer: Report of three cases
Authors: Fallahi B, Beiki D, Assadi M, Fard-Esfahani A,
Hell J Nucl Med , Vol.9, No.2, Year. 2006, Page:106-108,
Download
133.
Authors: Saghari M, Gholamrezanezhad A, Mirpour S, Eftekhari M, Takavar A, Fard-Esfahani A, Fallahi B, Beiki D,
Nucl Med Commun, Vol.27, No.7, Year. 2006, Page:567-72,
Download
Efficacy of radioiodine therapy in the treatment of elevated serum thyroglobulin in patients with differentiated thyroid carcinoma and negative whole-body iodine scan
Authors: Saghari M, Gholamrezanezhad A, Mirpour S, Eftekhari M, Takavar A, Fard-Esfahani A, Fallahi B, Beiki D,
Nucl Med Commun, Vol.27, No.7, Year. 2006, Page:567-72,
Download
134.
Authors: Saghari M, Assadi M, Eftekhari M, Yaghoubi M, Fard-Esfahani A, Malekzadeh J, Fallahi B, Beiki D, Takavar A,
BMC Nucl Med, Vol.6:1, Year. 2006,
Download
Frequency and severity of myocardial perfusion abnormalities using Tc-99m-MIBI SPECT in cardiac syndrome X
Authors: Saghari M, Assadi M, Eftekhari M, Yaghoubi M, Fard-Esfahani A, Malekzadeh J, Fallahi B, Beiki D, Takavar A,
BMC Nucl Med, Vol.6:1, Year. 2006,
Download
135.
Authors: Fard-Esfahani A, Nazar-Ahari M, Assadi M, Saghari M, Eftekhari M, Fallahi B, Beiki D, Takavar A,
Alasbimn J, Vol.8, No.32, Year. 2006, Page:1-5,
Download
Role of Tc-99m RBC scintigraphy in specific diagnosis of liver hemangioma
Authors: Fard-Esfahani A, Nazar-Ahari M, Assadi M, Saghari M, Eftekhari M, Fallahi B, Beiki D, Takavar A,
Alasbimn J, Vol.8, No.32, Year. 2006, Page:1-5,
Download
136.
Authors: Eftekhari M, Assadi M, Kazemi M, Saghari M, Fard-Esfahani A, Fallahi Sichani B, Gholamrezanezhad A, Beiki D,
BMC Nuclear Medicine , Vol.5, No.6, Year. 2005,
Download
A preliminary study of neuroSPECT evaluation of patients with posttraumatic smell impairment
Authors: Eftekhari M, Assadi M, Kazemi M, Saghari M, Fard-Esfahani A, Fallahi Sichani B, Gholamrezanezhad A, Beiki D,
BMC Nuclear Medicine , Vol.5, No.6, Year. 2005,
Download
137.
Authors: Gholamrezanezhad A, Eftekhari M, Fard A, Fallahi B, Beiki D,
Hell J Nucl Med , Vol.8, No.3, Year. 2005, Page:169-170,
Download
Unilateral absent lung ventilation and perfusion due to hilar mass
Authors: Gholamrezanezhad A, Eftekhari M, Fard A, Fallahi B, Beiki D,
Hell J Nucl Med , Vol.8, No.3, Year. 2005, Page:169-170,
Download
138.
Authors: Avadi MR, Ghassemi AH, Sadeghi AMM, Beiki D, Akbarzadeh A, Ebrahimnejad P, Shahhosseini S, Bayati KH, Rafiiee-Tehrani M,
J Drug Del Sci Technol, Vol.15, No.5, Year. 2005, Page:383-387,
Download
γ-Scintigraphic evaluation of enteric-coated capsules containing chitosan-brilliant blue gel beads as hydrophilic model for colon drug delivery
Authors: Avadi MR, Ghassemi AH, Sadeghi AMM, Beiki D, Akbarzadeh A, Ebrahimnejad P, Shahhosseini S, Bayati KH, Rafiiee-Tehrani M,
J Drug Del Sci Technol, Vol.15, No.5, Year. 2005, Page:383-387,
Download
139.
Authors: Fallahi B, Saghari M, Fard A, Eftekhari M, Iravani M, Beiki D, Dabbagh VR, Sadeghi R,
Hell J Nucl Med , Vol.8, No.3, Year. 2005, Page:158-161,
Download
The value of 99mTc-MIBI whole body scintigraphy in active and in remission multiple myeloma
Authors: Fallahi B, Saghari M, Fard A, Eftekhari M, Iravani M, Beiki D, Dabbagh VR, Sadeghi R,
Hell J Nucl Med , Vol.8, No.3, Year. 2005, Page:158-161,
Download
140.
Authors: Beiki O, Beiki D,
J Med Libr Assoc , Vol.93, No.3, Year. 2005, Page:400-403,
Download
Parsmedline: establishment of a web-based bibliographic database related to Iranian health and medical research
Authors: Beiki O, Beiki D,
J Med Libr Assoc , Vol.93, No.3, Year. 2005, Page:400-403,
Download
141.
Authors: Fard A, Dabbagh VR, Fallahi B, Eftekhari M, Beiki D, Saghari M, Takavar A,
Hell J Nucl Med , Vol.8, No.3, Year. 2005, Page:165-168,
Download
Comparative evaluation of two fixed doses of 185 and 370 MBq 131I, for the treatment of Graves' disease resistant to antithyroid drugs
Authors: Fard A, Dabbagh VR, Fallahi B, Eftekhari M, Beiki D, Saghari M, Takavar A,
Hell J Nucl Med , Vol.8, No.3, Year. 2005, Page:165-168,
Download
142.
Authors: Dowlatabadi R, Khalaj A, Beiki D, Eftekhari M, Al-Seyed Hosein MH, Khoshayand MR,
DARU Journal of Pharmaceutical Sciences, Vol.13, No.1, Year. 2005, Page:6-10,
Download
Microdose 14C Urea breath test for the diagnosis of Helicobacter Pylori: a survey in Iranian population
Authors: Dowlatabadi R, Khalaj A, Beiki D, Eftekhari M, Al-Seyed Hosein MH, Khoshayand MR,
DARU Journal of Pharmaceutical Sciences, Vol.13, No.1, Year. 2005, Page:6-10,
Download
143.
Authors: Saghari M, Moslehi M, Esmaeili J, Tahmasebi MN, Radmehr A, Eftekhari M, Fard-Esfahani A, Beiki D, Fallahi B, Gholamrezanezhad A,
Iran J Nucl Med , Vol.13, No.1, Year. 2005, Page:1-6,
Download
Accuracy of SPECT bone scintigraphy in diagnosis of meniscal tears
Authors: Saghari M, Moslehi M, Esmaeili J, Tahmasebi MN, Radmehr A, Eftekhari M, Fard-Esfahani A, Beiki D, Fallahi B, Gholamrezanezhad A,
Iran J Nucl Med , Vol.13, No.1, Year. 2005, Page:1-6,
Download
144.
Authors: Beiki D, Khalaj A, Dowlatabadi R, Eftekhari M, Eftekhari M, Al-Seyed Hosein MH, Fard A, Fallahi B, Khoshayand MR.,
DARU Journal of Pharmaceutical Sciences, Vol.13, No.2, Year. 2005, Page:52-55,
Download
Validation of 13C-urea breath test with non dispersive isotope selective infrared spectroscopy for the diagnosis of Helicobacter pylori infection: a survey in Iranian population
Authors: Beiki D, Khalaj A, Dowlatabadi R, Eftekhari M, Eftekhari M, Al-Seyed Hosein MH, Fard A, Fallahi B, Khoshayand MR.,
DARU Journal of Pharmaceutical Sciences, Vol.13, No.2, Year. 2005, Page:52-55,
Download
145.
Authors: Shahhosseini S, Beiki D, Dadashzadeh S, Eftekhari M, Tayebi H, Moosazadeh G,
Hell J Nucl Med, Vol.7, No.3, Year. 2004, Page:192-194,
Download
Radiation dose rate and urinary activity in patients with differentiated thyroid carcinoma treated with radioiodine-131; a survey in Iranian population
Authors: Shahhosseini S, Beiki D, Dadashzadeh S, Eftekhari M, Tayebi H, Moosazadeh G,
Hell J Nucl Med, Vol.7, No.3, Year. 2004, Page:192-194,
Download
146.
Authors: Fard A, Fallahi B, Olamaei R, Eftekhari M, Beiki D, Saghari M,
Hell J Nucl Med , Vol.7, No.3, Year. 2004, Page:206-209,
Download
Semi-quantitative assessment of salivary gland function in patients with differentiated thyroid carcinoma after radioiodine-131 treatment
Authors: Fard A, Fallahi B, Olamaei R, Eftekhari M, Beiki D, Saghari M,
Hell J Nucl Med , Vol.7, No.3, Year. 2004, Page:206-209,
Download
147.
Authors: Takavar A, Eftekhari M, Beiki D, Saghari M, Mostaghim M, Sohrabi M,
Iran J Nucl Med , Vol.11, No.2, Year. 2003, Page:13-17,
Download
Qualitative evaluation of Chang method of attenuation correction on heart SPECT by using custom made heart phantom
Authors: Takavar A, Eftekhari M, Beiki D, Saghari M, Mostaghim M, Sohrabi M,
Iran J Nucl Med , Vol.11, No.2, Year. 2003, Page:13-17,
Download
148.
Authors: Eftekhari M, Takavar A, Ansari-Gilani K, Akhzari F, Fard A, Beiki D,
Iran J Nucl Med , Vol.11, No.2, Year. 2003, Page:7-12,
Download
Effects of treatment with radioiodine (131I) on the gonadal function of the hyperthyroid patients
Authors: Eftekhari M, Takavar A, Ansari-Gilani K, Akhzari F, Fard A, Beiki D,
Iran J Nucl Med , Vol.11, No.2, Year. 2003, Page:7-12,
Download
149.
Authors: Beiki D, Amini M, Dowlatabadi R, Pirali M,
Iran J Pharm Res , Vol.2, No.4, Year. 2003, Page:213-216,
Download
Comparative bioavailability of two tablet formulation of dipyridamole in healthy male volunteers
Authors: Beiki D, Amini M, Dowlatabadi R, Pirali M,
Iran J Pharm Res , Vol.2, No.4, Year. 2003, Page:213-216,
Download
150.
Authors: Matloobi M, Rafii H, Beiki D, Khalaj A, Kamali-Dehghan M,
J Radioanal Nucl Chem , Vol.257, No.1, Year. 2003, Page:71-73,
Download
Synthesis of radioiodinated labeled peptides
Authors: Matloobi M, Rafii H, Beiki D, Khalaj A, Kamali-Dehghan M,
J Radioanal Nucl Chem , Vol.257, No.1, Year. 2003, Page:71-73,
Download
151.
Authors: Kumar P, Ohkura K, Beiki D, Wiebe LI, Seki KI,
Chem Pharm Bull, Vol.51, No.4, Year. 2003, Page:399-403,
Download
Synthesis of 1-b-D-(5-deoxy-5-iodoarabinofuranosyl)-2-nitroimidazole (b-IAZA): a novel marker of tissue hypoxia
Authors: Kumar P, Ohkura K, Beiki D, Wiebe LI, Seki KI,
Chem Pharm Bull, Vol.51, No.4, Year. 2003, Page:399-403,
Download
152.
Authors: Kumar P, Wiebe LI, Beiki D, Ohkura K, Seki KI,
Tetrahedron Lett, Vol.43, Year. 2002, Page:4427-4429,
Download
Synthesis of b-azomycin nucleosides: 1-(b-D-2-iodo-2-deoxyarabinofuranosyl)-2-nitroimidazole, a novel marker of tissue hypoxia
Authors: Kumar P, Wiebe LI, Beiki D, Ohkura K, Seki KI,
Tetrahedron Lett, Vol.43, Year. 2002, Page:4427-4429,
Download
153.
Authors: Beiki D, Shahhosseini S, Khalaj A, Eftekhari M,
J Label Compd Radiopharm , Vol.45, No.11, Year. 2002, Page:927-934,
Download
Increased selectivity in inflammatory site identification via labelling of IgG with N-succinimidyl-4-[125I]iodobenzoate
Authors: Beiki D, Shahhosseini S, Khalaj A, Eftekhari M,
J Label Compd Radiopharm , Vol.45, No.11, Year. 2002, Page:927-934,
Download
154.
Authors: Khalaj A, Beiki D, Rafiee H, Najafi R,
J Label Compd Radiopharm , Vol.44, No.3, Year. 2001, Page:235-240,
Download
A new and simple synthesis of N-succinimidyl-4-[125I]iodobenzoate involving a microwave-accelerated iodination step
Authors: Khalaj A, Beiki D, Rafiee H, Najafi R,
J Label Compd Radiopharm , Vol.44, No.3, Year. 2001, Page:235-240,
Download
155.
Authors: Beiki D, Pirali M, Amini M, Shafiee A,
DARU, Vol.7, No.2, Year. 1999, Page:14-17,
Download
High performance liquid chromatographic method for determination of dipyridamole in human plasma
Authors: Beiki D, Pirali M, Amini M, Shafiee A,
DARU, Vol.7, No.2, Year. 1999, Page:14-17,
Download
Farsi
1.
Authors: Emami-Ardekani A, Karamzade-Ziarati N, Salehi Y, Manafi-Farid R, Fard-Esfahani A, Geramifar P, Beiki D, Akhlaghi M, Fallahi B,
Iran South Med J, Vol.25, No.4, Year. 2022, Page:394-407,
Download
Nuclear imaging in patients with differentiated thyroid cancer and negative radioactive iodine scan
Authors: Emami-Ardekani A, Karamzade-Ziarati N, Salehi Y, Manafi-Farid R, Fard-Esfahani A, Geramifar P, Beiki D, Akhlaghi M, Fallahi B,
Iran South Med J, Vol.25, No.4, Year. 2022, Page:394-407,
Download
2.
Authors: Ranjbar H, Bahrami-Samani A, beiki D, Ghannadi-Maragheh M,
J Nucl Sci Technol, No.73, Year. 2015, Page:42-47,
Download
Investigation of radial dose distribution and cumulative dose of radiopharmaceuticals used for pain palliation of bone metastases
Authors: Ranjbar H, Bahrami-Samani A, beiki D, Ghannadi-Maragheh M,
J Nucl Sci Technol, No.73, Year. 2015, Page:42-47,
Download
3.
Authors: Fard-Esfahani P, Fallahi B, Beiki D, Fard-Esfahani A, Emami-Ardekani A, Eftekhari M, Ansari M,
Iran South Med J, Vol.15, No.1, Year. 2012, Page:69-80,
Download
Molecular imaging with PET/CT in oncology
Authors: Fard-Esfahani P, Fallahi B, Beiki D, Fard-Esfahani A, Emami-Ardekani A, Eftekhari M, Ansari M,
Iran South Med J, Vol.15, No.1, Year. 2012, Page:69-80,
Download
4.
Authors: Gholamrezanezhad A, Bagheri M, Mohammadnezhad M, Mirpour S, Majd Ardekani J, Alimoghadam K, Bashtar M, Beiki D, Ansari Gilani K, Saghari M, Ghavamzadeh A, Malekzadeh R,
Iran J Nucl Med , Vol.15, No.2, Year. 2007, Page:25-27,
Download
The First Experience of Stem Cell Labeling in Iran Using 111In- Oxine
Authors: Gholamrezanezhad A, Bagheri M, Mohammadnezhad M, Mirpour S, Majd Ardekani J, Alimoghadam K, Bashtar M, Beiki D, Ansari Gilani K, Saghari M, Ghavamzadeh A, Malekzadeh R,
Iran J Nucl Med , Vol.15, No.2, Year. 2007, Page:25-27,
Download
5.
Authors: Fard-Esfahani A, Fallahi B, Saghari M, Eftekhari M, Beiki D,
Iran J Nucl Med , Vol.15, No.1, Year. 2007, Page:16-23,
Download
Myocardial perfusion scan accuracy in detection of coronary artery disease - Comparison with exercise stress test
Authors: Fard-Esfahani A, Fallahi B, Saghari M, Eftekhari M, Beiki D,
Iran J Nucl Med , Vol.15, No.1, Year. 2007, Page:16-23,
Download
6.
Authors: Beiki D, Gholamrezanezhad A, Mirpour S, Fallahi B, Saghari M, Eftekhari M, Fard-Esfahani A, Hajimahmoudi H,
J Mazandaran Univ Med Sci , Vol.16, No.56, Year. 2007, Page:1-8,
Download
The relationship between dyspepsia and increased radiotracer uptake in the gastric wall during 99mTc-MIBI myocardial perfusion imaging
Authors: Beiki D, Gholamrezanezhad A, Mirpour S, Fallahi B, Saghari M, Eftekhari M, Fard-Esfahani A, Hajimahmoudi H,
J Mazandaran Univ Med Sci , Vol.16, No.56, Year. 2007, Page:1-8,
Download
7.
Authors: Fard-Esfahani A, Fallahi B, Khatami K, Eftekhari M, Saghari M, Beiki D, Ansari-Gilani K, Takavar A,
Iran J Nucl Med , Vol.14, No.2, Year. 2006, Page:8-12,
Download
Agreement of two methods of planar and SPECT scintigraphy with 99mTc-RBC in detection of liver hemangioma
Authors: Fard-Esfahani A, Fallahi B, Khatami K, Eftekhari M, Saghari M, Beiki D, Ansari-Gilani K, Takavar A,
Iran J Nucl Med , Vol.14, No.2, Year. 2006, Page:8-12,
Download
8.
Authors: Fard-Esfahani A, Assadi M, Saghari M, Eftekhari M, Fallahi Sichani B, Beiki D, Akbarpour S, Mohammadian B,
Iran J Nucl Med , Vol.13, No.2, Year. 2005, Page:1-5,
Download
Myocardial 99mTc-MDP uptake on the bone scintigraphy in the hemodialysis-associated amyloidosis: A case report
Authors: Fard-Esfahani A, Assadi M, Saghari M, Eftekhari M, Fallahi Sichani B, Beiki D, Akbarpour S, Mohammadian B,
Iran J Nucl Med , Vol.13, No.2, Year. 2005, Page:1-5,
Download
9.
Authors: Eftekhari M, Saghari M, Noorani MH, Fard-Esfahani A, Beiki D, Fallahi B,
Iran J Nucl Med , Vol.13, No.2, Year. 2005, Page:25-29,
Download
Evaluation of diagnostic role of 99mTc-Tetrofosmin scintigraphy in cold thyroid nodules
Authors: Eftekhari M, Saghari M, Noorani MH, Fard-Esfahani A, Beiki D, Fallahi B,
Iran J Nucl Med , Vol.13, No.2, Year. 2005, Page:25-29,
Download
10.
Authors: Fard Esfahani A, Akhzari F, Mirshekarpour H, Saghari M, Izadyar S, Esmaili J, Fallahi B, Beiki D,
Iran J Nucl Med, Vol.13, No.2, Year. 2005, Page:6-14,
Download
Radioiodine treatment effects on lacrimal glands function in patients with thyroid cancer
Authors: Fard Esfahani A, Akhzari F, Mirshekarpour H, Saghari M, Izadyar S, Esmaili J, Fallahi B, Beiki D,
Iran J Nucl Med, Vol.13, No.2, Year. 2005, Page:6-14,
Download
11.
Authors: Dowlatabadi R, Beiki D, Khalaj A,
Iran J Nucl Med , Vol.13, No.1, Year. 2005, Page:1-13,
Download
Radiopharmaceutical regulation world wide - the resemblances and the differences
Authors: Dowlatabadi R, Beiki D, Khalaj A,
Iran J Nucl Med , Vol.13, No.1, Year. 2005, Page:1-13,
Download
12.
Authors: Fard A, Emami F, Eftekhari M, Saghari M, Fallahi B, Beiki D, Takavar A,
Iran J Nucl Med , Vol.12, No.2, Year. 2004, Page:15-20,
Download
The value of myocardial perfusion imaging in differentiating between idiopathic dilated cardiomyopathy from the ischemic form
Authors: Fard A, Emami F, Eftekhari M, Saghari M, Fallahi B, Beiki D, Takavar A,
Iran J Nucl Med , Vol.12, No.2, Year. 2004, Page:15-20,
Download
13.
Authors: Fard-Esfehani A, Eftekhari M, Aliyari N, Saghari M, Beiki D,
Tehran Univ Med J -TUMJ, Vol.62, No.1, Year. 2004, Page:31-36,
Download
Effects of treatment with radioactive iodine on gonadal functions in patients with differentiated thyroid cancer
Authors: Fard-Esfehani A, Eftekhari M, Aliyari N, Saghari M, Beiki D,
Tehran Univ Med J -TUMJ, Vol.62, No.1, Year. 2004, Page:31-36,
Download
14.
Authors: Eftekhari M, Assadi M, Fard-Esfehani A, Beiki D, Fallahi B,
Iran J Nucl Med , Vol.12, No.2, Year. 2004, Page:1-4,
Download
Dystrophic calcinosis cutis and SLE; the bone scan pattern
Authors: Eftekhari M, Assadi M, Fard-Esfehani A, Beiki D, Fallahi B,
Iran J Nucl Med , Vol.12, No.2, Year. 2004, Page:1-4,
Download
15.
Authors: Eftekhari M, Sadeghi R, Fard A, Beiki D, Fallahi B, Saghari M,
Iran J Nucl Med , Vol.12, No.1, Year. 2004, Page:25-32,
Download
Reverse re-distribution in myocardial perfusion scan with 201Tl
Authors: Eftekhari M, Sadeghi R, Fard A, Beiki D, Fallahi B, Saghari M,
Iran J Nucl Med , Vol.12, No.1, Year. 2004, Page:25-32,
Download
16.
Authors: Saghari M, Fallahi B, Eftekhari M, Iravani M, Izadyar S, Esmaili J, Beiki D, Fard A,
Iran J Nucl Med , Vol.12, No.1, Year. 2004, Page:15-23,
Download
Value of 99mTc-MIBI scintigraphy in active disease and remission phase of multiple myeloma
Authors: Saghari M, Fallahi B, Eftekhari M, Iravani M, Izadyar S, Esmaili J, Beiki D, Fard A,
Iran J Nucl Med , Vol.12, No.1, Year. 2004, Page:15-23,
Download
17.
Authors: Beiki D, Shahhosseini S, Dadashzadeh S, Eftekhari M, Tayebi H, Moosazadeh-Rashti G,
Iran J Nucl Med , Vol.12, No.1, Year. 2004, Page:1-13,
Download
Determination of radiation dose rates and urinary activity of patients received sodium iodide-131 for treatment of differentiated thyroid carcinoma
Authors: Beiki D, Shahhosseini S, Dadashzadeh S, Eftekhari M, Tayebi H, Moosazadeh-Rashti G,
Iran J Nucl Med , Vol.12, No.1, Year. 2004, Page:1-13,
Download
18.
Authors: Eftekhari M, Olamaei R, Fard A, Beiki D, Saghari M,
Iran J Nucl Med , Vol.11, No.2, Year. 2003, Page:7-11,
Download
131I-MIBG scintigraphy in carcinoid tumor with liver metastases
Authors: Eftekhari M, Olamaei R, Fard A, Beiki D, Saghari M,
Iran J Nucl Med , Vol.11, No.2, Year. 2003, Page:7-11,
Download
19.
Authors: Shahosseini S, Beiki D, Eftekhari M,
Iran J Nucl Med , Vol.11, No.2, Year. 2003, Page:21-33,
Download
Gamma-scintigraphy in the evaluation of drug delivery systems
Authors: Shahosseini S, Beiki D, Eftekhari M,
Iran J Nucl Med , Vol.11, No.2, Year. 2003, Page:21-33,
Download
20.
Authors: Fard-Esfahani A, Olamaei R, Eftekhari M, Saghari M, Beiki D,
Iran J Nucl Med , Vol.11, No.1, Year. 2003, Page:17-21,
Download
Radioiodine therapy effects on salivaroy gland function in patients with differentiated thyroid cancer
Authors: Fard-Esfahani A, Olamaei R, Eftekhari M, Saghari M, Beiki D,
Iran J Nucl Med , Vol.11, No.1, Year. 2003, Page:17-21,
Download
21.
Authors: Beiki D, Shahhosseini S, Eftekhari M, Takavar A,
Iran J Nucl Med , Vol.11, No.1, Year. 2003, Page:9-16,
Download
Contamination monitoring of Na 131I level in therapy unit of Research Institute for Nuclear Medicine, Tehran University of Medical Sciences, by indirect method: wipe test
Authors: Beiki D, Shahhosseini S, Eftekhari M, Takavar A,
Iran J Nucl Med , Vol.11, No.1, Year. 2003, Page:9-16,
Download
Abstracts and Presentations
Farsi
1.
The 4th Euro-Asian pharmacoepidemiology congress (EAPEC 2022)
13-15 December, 2022
Global market and pharmacoepidemiology of radiopharmaceuticals: Latest trends and insights
The 4th Euro-Asian pharmacoepidemiology congress (EAPEC 2022)
13-15 December, 2022
2.
Seminar on Role of Radiopharmaceuticals in Diagnosis and Treatment of Cancers
Location: Tehran, Iran,
12 May, 2022
Radiopharmaceuticals market: The latest trend & analysis report of 2020
Seminar on Role of Radiopharmaceuticals in Diagnosis and Treatment of Cancers
Location: Tehran, Iran,
12 May, 2022
3.
5th Pharmacy-Updates Congress
Location: Tehran, Iran,
15 February, 2022
Clinical application of radiopharmaceuticals
5th Pharmacy-Updates Congress
Location: Tehran, Iran,
15 February, 2022
4.
Third Conference on New Horizons in Pharmacy Education
Location: Tehran, Iran,
7 July, 2021
Translational Nuclear Pharmacy and Radiopharmaceuticals, Future Research and Practice
Third Conference on New Horizons in Pharmacy Education
Location: Tehran, Iran,
7 July, 2021
5.
3rd TPCF Preclinical Imaging Symposium
Location: Tehran, Iran,
5-6 August, 2020
Preclinical studies for radiopharmaceuticals: The Iranian activities & experiences
3rd TPCF Preclinical Imaging Symposium
Location: Tehran, Iran,
5-6 August, 2020
6.
23rd Iranian Congress of Nuclear Medicine
Location: Tehran, Iran,
27-29 November, 2019
Computational, radiolabeling and biological studies: A diagnostic biomolecule for targeting amyloid-β plaques in Alzheimer ’s disease rat model
23rd Iranian Congress of Nuclear Medicine
Location: Tehran, Iran,
27-29 November, 2019
7.
23rd Iranian Congress of Nuclear Medicine
Location: Tehran, Iran,
27-29 November, 2019
68Ga-labeled RGD peptide as an early diagnostic agent for overexpressed αvβ3 integrin receptors in Non-small cell lung cancer (NSCLC)
23rd Iranian Congress of Nuclear Medicine
Location: Tehran, Iran,
27-29 November, 2019
8.
23rd Iranian Congress of Nuclear Medicine
Location: Tehran, Iran,
27-29 November, 2019
Fibroblast activation protein (FAP) inhibitors: Novel ligands for PET/CT imaging
23rd Iranian Congress of Nuclear Medicine
Location: Tehran, Iran,
27-29 November, 2019
9.
23rd Iranian Congress of Nuclear Medicine
Location: Tehran, Iran,
27-29 November, 2019
Development of Ga-68 radiolabeled, biotinylated thiosemicarbazone dextran-coated iron oxide nanoparticles as the multimodal PET/MRI probe
23rd Iranian Congress of Nuclear Medicine
Location: Tehran, Iran,
27-29 November, 2019
10.
23rd Iranian Congress of Nuclear Medicine
Location: Tehran, Iran,
27-29 November, 2019
Practical flowchart for theragnostics: An experience fromShariati Hospital
23rd Iranian Congress of Nuclear Medicine
Location: Tehran, Iran,
27-29 November, 2019
11.
23rd Iranian Congress of Nuclear Medicine
Location: Tehran, Iran,
27-29 November, 2019
Theragnostics with Lutetium-177 labelled peptides: Changes and challenges
23rd Iranian Congress of Nuclear Medicine
Location: Tehran, Iran,
27-29 November, 2019
12.
23rd Iranian Congress of Nuclear Medicine
Location: Tehran, Iran,
27-29 November, 2019
Months of experience in 68Ga-DOTATATE PET/CT imaging in SSTR positive malignancies
23rd Iranian Congress of Nuclear Medicine
Location: Tehran, Iran,
27-29 November, 2019
13.
23rd Iranian Congress of Nuclear Medicine
Location: Tehran, Iran,
27-29 November, 2019
Preliminary results of treating metastatic castration-resistant prostate cancer (mCRPC) patients using Lu-177-PSMA
23rd Iranian Congress of Nuclear Medicine
Location: Tehran, Iran,
27-29 November, 2019
14.
23rd Iranian Congress of Nuclear Medicine
Location: Tehran, Iran,
27-29 November, 2019
Nuclear pharmacy practice - An overview
23rd Iranian Congress of Nuclear Medicine
Location: Tehran, Iran,
27-29 November, 2019
15.
23rd Iranian Congress of Nuclear Medicine
Location: Tehran, Iran,
27-29 November, 2019
Radiopharmaceuticals market: Latest trend & analysis report of 2018
23rd Iranian Congress of Nuclear Medicine
Location: Tehran, Iran,
27-29 November, 2019
16.
22nd Iranian Congress of Nuclear Medicine
Location: Yazd, Iran,
23-25 November, 2018
18F-FDG production and quality control: An overview
22nd Iranian Congress of Nuclear Medicine
Location: Yazd, Iran,
23-25 November, 2018
17.
22nd Iranian Congress of Nuclear Medicine
Location: Yazd, Iran,
23-25 November, 2018
Radiopharmaceuticals market: Latest trend & analysis report of 2017
22nd Iranian Congress of Nuclear Medicine
Location: Yazd, Iran,
23-25 November, 2018
18.
1st TUMS preclinical Imaging Symposium
Location: Tehran, Iran,
14 May, 2018
Gallium-68: A magic radioisotope from preclinical to clinical applications
1st TUMS preclinical Imaging Symposium
Location: Tehran, Iran,
14 May, 2018
19.
21st Iranian Congress of Nuclear Medicine
Location: Mashhad, Iran,
22-24 November, 2017
Synthesis, characterization and Ga-68 radiolabelling of dextran dialdehyde thiosemicarbazone
21st Iranian Congress of Nuclear Medicine
Location: Mashhad, Iran,
22-24 November, 2017
20.
Location: Mashhad, Iran,
22-24 November, 2017
Synthesis, spectroscopic, in vitro anti-tumor and Ga-68 radiolabelling studies of a novel chelating agent: Mercapto acetic acid (2-hydroxy-benzyl hdrazone)
Location: Mashhad, Iran,
22-24 November, 2017
21.
21st Iranian Congress of Nuclear Medicine
Location: Mashhad, Iran,
22-24 November, 2017
Biodistribution assessment of 68Ga-PSMA-617 in breast adenocarcinoma B mice
21st Iranian Congress of Nuclear Medicine
Location: Mashhad, Iran,
22-24 November, 2017
22.
Location: Mashhad, Iran,
22-24 November, 2017
Biological evaluation of 68Ga-pyridoxal isonicotinoyl hdrazone as a PET radiotracer
Location: Mashhad, Iran,
22-24 November, 2017
23.
21st Iranian Congress of Nuclear Medicine
Location: Mashhad, Iran,
22-24 November, 2017
Synthesis, characterization and Ga-68 radiolabelling of dicarboxy dextran for PET-CT studies
21st Iranian Congress of Nuclear Medicine
Location: Mashhad, Iran,
22-24 November, 2017
24.
21st Iranian Congress of Nuclear Medicine
Location: Mashhad, Iran,
22-24 November, 2017
Dextran coated Fe3O4 thiosemicarbazone nanoparticles: Fabrication, characterization, Ga-68 labelling and primary biological evaluation as a novel potential multifunctional PET-MRI contrast agent
21st Iranian Congress of Nuclear Medicine
Location: Mashhad, Iran,
22-24 November, 2017
25.
21st Iranian Congress of Nuclear Medicine
Location: Mashhad, Iran,
22-24 November, 2017
The global vs. local market for radiopharmaceuticals: Report of 2016
21st Iranian Congress of Nuclear Medicine
Location: Mashhad, Iran,
22-24 November, 2017
26.
PET/CT Seminar
Location: Tehran, Iran,
13-14 April, 2017
18F-FDG: The Production and Quality Control
PET/CT Seminar
Location: Tehran, Iran,
13-14 April, 2017
27.
20th Iranian Congress of Nuclear Medicine
Location: Mahmoudabad, Iran,
26-28 October, 2016
New peptide based radiopharmaceutical for melanoma imaging
20th Iranian Congress of Nuclear Medicine
Location: Mahmoudabad, Iran,
26-28 October, 2016
28.
20th Iranian Congress of Nuclear Medicine
Location: Mahmoudabad, Iran,
26-28 October, 2016
Factors interfering with myocardial 18F-FDG uptake in oncologic PET-CT imaging
20th Iranian Congress of Nuclear Medicine
Location: Mahmoudabad, Iran,
26-28 October, 2016
29.
20th Iranian Congress of Nuclear Medicine
Location: Mahmoudabad, Iran,
26-28 October, 2016
68Ga-Radiopharmaceuticals in PET Imaging: The future Perspectives
20th Iranian Congress of Nuclear Medicine
Location: Mahmoudabad, Iran,
26-28 October, 2016
30.
20th Iranian Congress of Nuclear Medicine
Location: Mahmoudabad, Iran,
26-28 October, 2016
Radiopharmaceuticals Consumption: Iran vs. Global Market Review in 2014
20th Iranian Congress of Nuclear Medicine
Location: Mahmoudabad, Iran,
26-28 October, 2016
31.
19th Iranian Congress of Nuclear Medicine
Location: Hamedan, Iran,
16-18 September, 2015
Preparation and Evaluation of 68Ga-ECC as a PET Renal Imaging Agent
19th Iranian Congress of Nuclear Medicine
Location: Hamedan, Iran,
16-18 September, 2015
32.
19th Iranian Congress of Nuclear Medicine
Location: Hamedan, Iran,
16-18 September, 2015
Optimized production and quality control of 68Ga-EDTMP for small clinical trials
19th Iranian Congress of Nuclear Medicine
Location: Hamedan, Iran,
16-18 September, 2015
33.
19th Iranian Congress of Nuclear Medicine
Location: Hamedan, Iran,
16-18 September, 2015
Production of 68Ga-Ethyl cysteinate dimmer for PET studies
19th Iranian Congress of Nuclear Medicine
Location: Hamedan, Iran,
16-18 September, 2015
34.
19th Iranian Congress of Nuclear Medicine
Location: Hamedan, Iran,
16-18 September, 2015
Nuclear Medicine Market Worldwide
19th Iranian Congress of Nuclear Medicine
Location: Hamedan, Iran,
16-18 September, 2015
35.
18th Iranian Congress of Nuclear Medicine
Location: Tehran, Iran,
12-14 November, 2014
Turkey vs. Iran – Nuclear Medicine Comparison
18th Iranian Congress of Nuclear Medicine
Location: Tehran, Iran,
12-14 November, 2014
36.
18th Iranian Congress of Nuclear Medicine
Location: Tehran, Iran,
12-14 November, 2014
Prospective management of the production and clinical applications of radiopharmaceuticals in Iran: Opportunities and challenges
18th Iranian Congress of Nuclear Medicine
Location: Tehran, Iran,
12-14 November, 2014
37.
18th Iranian Congress of Nuclear Medicine
Location: Tehran, Iran,
12-14 November, 2014
preparation and quality control of 111In-Plerixafor for CXCR4 imaging
18th Iranian Congress of Nuclear Medicine
Location: Tehran, Iran,
12-14 November, 2014
38.
18th Iranian Congress of Nuclear Medicine
Location: Tehran, Iran,
12-14 November, 2014
synthesis and evaluation of 67Ga-plerixafor; a novel imaging agent for targeting chemokine receptor CXCR4
18th Iranian Congress of Nuclear Medicine
Location: Tehran, Iran,
12-14 November, 2014
39.
18th Iranian Congress of Nuclear Medicine
Location: Tehran, Iran,
12-14 November, 2014
Synthesis and Evaluation of [68Ga]- plerixafor for PET imaging of human colorectal carcinoma
18th Iranian Congress of Nuclear Medicine
Location: Tehran, Iran,
12-14 November, 2014
40.
18th Iranian Congress of Nuclear Medicine
Location: Tehran, Iran,
12-14 November, 2014
Radiosynthesis and biodistribution studies of [62Zn/62Cu]– plerixafor complex as a novel in vivo PET generator for chemokine receptor imaging
18th Iranian Congress of Nuclear Medicine
Location: Tehran, Iran,
12-14 November, 2014
41.
18th Iranian Congress of Nuclear Medicine
Location: Tehran, Iran,
12-14 November, 2014
Radiolabeling of a melanocyte stimulating hormone derivative for single photon imaging
18th Iranian Congress of Nuclear Medicine
Location: Tehran, Iran,
12-14 November, 2014
42.
18th Iranian Congress of Nuclear Medicine
Location: Tehran, Iran,
12-14 November, 2014
Production, Radiolabeling Optimization and Imaging Studies a combined 153Sm/177Lu-EDTMP formulation as a novel potential radiopharmaceutical for metastatic bone pain palliation therapy
18th Iranian Congress of Nuclear Medicine
Location: Tehran, Iran,
12-14 November, 2014
43.
18th Iranian Congress of Nuclear Medicine
Location: Tehran, Iran,
12-14 November, 2014
One step radiolabeling of peptide LIKKPF with 18FDG for detecting of apoptosis
18th Iranian Congress of Nuclear Medicine
Location: Tehran, Iran,
12-14 November, 2014
44.
18th Iranian Congress of Nuclear Medicine
Location: Tehran, Iran,
12-14 November, 2014
Comparison of curability of tumors treated with targeted radionuclide therapy and external beam radiotherapy
18th Iranian Congress of Nuclear Medicine
Location: Tehran, Iran,
12-14 November, 2014
45.
18th Iranian Congress of Nuclear Medicine
Location: Tehran, Iran,
12-14 November, 2014
Lower Limbs Perfusion Scintigraphy in Patients Referred for Myocardial Perfusion Imaging
18th Iranian Congress of Nuclear Medicine
Location: Tehran, Iran,
12-14 November, 2014
46.
14th Iranian Annual and International Congress of Nuclear Medicine
Location: Mashhad, Iran,
4-6 November, 2010
Nasolacrimal duct obstruction as a complication of iodine-131 therapy in patients with thyroid cancer
14th Iranian Annual and International Congress of Nuclear Medicine
Location: Mashhad, Iran,
4-6 November, 2010
47.
14th Iranian Annual and International Congress of Nuclear Medicine
Location: Mashhad, Iran,
4-6 November, 2010
The effectiveness of 153Sm-EDTMP for palliative therapy of patients with painful multiple bone metastases
14th Iranian Annual and International Congress of Nuclear Medicine
Location: Mashhad, Iran,
4-6 November, 2010
48.
14th Iranian Annual and International Congress of Nuclear Medicine
Location: Mashhad, Iran,
4-6 November, 2010
The distribution of bone metastases on 146 whole body scans
14th Iranian Annual and International Congress of Nuclear Medicine
Location: Mashhad, Iran,
4-6 November, 2010
49.
14th Iranian Annual and International Congress of Nuclear Medicine
Location: Mashhad, Iran,
4-6 November, 2010
Predicting factors of successful post-surgical remnant ablation in radioiodine-treated patients with differentiated thyroid carcinoma
14th Iranian Annual and International Congress of Nuclear Medicine
Location: Mashhad, Iran,
4-6 November, 2010
50.
14th Iranian Annual and International Congress of Nuclear Medicine
Location: Mashhad, Iran,
4-6 November, 2010
Development of second primary cancer in radioiodine treated patients with differentiated thyroid carcinoma
14th Iranian Annual and International Congress of Nuclear Medicine
Location: Mashhad, Iran,
4-6 November, 2010
51.
20th international congress of pediatrics
Location: Tehran, Iran,
7-14 October, 2008
PET scanning of pediatric tumors
20th international congress of pediatrics
Location: Tehran, Iran,
7-14 October, 2008
52.
12th Iranian Annual Congress of Nuclear Medicine
Location: Sari, Iran,
25-27 June, 2008
New therapeutic radiopharmaceuticals in Iran
12th Iranian Annual Congress of Nuclear Medicine
Location: Sari, Iran,
25-27 June, 2008
53.
12th Iranian Annual Congress of Nuclear Medicine
Location: Sari, Iran,
25-27 June, 2008
Preparation of patients with thyroid cancer for I-131 scintigraphy or therapy by 1-3 weeks of levothyroxine discontinuation or after total thyroidectomy
12th Iranian Annual Congress of Nuclear Medicine
Location: Sari, Iran,
25-27 June, 2008
54.
12th Iranian Annual Congress of Nuclear Medicine
Location: Sari, Iran,
25-27 June, 2008
Pitfalls of FDG-PET imaging in oncology
12th Iranian Annual Congress of Nuclear Medicine
Location: Sari, Iran,
25-27 June, 2008
55.
12th Iranian Annual Congress of Nuclear Medicine
Location: Sari, Iran,
25-27 June, 2008
Renal axis deviation in urinary tract abnormalities of children; the role of DMSA renal scintigraphy
12th Iranian Annual Congress of Nuclear Medicine
Location: Sari, Iran,
25-27 June, 2008
56.
12th Iranian Annual Congress of Nuclear Medicine
Location: Sari, Iran,
25-27 June, 2008
The role of myocardial perfusion scan in diabetic patients
12th Iranian Annual Congress of Nuclear Medicine
Location: Sari, Iran,
25-27 June, 2008
57.
12th Iranian Annual Congress of Nuclear Medicine
Location: Sari, Iran,
25-27 June, 2008
PET in gastrointestinal oncology-advantages and a few pitfalls
12th Iranian Annual Congress of Nuclear Medicine
Location: Sari, Iran,
25-27 June, 2008
58.
12th Iranian Annual Congress of Nuclear Medicine
Location: Sari, Iran,
25-27 June, 2008
Radioiodine treatment complication in mother and child in patients with differentiated thyroid carcinoma
12th Iranian Annual Congress of Nuclear Medicine
Location: Sari, Iran,
25-27 June, 2008
59.
12th Iranian Annual Congress of Nuclear Medicine
Location: Sari, Iran,
25-27 June, 2008
Cytotoxicity of 111In-oxine on mesenchymal stem cells: a time dependent adverse effect
12th Iranian Annual Congress of Nuclear Medicine
Location: Sari, Iran,
25-27 June, 2008
60.
10th Iranian Annual Congress of Nuclear Medicine
Location: Tehran, Iran,
6-7 December, 2006
Comparison between brain perfusion single photon emission computed tomography (SPECT) and anatomical imaging in chronic complications of traumatic head injury
10th Iranian Annual Congress of Nuclear Medicine
Location: Tehran, Iran,
6-7 December, 2006
61.
10th Iranian Annual Congress of Nuclear Medicine
Location: Tehran, Iran,
6-7 December, 2006
NeuroSPECT evaluation in patients with post-traumatic anosmia, a preliminary study
10th Iranian Annual Congress of Nuclear Medicine
Location: Tehran, Iran,
6-7 December, 2006
62.
10th Iranian Annual Congress of Nuclear Medicine
Location: Tehran, Iran,
6-7 December, 2006
Assessment of the accuracy of lacrimal scintigraphy based on a prospective analysis of patients’ symptomatology
10th Iranian Annual Congress of Nuclear Medicine
Location: Tehran, Iran,
6-7 December, 2006
63.
10th Iranian Annual Congress of Nuclear Medicine
Location: Tehran, Iran,
6-7 December, 2006
Analysis of dacryoscintigraphic images based on a simple quantitative measure
10th Iranian Annual Congress of Nuclear Medicine
Location: Tehran, Iran,
6-7 December, 2006
64.
10th Iranian Annual Congress of Nuclear Medicine
Location: Tehran, Iran,
6-7 December, 2006
On-levothyroxine measurement of thyroglobulin is not a reliable screening test for patients at high risk of remnant/recurrent differentiated thyroid carcinoma
10th Iranian Annual Congress of Nuclear Medicine
Location: Tehran, Iran,
6-7 December, 2006
65.
10th Iranian Annual Congress of Nuclear Medicine
Location: Tehran, Iran,
6-7 December, 2006
Nuclear medicine imaging techniques in the evaluation of pharmaceutical formulations
10th Iranian Annual Congress of Nuclear Medicine
Location: Tehran, Iran,
6-7 December, 2006
66.
10th Iranian Annual Congress of Nuclear Medicine
Location: Tehran, Iran,
6-7 December, 2006
Accuracy of myocardial perfusion scan in detection of coronary artery disease- comparison with exercise stress test
10th Iranian Annual Congress of Nuclear Medicine
Location: Tehran, Iran,
6-7 December, 2006
67.
10th Iranian Annual Congress of Nuclear Medicine
Location: Tehran, Iran,
6-7 December, 2006
Discontinuing of long-term beta-blocker therapy may falsely overestimate the fixed defects in dipyridamole myocardial perfusion imaging
10th Iranian Annual Congress of Nuclear Medicine
Location: Tehran, Iran,
6-7 December, 2006
68.
10th Iranian Annual Congress of Nuclear Medicine
Location: Tehran, Iran,
6-7 December, 2006
The best pattern of interpretation in dipyridamole myocardial perfusion scan for diagnosis of coronary artery disease in the territory of left anterior descending artery in patients with left bundle branch block
10th Iranian Annual Congress of Nuclear Medicine
Location: Tehran, Iran,
6-7 December, 2006
69.
10th Iranian Annual Congress of Nuclear Medicine
Location: Tehran, Iran,
6-7 December, 2006
Evaluation of a new mono-phasic imaging protocol in comparison with conventional dual-phase study of myocardial perfusion
10th Iranian Annual Congress of Nuclear Medicine
Location: Tehran, Iran,
6-7 December, 2006
70.
10th Iranian Annual Congress of Nuclear Medicine
Location: Tehran, Iran,
6-7 December, 2006
The relation between helicobacter pylori infection and cardiac syndrome X; a preliminary study
10th Iranian Annual Congress of Nuclear Medicine
Location: Tehran, Iran,
6-7 December, 2006
71.
10th Iranian Annual Congress of Nuclear Medicine
Location: Tehran, Iran,
6-7 December, 2006
The long term effects of mustard gas on myocardial perfusion pattern of intoxicated warfare patients
10th Iranian Annual Congress of Nuclear Medicine
Location: Tehran, Iran,
6-7 December, 2006
72.
10th Iranian Annual Congress of Nuclear Medicine
Location: Tehran, Iran,
6-7 December, 2006
The role of scintigraphicperfusion imaging in the evaluation of patients before and after percutaneous transluminal coronary angioplasty
10th Iranian Annual Congress of Nuclear Medicine
Location: Tehran, Iran,
6-7 December, 2006
73.
18th International Congress of Pediatrics
Location: Tehran, Iran,
27 Oct-1 Nov, 2006
Indirect radionuclide cystography in children
18th International Congress of Pediatrics
Location: Tehran, Iran,
27 Oct-1 Nov, 2006
74.
18th International Congress of Pediatrics
Location: Tehran, Iran,
27 Oct-1 Nov, 2006
Renal cortical scintigraphy in children
18th International Congress of Pediatrics
Location: Tehran, Iran,
27 Oct-1 Nov, 2006
75.
18th International Congress of Pediatrics
Location: Tehran, Iran,
27 Oct-1 Nov, 2006
Nuclear medicine role in neonatal jaundice
18th International Congress of Pediatrics
Location: Tehran, Iran,
27 Oct-1 Nov, 2006
76.
The 8th National Congress of Microbiology
Location: Isfahan, Iran,
23-25 May, 2006
Application of Microdose Radiolabeled 14C-Urea for the Detection of Helicobacter Pylori Infection
The 8th National Congress of Microbiology
Location: Isfahan, Iran,
23-25 May, 2006
77.
13th Asia-Oceania Congress of Endocrinology
Location: Tehran, Iran,
10-12 May, 2006
Review of the role of nuclear medicine in the management of the adrenal diseases
13th Asia-Oceania Congress of Endocrinology
Location: Tehran, Iran,
10-12 May, 2006
78.
17th International Congress of Pediatrics
Location: Tehran, Iran,
8-13 October, 2005
Evaluation of congenital renal fusion anomalies with 99mTc-DMSA
17th International Congress of Pediatrics
Location: Tehran, Iran,
8-13 October, 2005
79.
17th International Congress of Pediatrics
Location: Tehran, Iran,
8-13 October, 2005
The role of thyroid scan in evaluating of congenital hypothyroidism
17th International Congress of Pediatrics
Location: Tehran, Iran,
8-13 October, 2005
80.
17th International Congress of Pediatrics
Location: Tehran, Iran,
8-13 October, 2005
Sedation Protocols In Pediatric Nuclear Medicine
17th International Congress of Pediatrics
Location: Tehran, Iran,
8-13 October, 2005
81.
17th International Congress of Pediatrics
Location: Tehran, Iran,
8-13 October, 2005
Current concepts on the diagnostic and therapeutic use of MIBG in children
17th International Congress of Pediatrics
Location: Tehran, Iran,
8-13 October, 2005
82.
17th International Congress of Pediatrics
Location: Tehran, Iran,
8-13 October, 2005
Renal dynamic scan in the pediatric urinary infections
17th International Congress of Pediatrics
Location: Tehran, Iran,
8-13 October, 2005
83.
17th International Congress of Pediatrics
Location: Tehran, Iran,
8-13 October, 2005
PET and pediatric neurological disorders
17th International Congress of Pediatrics
Location: Tehran, Iran,
8-13 October, 2005
84.
The 8th Annual Meeting of Nuclear Medicine
Location: Tehran, Iran,
17-18 November, 2004
Production of positron emitter radiopharmaceuticals: radiolabelling techniques
The 8th Annual Meeting of Nuclear Medicine
Location: Tehran, Iran,
17-18 November, 2004
85.
The 8th Annual Meeting of Nuclear Medicine
Location: Tehran, Iran,
17-18 November, 2004
The value of myocardial perfusion imaging in differentiating between idiopathic dilated cardiomyopathy from the ischemic form
The 8th Annual Meeting of Nuclear Medicine
Location: Tehran, Iran,
17-18 November, 2004
86.
The 8th Annual Meeting of Nuclear Medicine
Location: Tehran, Iran,
17-18 November, 2004
Evaluation of diagnostic of 99mTc-Tetrofosmin scintigraphy in cold thyroid nodules
The 8th Annual Meeting of Nuclear Medicine
Location: Tehran, Iran,
17-18 November, 2004
87.
The 8th Annual Meeting of Nuclear Medicine
Location: Tehran, Iran,
17-18 November, 2004
The effectiveness of 131I therapy in thyrogloboline positive 131I whole body scan negative patients with differentiated thyroid carcinoma
The 8th Annual Meeting of Nuclear Medicine
Location: Tehran, Iran,
17-18 November, 2004
88.
The 8th Annual Meeting of Nuclear Medicine
Location: Tehran, Iran,
17-18 November, 2004
Internal dosimetry in nuclear medicine using a thyroid mathematical model
The 8th Annual Meeting of Nuclear Medicine
Location: Tehran, Iran,
17-18 November, 2004
89.
The 8th Annual Meeting of Nuclear Medicine
Location: Tehran, Iran,
17-18 November, 2004
Health and safety aspects of nuclear medicine
The 8th Annual Meeting of Nuclear Medicine
Location: Tehran, Iran,
17-18 November, 2004
90.
The 8th Annual Meeting of Nuclear Medicine
Location: Tehran, Iran,
17-18 November, 2004
Comparative study of renal function with 99mTc-MAG3 and 99mTc-EC
The 8th Annual Meeting of Nuclear Medicine
Location: Tehran, Iran,
17-18 November, 2004
91.
The 8th Annual Meeting of Nuclear Medicine
Location: Tehran, Iran,
17-18 November, 2004
Prevalence of depression in patients with differentiated thyroid cancer treated with radioactive iodine
The 8th Annual Meeting of Nuclear Medicine
Location: Tehran, Iran,
17-18 November, 2004
92.
The 8th Annual Meeting of Nuclear Medicine
Location: Tehran, Iran,
17-18 November, 2004
Quantitative assessment of salivary glands function in thyroid cancer patients after radioiodine therapy
The 8th Annual Meeting of Nuclear Medicine
Location: Tehran, Iran,
17-18 November, 2004
93.
The 8th Annual Meeting of Nuclear Medicine
Location: Tehran, Iran,
17-18 November, 2004
90Y-Ibritumomab Tiuxetan in the treatment of relapsed or refractory B-cell non-Hodgkin's Lymphoma
The 8th Annual Meeting of Nuclear Medicine
Location: Tehran, Iran,
17-18 November, 2004
94.
16th International Congress of Pediatrics
Location: Tehran, Iran,
8-13 October, 2004
Radioisotopic cystography in diagnosis of vesicoureteral reflux
16th International Congress of Pediatrics
Location: Tehran, Iran,
8-13 October, 2004
95.
4th National Iranian Congress of Hematology & Oncology and Nursing Meeting
Location: Mashhad, Iran,
24-26 June, 2004
The value of 99mTc-MIBI Scintigraphy in active disease and remission phase of multiple myeloma
4th National Iranian Congress of Hematology & Oncology and Nursing Meeting
Location: Mashhad, Iran,
24-26 June, 2004
96.
The First Congress of Early Detection of Disease
Location: Hamedan, Iran,
12-15 May , 2003
Leukocyte radiolabelling with 99mTc-HMPAO for imaging of inflammation and infection
The First Congress of Early Detection of Disease
Location: Hamedan, Iran,
12-15 May , 2003
97.
1st National Conference on Novel Drug Delivery Systems
Location: Tehran, Iran,
26-27 February, 2003
Evaluation of new drug delivery systems using gammascintigraphy”, 1st National Conference on Novel Drug Delivery Systems
1st National Conference on Novel Drug Delivery Systems
Location: Tehran, Iran,
26-27 February, 2003
98.
The 6th Iranian Annual Meeting of Nuclear Medicine
Location: Mashhad, Iran,
19-21 October, 2002
Synthesis of b-2-IAZA, a novel radiotracer of tissue hypoxia
The 6th Iranian Annual Meeting of Nuclear Medicine
Location: Mashhad, Iran,
19-21 October, 2002
99.
8th Iranian Seminar of Pharmaceutical Sciences
Location: Shiraz, Iran,
27-29 August, 2002
A novel synthesis of 125I-labelled N-succinimidyl-4-idobenzoate for use in antibody labelling
8th Iranian Seminar of Pharmaceutical Sciences
Location: Shiraz, Iran,
27-29 August, 2002
100.
Second Iranian Seminar of Pharmacy Students
Location: Mashhad, Iran,
21-22 October, 1995
A HPLC method for evaluation of bioavailability of generic dipyridamole tablets
Second Iranian Seminar of Pharmacy Students
Location: Mashhad, Iran,
21-22 October, 1995
101.
7th Iranian Organic Chemistry Conferences
Location: Tehran, Iran,
12-13 September, 1999
Synthesis of radioiodinated of N-succinimidyl-4-idobenzoate for the radiohalogenation of proteins resulting in decreased thyroid uptake of radioiodine
7th Iranian Organic Chemistry Conferences
Location: Tehran, Iran,
12-13 September, 1999
English
1.
44th Meeting of Australian Society for Biophysics
Location: Sydney, Australia,
Date: 2-4 December, 2020-
Evaluation of the intermolecular interactions between the peptide- based inhibitors and amyloid-β monomer/fibril structures
44th Meeting of Australian Society for Biophysics
Location: Sydney, Australia,
Date: 2-4 December, 2020-
2.
32nd Annual Congress of the European Association of Nuclear Medicine
Location: Barcelona, Spain,
12-16 October, 2019
Association between 18F-FDG PET/CT findings and bone mineral densitometry results
32nd Annual Congress of the European Association of Nuclear Medicine
Location: Barcelona, Spain,
12-16 October, 2019
3.
31st Annual Congress of the European Association of Nuclear Medicine
Location: Düsseldorf, Germany,
13-17 October, 2018
Role of 99mTc-α-MSH Scan in Diagnosis of Malignant Melanoma
31st Annual Congress of the European Association of Nuclear Medicine
Location: Düsseldorf, Germany,
13-17 October, 2018
4.
30th Annual Congress of the European Association of Nuclear Medicine
Location: Vienna, Austria,
21-25 October, 2017
Association Between Gastric FDG Uptake in PET-CT and 14-C UBT Results in Patients Referred for Non-Gastric Cancer PET-CT Studies
30th Annual Congress of the European Association of Nuclear Medicine
Location: Vienna, Austria,
21-25 October, 2017
5.
29th Annual Congress of the European Association of Nuclear Medicine
Location: Barcelona, Spain,
15-19 October, 2016
Diagnostic nuclear medicine procedures and resulting radiation dose of Tehran population in 2011-2014
29th Annual Congress of the European Association of Nuclear Medicine
Location: Barcelona, Spain,
15-19 October, 2016
6.
29th Annual Congress of the European Association of Nuclear Medicine
15-19 October, 2016
Factors Influencing the Pattern and Intensity of Myocardial FDG Uptake in Oncologic PET-CT Imaging
29th Annual Congress of the European Association of Nuclear Medicine
15-19 October, 2016
7.
29th Annual Congress of the European Association of Nuclear Medicine
15-19 October, 2016
Comparison of sensitivity and specificity of Tc-99m octreotide and I-131 MIBG scintigraphies in diagnosis and localization of pheochromocytoma and neuroblastoma
29th Annual Congress of the European Association of Nuclear Medicine
15-19 October, 2016
8.
29th Annual Congress of the European Association of Nuclear Medicine
15-19 October, 2016
Association between FDG-PET/CT Findings and Tumor Markers in Patients with Colorectal Carcinoma
29th Annual Congress of the European Association of Nuclear Medicine
15-19 October, 2016
9.
29th Annual Congress of the European Association of Nuclear Medicine
15-19 October, 2016
Preparation and biological evaluation of 99mTc-HYNIC-LIKKPF for the detection of apoptosis
29th Annual Congress of the European Association of Nuclear Medicine
15-19 October, 2016
10.
29th Annual Congress of the European Association of Nuclear Medicine
15-19 October, 2016
18F-FDG-Aoe-LIKKP-Pyr-A: A new peptide radiotracer for apoptosis imaging
29th Annual Congress of the European Association of Nuclear Medicine
15-19 October, 2016
11.
29th Annual Congress of the European Association of Nuclear Medicine
Location: Barcelona, Spain,
15-19 October, 2016
Early and late follow-up myocardial perfusion scan in patients with breast cancer after external radiotherapy
29th Annual Congress of the European Association of Nuclear Medicine
Location: Barcelona, Spain,
15-19 October, 2016
12.
World Congress of Brachytherapy
Location: San Francisco, USA,
27-29 June, 2016
Efficacy and complications of 153Sm-EDTMP added to palliative local radiotherapy for bone metastases
World Congress of Brachytherapy
Location: San Francisco, USA,
27-29 June, 2016
13.
28th Annual Congress of the European Association of Nuclear Medicine
Location: Hamburg, Germany,
10-14 October, 2015
Preliminary report of long term follow-up with myocardial perfusion scan in breast cancer patients after external beam radiation therapy
28th Annual Congress of the European Association of Nuclear Medicine
Location: Hamburg, Germany,
10-14 October, 2015
14.
28th Annual Congress of the European Association of Nuclear Medicine
Location: Hamburg, Germany,
10-14 October, 2015
Evaluation of 99mTc-TRODAT-1 SPECT in the diagnosis of Parkinson’s disease and its differentiation from the other types of parkinsonism syndroms - A pilot study
28th Annual Congress of the European Association of Nuclear Medicine
Location: Hamburg, Germany,
10-14 October, 2015
15.
28th Annual Congress of the European Association of Nuclear Medicine
Location: Hamburg, Germany,
10-14 October, 2015
Effect of I-131 MIBG Thyroid Uptake on Thyroid Function Tests
28th Annual Congress of the European Association of Nuclear Medicine
Location: Hamburg, Germany,
10-14 October, 2015
16.
28th Annual Congress of the European Association of Nuclear Medicine
Location: Hamburg, Germany,
10-14 October, 2015
A new lactam bridge 99mTc-α -melanocyte-stimulating hormone analog for diagnosis of metastatic melanoma
28th Annual Congress of the European Association of Nuclear Medicine
Location: Hamburg, Germany,
10-14 October, 2015
17.
28th Annual Congress of the European Association of Nuclear Medicine
Location: Hamburg, Germany,
10-14 October, 2015
Synthesis and radiolabeling of HYNIC-conjugated LIKKPF peptide with 18F-FDG for the detection of apoptosis
28th Annual Congress of the European Association of Nuclear Medicine
Location: Hamburg, Germany,
10-14 October, 2015
18.
28th Annual Congress of the European Association of Nuclear Medicine
Location: Hamburg, Germany,
10-14 October, 2015
Assessment of prognosis in differentiated thyroid carcinoma patients showing detectable thyroglobulin level 6 months after therapy based on radioactive iodine whole body scan results (A preliminary report)
28th Annual Congress of the European Association of Nuclear Medicine
Location: Hamburg, Germany,
10-14 October, 2015
19.
28th Annual Congress of the European Association of Nuclear Medicine
Location: Hamburg, Germany,
10-14 October, 2015
Radioioeine retreatment or wait for a limited time in patients with differentiated thyroid carcinoma with negative thyroglobulin and antithyroglobulin, but remained thyroid residue after post-surgery radioiodine ablative therapy
28th Annual Congress of the European Association of Nuclear Medicine
Location: Hamburg, Germany,
10-14 October, 2015
20.
45th Annual Scientific Meeting of the Australian and New Zealand Society of Nuclear Medicine (ANZSNM)
Location: Brisbane, Australia,
17-20 April, 2015
Preparation and evaluation of 68Ga-ECC as a PET renal imaging agent
45th Annual Scientific Meeting of the Australian and New Zealand Society of Nuclear Medicine (ANZSNM)
Location: Brisbane, Australia,
17-20 April, 2015
21.
27th Annual Congress of the European Association of Nuclear Medicine
Location: Gothenburg, Sweden,
18-22 October, 2014
Preparation and preliminary biological evaluation of [153Sm] samarium AMD3100; towards a possible therapeutic chemokine receptor CXCR4 targeting complex
27th Annual Congress of the European Association of Nuclear Medicine
Location: Gothenburg, Sweden,
18-22 October, 2014
22.
11th Congress of World Federation of Nuclear Medicine & Biology
Location: Cancun, Mexico,
27-31 September, 2014
Relationship between myocardial perfusion indices and mechanical dyssynchrony based on gated SPECT phase analyses in patients with coronary artery disease and heart failure
11th Congress of World Federation of Nuclear Medicine & Biology
Location: Cancun, Mexico,
27-31 September, 2014
23.
11th Congress of World Federation of Nuclear Medicine & Biology
Location: Cancun, Mexico,
27-31 September, 2014
Radionuclide bone pain palliation, experience in Iran
11th Congress of World Federation of Nuclear Medicine & Biology
Location: Cancun, Mexico,
27-31 September, 2014
24.
11th Congress of World Federation of Nuclear Medicine & Biology
Location: Cancun, Mexico,
27-31 September, 2014
Radiosynthesis and biodistribution studies of [62Zn/62Cu]-Plerixafor complex as a novel in vivo PET generator for chemokine receptor imaging
11th Congress of World Federation of Nuclear Medicine & Biology
Location: Cancun, Mexico,
27-31 September, 2014
25.
11th Congress of World Federation of Nuclear Medicine & Biology
Location: Cancun, Mexico,
27-31 September, 2014
Synthesis and preliminary evaluation of a new 99mTc labeled substance P analogue as a potential tumor imaging agent
11th Congress of World Federation of Nuclear Medicine & Biology
Location: Cancun, Mexico,
27-31 September, 2014
26.
11th Congress of World Federation of Nuclear Medicine & Biology
Location: Cancun, Mexico,
27-31 September, 2014
Evaluation of a new 99mTc-Bombesin analog in differentiation of malignant from benign breast tumors
11th Congress of World Federation of Nuclear Medicine & Biology
Location: Cancun, Mexico,
27-31 September, 2014
27.
11th Congress of World Federation of Nuclear Medicine & Biology
Location: Cancun, Mexico,
27-31 September, 2014
Evaluation of 188Re-HEDP efficacy in metastatic bone pain palliation therapy
11th Congress of World Federation of Nuclear Medicine & Biology
Location: Cancun, Mexico,
27-31 September, 2014
28.
26th Annual Congress of the European Association of Nuclear Medicine
Location: Lyon, France,
19-23 October, 2013
Quality of life and associated factors in radio-iodine treated patients with differentiated thyroid carcinoma
26th Annual Congress of the European Association of Nuclear Medicine
Location: Lyon, France,
19-23 October, 2013
29.
26th Annual Congress of the European Association of Nuclear Medicine
Location: Lyon, France,
19-23 October, 2013
Comparison of Salivary Gland Function Side Effect of 30-100 mCi versus <30 mCi of Radioiodine Therapy
26th Annual Congress of the European Association of Nuclear Medicine
Location: Lyon, France,
19-23 October, 2013
30.
26th Annual Congress of the European Association of Nuclear Medicine
Location: Lyon, France,
19-23 October, 2013
Preliminary report of randomized clinical trial for assessment of the short term Folate therapy on transient ischemic dilatation in myocardial perfusion scan of diabetic patients
26th Annual Congress of the European Association of Nuclear Medicine
Location: Lyon, France,
19-23 October, 2013
31.
25th Annual Congress of the European Association of Nuclear Medicine
Location: Milan, Italy,
27-31 October, 2012
Evaluation of Myocardial Perfusion and Function after Kidney Transplantation by Gated Myocardial Perfusion Scintigraphy
25th Annual Congress of the European Association of Nuclear Medicine
Location: Milan, Italy,
27-31 October, 2012
32.
25th Annual Congress of the European Association of Nuclear Medicine
Location: Milan, Italy,
27-31 October, 2012
The Influence of resolution recovery during image reconstruction on quantitative brain SPECT imaging
25th Annual Congress of the European Association of Nuclear Medicine
Location: Milan, Italy,
27-31 October, 2012
33.
25th Annual Congress of the European Association of Nuclear Medicine
Location: Milan, Italy,
27-31 October, 2012
Comparative evaluation of the diagnostic accuracy of Tc-99m-sestamibi gated SPECT using five different sets of image acquisitions at stress and rest phases for the diagnosis of coronary artery disease
25th Annual Congress of the European Association of Nuclear Medicine
Location: Milan, Italy,
27-31 October, 2012
34.
25th Annual Congress of the European Association of Nuclear Medicine
Location: Milan, Italy,
27-31 October, 2012
Evaluation of 99mTc-Bombesin in differentiation of malignant from benign breast tumors
25th Annual Congress of the European Association of Nuclear Medicine
Location: Milan, Italy,
27-31 October, 2012
35.
25th Annual Congress of the European Association of Nuclear Medicine
Location: Milan, Italy,
27-31 October, 2012
The value of quantitative myocardial perfusion scintigraphy using 99mTc-MIBI ECG-Gated SPECT for determining the clinical prognosis in patients suspicious for coronary artery disease
25th Annual Congress of the European Association of Nuclear Medicine
Location: Milan, Italy,
27-31 October, 2012
36.
24th Annual Congress of the European Association of Nuclear Medicine
Location: Birmingham, UK,
15-19 October, 2011
Evaluation of 99mTc-Ubiquicidin 29-41 Scintigraphy in Differentiation of Bacterial Infection from Sterile Inflammation in Diabetic Foot
24th Annual Congress of the European Association of Nuclear Medicine
Location: Birmingham, UK,
15-19 October, 2011
37.
24th Annual Congress of the European Association of Nuclear Medicine
Location: Birmingham, UK,
15-19 October, 2011
Evaluation of treatment efficacy of metastatic bone pain with 153Sm-EDTMP
24th Annual Congress of the European Association of Nuclear Medicine
Location: Birmingham, UK,
15-19 October, 2011
38.
24th Annual Congress of the European Association of Nuclear Medicine
Location: Birmingham, UK,
15-19 October, 2011
Evaluation of 99mTc-Ubiquicidin scintigrapghy in differentiation of bacterial infection from sterile inflammation in suspected orthopedic implants
24th Annual Congress of the European Association of Nuclear Medicine
Location: Birmingham, UK,
15-19 October, 2011
39.
24th Annual Congress of the European Association of Nuclear Medicine
Location: Birmingham, UK,
15-19 October, 2011
of estimates of renal function by Modification of Diet for Renal Disease equation in Iranian patients with acute renal failure
24th Annual Congress of the European Association of Nuclear Medicine
Location: Birmingham, UK,
15-19 October, 2011
40.
24th Annual Congress of the European Association of Nuclear Medicine
Location: Birmingham, UK,
15-19 October, 2011
Nasolacrimal Duct Obstruction as a Complication of Iodine-131 Therapy in Patients with Thyroid Cancer
24th Annual Congress of the European Association of Nuclear Medicine
Location: Birmingham, UK,
15-19 October, 2011
41.
24th Annual Congress of the European Association of Nuclear Medicine
Location: Birmingham, UK,
15-19 October, 2011
The role of tecnetium-99m ECD SPECT in the evaluation of long-term outcome after mild traumatic brain injury
24th Annual Congress of the European Association of Nuclear Medicine
Location: Birmingham, UK,
15-19 October, 2011
42.
23rd Annual Congress of the European Association of Nuclear Medicine
Location: Vienna, Austria,
9-13 October, 2010
Predicting factors of successful postsurgical remnant ablation with I-131 in patients with differentiated thyroid carcinoma
23rd Annual Congress of the European Association of Nuclear Medicine
Location: Vienna, Austria,
9-13 October, 2010
43.
23rd Annual Congress of the European Association of Nuclear Medicine
Location: Vienna, Austria,
9-13 October, 2010
The effect of radioiodine treatment on the development of second primary cancer in patients with differentiated thyroid carcinoma
23rd Annual Congress of the European Association of Nuclear Medicine
Location: Vienna, Austria,
9-13 October, 2010
44.
23rd Annual Congress of the European Association of Nuclear Medicine
Location: Vienna, Austria,
9-13 October, 2010
Scintigraphic pattern of bone metastases in 146 patients with different types of cancers
23rd Annual Congress of the European Association of Nuclear Medicine
Location: Vienna, Austria,
9-13 October, 2010
45.
23rd Annual Congress of the European Association of Nuclear Medicine
Location: Vienna, Austria,
9-13 October, 2010
The precision of Cockcroft-Gault formula for estimation of glomrular filtration rate in acute renal failure in comparison with double plasma sample method using Tc-99m DTPA
23rd Annual Congress of the European Association of Nuclear Medicine
Location: Vienna, Austria,
9-13 October, 2010
46.
23rd Annual Congress of the European Association of Nuclear Medicine
Location: Vienna, Austria,
9-13 October, 2010
Is gall bladder ejection fraction using fatty meal CCK cholescintigraphy useful for diagnosis of chronic cholecystitis
23rd Annual Congress of the European Association of Nuclear Medicine
Location: Vienna, Austria,
9-13 October, 2010
47.
10th Congress of World Federation of Nuclear Medicine & Biology
Location: Cape Town, South Africa,
18-23 September, 2010
Diffusion ofnuclear medicine in developing countries: the obstacles and barriers
10th Congress of World Federation of Nuclear Medicine & Biology
Location: Cape Town, South Africa,
18-23 September, 2010
48.
10th Congress of World Federation of Nuclear Medicine & Biology
Location: Cape Town, South Africa,
18-23 September, 2010
Is gall bladder ejection fraction using fatty meal CCK cholescintigraphy useful for diagnosis of chronic cholecystitis
10th Congress of World Federation of Nuclear Medicine & Biology
Location: Cape Town, South Africa,
18-23 September, 2010
49.
10th Congress of World Federation of Nuclear Medicine & Biology
Location: Cape Town, South Africa,
18-23 September, 2010
Radiation synovectomy, effectiveness of P-32 in treatment of chronic haemophilic synovitis
10th Congress of World Federation of Nuclear Medicine & Biology
Location: Cape Town, South Africa,
18-23 September, 2010
50.
10th Congress of World Federation of Nuclear Medicine & Biology
Location: Cape Town, South Africa,
18-23 September, 2010
Controversies in treatment of differentiated thyroid carcinoma, concerns regarding response vs adverse effects of I-131
10th Congress of World Federation of Nuclear Medicine & Biology
Location: Cape Town, South Africa,
18-23 September, 2010
51.
10th Congress of World Federation of Nuclear Medicine & Biology
Location: Cape Town, South Africa,
18-23 September, 2010
Echocardiographic left ventricular functional changes in subclinical hyperthyroidism and acute hypothyroidism in patients with thyroid cancer
10th Congress of World Federation of Nuclear Medicine & Biology
Location: Cape Town, South Africa,
18-23 September, 2010
52.
10th Congress of World Federation of Nuclear Medicine & Biology
Location: Cape Town, South Africa,
18-23 September, 2010
In vitro tracking of 111In-Oxine labeled mesenchymal stem cells following intravenous infusion in patients with advanced cirrhosis
10th Congress of World Federation of Nuclear Medicine & Biology
Location: Cape Town, South Africa,
18-23 September, 2010
53.
10th Congress of World Federation of Nuclear Medicine & Biology
Location: Cape Town, South Africa,
18-23 September, 2010
The value of transient ischemic dilatation in the presence of normal myocardial perfusion
10th Congress of World Federation of Nuclear Medicine & Biology
Location: Cape Town, South Africa,
18-23 September, 2010
54.
10th Congress of World Federation of Nuclear Medicine & Biology
Location: Cape Town, South Africa,
18-23 September, 2010
The brain perfusion pattern in non-medicated schizopherenic patients
10th Congress of World Federation of Nuclear Medicine & Biology
Location: Cape Town, South Africa,
18-23 September, 2010
55.
10th Congress of World Federation of Nuclear Medicine & Biology
Location: Cape Town, South Africa,
18-23 September, 2010
P-Glycoprotein assay and 99mTc-MIBI imaging in relation to multiple drug resistance in patients with multiple myeloma
10th Congress of World Federation of Nuclear Medicine & Biology
Location: Cape Town, South Africa,
18-23 September, 2010
56.
10th Congress of World Federation of Nuclear Medicine & Biology
Location: Cape Town, South Africa,
18-23 September, 2010
SPECT vs. planar scintigraphy with 99mTc-RBC for diagnosis of liover hemangioma
10th Congress of World Federation of Nuclear Medicine & Biology
Location: Cape Town, South Africa,
18-23 September, 2010
57.
10th Congress of World Federation of Nuclear Medicine & Biology
Location: Cape Town, South Africa,
18-23 September, 2010
Planning a new policy based on dose rates and radioiodine urinary excretion measurements for determining a proper time of discharge in radioiodine treated patients with differentiated thyroid carcinoma
10th Congress of World Federation of Nuclear Medicine & Biology
Location: Cape Town, South Africa,
18-23 September, 2010
58.
10th Congress of World Federation of Nuclear Medicine & Biology
Location: Cape Town, South Africa,
18-23 September, 2010
Evaluation of radioprotective effects of new synthetic amino-alkyldithiocarbamic acid derivatives in mice
10th Congress of World Federation of Nuclear Medicine & Biology
Location: Cape Town, South Africa,
18-23 September, 2010
59.
22nd Annual Congress of the European Association of Nuclear Medicine
Location: Barcelona, Spain,
10-14 October, 2009
99mTc-MIBI redistribution in myocardial perfusion SPECT of the patients with coronary artery disease
22nd Annual Congress of the European Association of Nuclear Medicine
Location: Barcelona, Spain,
10-14 October, 2009
60.
22nd Annual Congress of the European Association of Nuclear Medicine
Location: Barcelona, Spain,
10-14 October, 2009
Does vitamin-E Decrease Salivary Gland Damage After Radioiodine Therapy in Patients with Thyroid Cancer
22nd Annual Congress of the European Association of Nuclear Medicine
Location: Barcelona, Spain,
10-14 October, 2009
61.
22nd Annual Congress of the European Association of Nuclear Medicine
Location: Barcelona, Spain,
10-14 October, 2009
Radioprotective effects of hesperidin as a flavonoid against genotoxic effects of 99mTc-MIBI in human cultured lymphocytes
22nd Annual Congress of the European Association of Nuclear Medicine
Location: Barcelona, Spain,
10-14 October, 2009
62.
22nd Annual Congress of the European Association of Nuclear Medicine
Location: Barcelona, Spain,
10-14 October, 2009
Echocardiographic functional changes in subclinical hyperthyroidism and acute hypothyroidism after L-thyroxine withdrawal in patients with thyroid cancer
22nd Annual Congress of the European Association of Nuclear Medicine
Location: Barcelona, Spain,
10-14 October, 2009
63.
22nd Annual Congress of the European Association of Nuclear Medicine
Location: Barcelona, Spain,
10-14 October, 2009
Genotoxicity effects of 99mTechnetium-MIBI in human peripheral blood lymphocytes
22nd Annual Congress of the European Association of Nuclear Medicine
Location: Barcelona, Spain,
10-14 October, 2009
64.
22nd Annual Congress of the European Association of Nuclear Medicine
Location: Barcelona, Spain,
10-14 October, 2009
The Changes of the Brain Perfusion Pattern in Schizophrenic Patients in Relation to Symptom Improvement after Treatment with Olanzapine
22nd Annual Congress of the European Association of Nuclear Medicine
Location: Barcelona, Spain,
10-14 October, 2009
65.
22nd Annual Congress of the European Association of Nuclear Medicine
Location: Barcelona, Spain,
10-14 October, 2009
Gated myocardial perfusion SPECT: Effect of patient position on left ventricular functional indices
22nd Annual Congress of the European Association of Nuclear Medicine
Location: Barcelona, Spain,
10-14 October, 2009
66.
22nd Annual Congress of the European Association of Nuclear Medicine
Location: Barcelona, Spain,
10-14 October, 2009
Value of single injection-double acquisition stress gated SPECT before and during low-dose dobutamine infusion for prediction of myocardial perfusion and function improvement after coronary artery bypass graft
22nd Annual Congress of the European Association of Nuclear Medicine
Location: Barcelona, Spain,
10-14 October, 2009
67.
SNM Annual Meeting
Location: Toronto, Canada,
13-17 June, 2009
value of myocardial perfusion imaging for prediction of perfusion improvement after percutaneous transluminal coronary angioplasty
SNM Annual Meeting
Location: Toronto, Canada,
13-17 June, 2009
68.
9th Acia-oceania Congress of Nuclear Medicine and Biology
Location: New Dehli, India,
24-29 October, 2008
Effects of 111In-Oxine labeling on the survival of human mesenchymal stem cells
9th Acia-oceania Congress of Nuclear Medicine and Biology
Location: New Dehli, India,
24-29 October, 2008
69.
21th Annual Congress of the European Association of Nuclear Medicine
Location: Munich, Germany,
11-15 October, 2008
Iodine-131 Therapy Complications In Mother And Child In Patients With Differentiated Thyroid Carcinoma
21th Annual Congress of the European Association of Nuclear Medicine
Location: Munich, Germany,
11-15 October, 2008
70.
21th Annual Congress of the European Association of Nuclear Medicine
Location: Munich, Germany,
11-15 October, 2008
Radio-iodine therapy and Helicobacter pylori infection: The first in vivo evidence on radiosensitivity of the bacteria
21th Annual Congress of the European Association of Nuclear Medicine
Location: Munich, Germany,
11-15 October, 2008
71.
21th Annual Congress of the European Association of Nuclear Medicine
Location: Munich, Germany,
11-15 October, 2008
Synthesis and radioprotective effects of novel amino-alkyldithiocarbamic acid derivatives against γ-irradiation in mice
21th Annual Congress of the European Association of Nuclear Medicine
Location: Munich, Germany,
11-15 October, 2008
72.
21th Annual Congress of the European Association of Nuclear Medicine
Location: Munich, Germany,
11-15 October, 2008
Deviated renal axis in children with urinary tract abnormalities
21th Annual Congress of the European Association of Nuclear Medicine
Location: Munich, Germany,
11-15 October, 2008
73.
21th Annual Congress of the European Association of Nuclear Medicine
Location: Munich, Germany,
11-15 October, 2008
Diagnostic value of transient left ventricular dilatation for diabetic and non-diabetic patients with no significant regional myocardial perfusion abnormality
21th Annual Congress of the European Association of Nuclear Medicine
Location: Munich, Germany,
11-15 October, 2008
74.
20th Annual Congress of the European Association of Nuclear Medicine
Location: Copenhagen, Denmark,
13-17 October, 2007
Evaluation of radioiodine therapy in differentiated thyroid cancer (DTC) in patients with negative diagnostic I-131 whole body scans and elevated serum thyroglobulin levels: a comparison study with thallium scan
20th Annual Congress of the European Association of Nuclear Medicine
Location: Copenhagen, Denmark,
13-17 October, 2007
75.
20th Annual Congress of the European Association of Nuclear Medicine
Location: Copenhagen, Denmark,
13-17 October, 2007
Hospital discharge policy in patients receiving iodine-131 therapy for thyroid carcinoma based on monitoring of radiation dose rate and radioiodine urinary excretion
20th Annual Congress of the European Association of Nuclear Medicine
Location: Copenhagen, Denmark,
13-17 October, 2007
76.
20th Annual Congress of the European Association of Nuclear Medicine
Location: Copenhagen, Denmark,
13-17 October, 2007
Simple synthesis of radioiodinated N-succinimidyl-4iodobenzoate: an intermediate compound for the indirect radioiodination of antibodies
20th Annual Congress of the European Association of Nuclear Medicine
Location: Copenhagen, Denmark,
13-17 October, 2007
77.
20th Annual Congress of the European Association of Nuclear Medicine
Location: Copenhagen, Denmark,
13-17 October, 2007
Brain perfusion abnormalities in patients with chronic symptoms studied with Technetium-99m ethyl cysteinate dimmer (99mTc-ECD) more than one year
20th Annual Congress of the European Association of Nuclear Medicine
Location: Copenhagen, Denmark,
13-17 October, 2007
78.
20th Annual Congress of the European Association of Nuclear Medicine
Location: Copenhagen, Denmark,
13-17 October, 2007
The value of 99mTc-MIBI scintigraphy for the diagnosis of multiple drug resistance in multiple myeloma patients
20th Annual Congress of the European Association of Nuclear Medicine
Location: Copenhagen, Denmark,
13-17 October, 2007
79.
20th Annual Congress of the European Association of Nuclear Medicine
Location: Copenhagen, Denmark,
13-17 October, 2007
Angiographic findings in cardiac syndrome X comparing with myocardial perfusion imaging and exercise treadmill test
20th Annual Congress of the European Association of Nuclear Medicine
Location: Copenhagen, Denmark,
13-17 October, 2007
80.
Joint Annual Scientific Meeting
Location: Toronto, Canada,
9-13 October, 2007
Radioiodine treatment complications in mother and child in patients with differentiated thyroid carcinoma
Joint Annual Scientific Meeting
Location: Toronto, Canada,
9-13 October, 2007
81.
2nd Conference of Asia Regional Cooperative Council of Nuclear Medicine
Location: Ulaanbaatar, Mongolia,
3-7 September, 2007
Efficacy of Radioiodine therapy in patients of differentiated thyroid cancer with elevated serum thyroglobulin and negative I-131 scan
2nd Conference of Asia Regional Cooperative Council of Nuclear Medicine
Location: Ulaanbaatar, Mongolia,
3-7 September, 2007
82.
2nd Conference of Asia Regional Cooperative Council of Nuclear Medicine
Location: Ulaanbaatar, Mongolia,
3-7 September, 2007
Mineral Density in patients with well-differentiated thyroid carcinoma
2nd Conference of Asia Regional Cooperative Council of Nuclear Medicine
Location: Ulaanbaatar, Mongolia,
3-7 September, 2007
83.
2nd Conference of Asia Regional Cooperative Council of Nuclear Medicine
Location: Ulaanbaatar, Mongolia,
3-7 September, 2007
Radioiodine therapy effects on lacrimal gland function in patients with thyroid cancer
2nd Conference of Asia Regional Cooperative Council of Nuclear Medicine
Location: Ulaanbaatar, Mongolia,
3-7 September, 2007
84.
9th Congress of World Federation of Nuclear Medicine & Biology
Location: Seoul, South Korea,
22-27 October, 2006
Assessing the diagnostic accuracy of sentinel lymph nodes lymphoscintigraphy using Tc-99m Phytate in breast cancer
9th Congress of World Federation of Nuclear Medicine & Biology
Location: Seoul, South Korea,
22-27 October, 2006
85.
9th Congress of World Federation of Nuclear Medicine & Biology
Location: Seoul, South Korea,
22-27 October, 2006
Diagnostic role of Tc-99m Tetrofosmin scintigraphy in cold thyroid nodules
9th Congress of World Federation of Nuclear Medicine & Biology
Location: Seoul, South Korea,
22-27 October, 2006
86.
9th Congress of World Federation of Nuclear Medicine & Biology
Location: Seoul, South Korea,
22-27 October, 2006
Changes in gonadal function in hyperthyroid patients treated with radioiodine
9th Congress of World Federation of Nuclear Medicine & Biology
Location: Seoul, South Korea,
22-27 October, 2006
87.
9th Congress of World Federation of Nuclear Medicine & Biology
Location: Seoul, South Korea,
22-27 October, 2006
C-13 UBT by non dispersive isotope selected infrared (NDIR) spectroscopy vs C-14 UBT in diagnosis of HP infection
9th Congress of World Federation of Nuclear Medicine & Biology
Location: Seoul, South Korea,
22-27 October, 2006
88.
9th Congress of World Federation of Nuclear Medicine & Biology
Location: Seoul, South Korea,
22-27 October, 2006
Microdose C-14 urea breath test for the diagnosis of helicobacter pylori
9th Congress of World Federation of Nuclear Medicine & Biology
Location: Seoul, South Korea,
22-27 October, 2006
89.
9th Congress of World Federation of Nuclear Medicine & Biology
Location: Seoul, South Korea,
22-27 October, 2006
Discontinuing of long-term beta-blocker therapy may falsely overestimate the fixed defects in dipyridamole myocardial perfusion imaging
9th Congress of World Federation of Nuclear Medicine & Biology
Location: Seoul, South Korea,
22-27 October, 2006
90.
9th Congress of World Federation of Nuclear Medicine & Biology
Location: Seoul, South Korea,
22-27 October, 2006
Comparison between three interpretative methods for diagnosis of coronary artery disease in the territory of left anterior descending artery by dipyridamole myocardial perfusion imaging in patients with left bundle branch block
9th Congress of World Federation of Nuclear Medicine & Biology
Location: Seoul, South Korea,
22-27 October, 2006
91.
9th Congress of World Federation of Nuclear Medicine & Biology
Location: Seoul, South Korea,
22-27 October, 2006
Myocardial perfusion scan accuracy in detection of coronary artery disease – comparison with exercise stress test
9th Congress of World Federation of Nuclear Medicine & Biology
Location: Seoul, South Korea,
22-27 October, 2006
92.
9th Congress of World Federation of Nuclear Medicine & Biology
Location: Seoul, South Korea,
22-27 October, 2006
Quantitative assessment of dacrioscintigraphic images in the evaluation of epiphora
9th Congress of World Federation of Nuclear Medicine & Biology
Location: Seoul, South Korea,
22-27 October, 2006
93.
9th Congress of World Federation of Nuclear Medicine & Biology
Location: Seoul, South Korea,
22-27 October, 2006
Radiopharmaceutical regulation world wide- the resemblances and differences
9th Congress of World Federation of Nuclear Medicine & Biology
Location: Seoul, South Korea,
22-27 October, 2006
94.
9th Congress of World Federation of Nuclear Medicine & Biology
Location: Seoul, South Korea,
22-27 October, 2006
Assessment of the Accuracy of lacrimal scintigraphy based on a prospective analysis of patients symptomatology
9th Congress of World Federation of Nuclear Medicine & Biology
Location: Seoul, South Korea,
22-27 October, 2006
95.
9th Congress of World Federation of Nuclear Medicine & Biology
Location: Seoul, South Korea,
22-27 October, 2006
Neurospect evaluation in patients with post traumatic anosmia; a preliminary study
9th Congress of World Federation of Nuclear Medicine & Biology
Location: Seoul, South Korea,
22-27 October, 2006
96.
9th Congress of World Federation of Nuclear Medicine & Biology
Location: Seoul, South Korea,
22-27 October, 2006
Comparison between brain perfusion single photon emission computed tomography and anatomical imaging in chronic complications of traumatic head injury
9th Congress of World Federation of Nuclear Medicine & Biology
Location: Seoul, South Korea,
22-27 October, 2006
97.
9th Congress of World Federation of Nuclear Medicine & Biology
Location: Seoul, South Korea,
22-27 October, 2006
Efficacy of radioiodine therapy in the treatment of elevated serum thyroglobuline in patients with differentiated thyroid carcinoma and negative whole body iodine scan
9th Congress of World Federation of Nuclear Medicine & Biology
Location: Seoul, South Korea,
22-27 October, 2006
98.
9th Congress of World Federation of Nuclear Medicine & Biology
Location: Seoul, South Korea,
22-27 October, 2006
Angiographic and scintigraphic features of cardiac X syndrome
9th Congress of World Federation of Nuclear Medicine & Biology
Location: Seoul, South Korea,
22-27 October, 2006
99.
9th Congress of World Federation of Nuclear Medicine & Biology
Location: Seoul, South Korea,
22-27 October, 2006
Myocardial perfusion scintigraphy role in evaluating percutaneous transluminal coronary angioplasty (PTCA) in patients with coronary artery disease
9th Congress of World Federation of Nuclear Medicine & Biology
Location: Seoul, South Korea,
22-27 October, 2006
100.
19th Annual Congress of the European Association of Nuclear Medicine
Location: Athens, Greece,
30 Sept-4 Oct, 2006
Discontinuing of long-term beta-blocker therapy may falsely overestimate the fixed defects in dipyridamole myocardial perfusion imaging
19th Annual Congress of the European Association of Nuclear Medicine
Location: Athens, Greece,
30 Sept-4 Oct, 2006
101.
19th Annual Congress of the European Association of Nuclear Medicine
Location: Athens, Greece,
30 Sept-4 Oct, 2006
Pre-treatment preparation of patients with differentiated thyroid carcinoma within three weeks
19th Annual Congress of the European Association of Nuclear Medicine
Location: Athens, Greece,
30 Sept-4 Oct, 2006
102.
19th Annual Congress of the European Association of Nuclear Medicine
Location: Athens, Greece,
30 Sept-4 Oct, 2006
99mTc-EC vs. 99mTc-MAG3: A comparative study of two radiopharmaceuticals for renal function assessment
19th Annual Congress of the European Association of Nuclear Medicine
Location: Athens, Greece,
30 Sept-4 Oct, 2006
103.
19th Annual Congress of the European Association of Nuclear Medicine
Location: Athens, Greece,
30 Sept-4 Oct, 2006
Radioiodine treatment effects on lacrimal gland function in patients with thyroid cancer
19th Annual Congress of the European Association of Nuclear Medicine
Location: Athens, Greece,
30 Sept-4 Oct, 2006
104.
19th Annual Congress of the European Association of Nuclear Medicine
Location: Athens, Greece,
30 Sept-4 Oct, 2006
Correlation of two methods of planar and SPECT scintigraphy with Tc-99m RBC in detection of liver hemangioma
19th Annual Congress of the European Association of Nuclear Medicine
Location: Athens, Greece,
30 Sept-4 Oct, 2006
105.
19th Annual Congress of the European Association of Nuclear Medicine
Location: Athens, Greece,
30 Sept-4 Oct, 2006
99mTc-Phytate vs. 99mTc-Sb2S3 for lymphatic mapping and gamma-guided sentinel lymph node biopsy in breast cancer: a comparative study
19th Annual Congress of the European Association of Nuclear Medicine
Location: Athens, Greece,
30 Sept-4 Oct, 2006
106.
19th Annual Congress of the European Association of Nuclear Medicine
Location: Athens, Greece,
30 Sept-4 Oct, 2006
Assessing the diagnostic accuracy of sentinel lymph nodes lymphoscintigraphy using 99mTc-phytate in breast cancer
19th Annual Congress of the European Association of Nuclear Medicine
Location: Athens, Greece,
30 Sept-4 Oct, 2006
107.
19th Annual Congress of the European Association of Nuclear Medicine
Location: Athens, Greece,
30 Sept-4 Oct, 2006
Comparison of methods for determination of glomerular filtration rate: low and high dose Tc-99m-DTPA renography, predicted creatinine clearance method and plasma sample method
19th Annual Congress of the European Association of Nuclear Medicine
Location: Athens, Greece,
30 Sept-4 Oct, 2006
108.
19th Annual Congress of the European Association of Nuclear Medicine
Location: Athens, Greece,
30 Sept-4 Oct, 2006
Is there any correlation between the severity of anxiety and myocardial perfusion abnormalities detected by SPECT imaging
19th Annual Congress of the European Association of Nuclear Medicine
Location: Athens, Greece,
30 Sept-4 Oct, 2006
109.
8th European Congress of Endocrinology
Location: Glasgow, UK,
1-5 April, 2006
On-levothyroxine measurement of thyroglobulin is not a reliable screening test for patients at high risk of remnant/recurrent differentiated thyroid carcinoma
8th European Congress of Endocrinology
Location: Glasgow, UK,
1-5 April, 2006
110.
8th European Congress of Endocrinology
Location: Glasgow, UK ,
1-5 April, 2006
Efficacy of high dose radioiodine in the treatment of elevated serum thyroglobulin in patients with differentiated thyroid carcinoma and negative whole body iodine scan
8th European Congress of Endocrinology
Location: Glasgow, UK ,
1-5 April, 2006
111.
Annual Congress of the European Association of Nuclear Medicine
Location: Istanbul, Turkey,
15-19 October, 2005
Bone SPECT value for differentiating malignant from benign lesions of vertebral column in patients with known primary malignancy
Annual Congress of the European Association of Nuclear Medicine
Location: Istanbul, Turkey,
15-19 October, 2005
112.
Annual Congress of the European Association of Nuclear Medicine
Location: Istanbul, Turkey,
15-19 October, 2005
The value of Tc-99m-MIBI scintigraphy in multiple myeloma for early detection of relapsed disease and decesion for treatment
Annual Congress of the European Association of Nuclear Medicine
Location: Istanbul, Turkey,
15-19 October, 2005
113.
Annual Congress of the European Association of Nuclear Medicine
Location: Istanbul, Turkey,
15-19 October, 2005
The value of myocardial perfusion imaging in differentiating between idiopathic dilated cardiomyopathy from the ischemic form
Annual Congress of the European Association of Nuclear Medicine
Location: Istanbul, Turkey,
15-19 October, 2005
114.
Annual Congress of the European Association of Nuclear Medicine
Location: Istanbul, Turkey,
15-19 October, 2005
Posttraumatic anosmia: quantitative brain perfusion SPECT and clinical evaluation
Annual Congress of the European Association of Nuclear Medicine
Location: Istanbul, Turkey,
15-19 October, 2005
115.
Annual Congress of the European Association of Nuclear Medicine
Location: Istanbul, Turkey,
15-19 October, 2005
Can rest phase study be replaced by acquisition during low-dose dobutamine infusion in ECG-gated myocardial perfusion SPECT? A novel protocol
Annual Congress of the European Association of Nuclear Medicine
Location: Istanbul, Turkey,
15-19 October, 2005
116.
International Conference on Radiopharmaceutical Therapy
Location: Limassol, Cyprus,
11-14 October, 2005
Study of ablation efficiency of 3600 MBq of I-131 in the treatment of thyroid carcinoma
International Conference on Radiopharmaceutical Therapy
Location: Limassol, Cyprus,
11-14 October, 2005
117.
International Conference on Radiopharmaceutical Therapy
Location: Limassol, Cyprus,
11-14 October, 2005
The rate of depression and its risk stratification in patients with differentiated thyroid cancers treated with radioactive iodine
International Conference on Radiopharmaceutical Therapy
Location: Limassol, Cyprus,
11-14 October, 2005
118.
International Conference on Radiopharmaceutical Therapy
Location: Limassol, Cyprus,
11-14 October, 2005
Comparative evaluation of the two fixed dose methods of radioiodine therapy (185 MBq and 370 MBq) for the treatment of graves' disease
International Conference on Radiopharmaceutical Therapy
Location: Limassol, Cyprus,
11-14 October, 2005
119.
52nd Annual Meeting of the Society of Nuclear Medicine
Location: Toronto, Canada,
18-22 June, 2005
Bone mineral density in patients with differentiated thyroid cancer receiving suppressive dose of levothyroxine
52nd Annual Meeting of the Society of Nuclear Medicine
Location: Toronto, Canada,
18-22 June, 2005
120.
51st Annual Meeting of the Society of Nuclear Medicine
Location: Philadelphia, PA, USA,
19-23 June, 2004
Effects of treatment with radioiodine (I-131) on the gonadal function of the hyperthyroid patients
51st Annual Meeting of the Society of Nuclear Medicine
Location: Philadelphia, PA, USA,
19-23 June, 2004
121.
8th Congress of The World Federation of Nuclear Medicine and Biology
Location: Santiago, Chile,
29 Sept - 4 Oct , 2002
Reduction of in vivo deiodination of radioiodinated of antibodies using N-succinimidyl-4-[125I]iodobenzoate
8th Congress of The World Federation of Nuclear Medicine and Biology
Location: Santiago, Chile,
29 Sept - 4 Oct , 2002
122.
4th International Conference on isotopes
Location: Capetown, South Africa,
10-14 March, 2002
Synthesis of I-125, I-131 labelled peptides
4th International Conference on isotopes
Location: Capetown, South Africa,
10-14 March, 2002
123.
International Atomic Energy Agency, Final Research Co-ordinated Meeting
Location: Shanghai, China,
30 October - 3 November, 2000
Optimization of synthesis and quality control procedures for the preparation of I-125-labelled peptides
International Atomic Energy Agency, Final Research Co-ordinated Meeting
Location: Shanghai, China,
30 October - 3 November, 2000
124.
Fourth International Symposium on Radiohalogens
Location: Whistler, Canada,
9-13 September, 2000
Microwave-accelerated radiohalogenation of nitroimidazole-based hypoxia markers
Fourth International Symposium on Radiohalogens
Location: Whistler, Canada,
9-13 September, 2000
125.
AFPC Conferences
Location: Saskatoon, Canada,
24-26 June, 2000
Synthesis and radiohalogenation of 2’-IAZA, a potential analog of IAZA, as a novel radiotracer for imaging tissue hypoxia
AFPC Conferences
Location: Saskatoon, Canada,
24-26 June, 2000
1.
Editorial Board Member,
Pharmaceutical and Biomedical Research
Editorial Board Member,
2.
Editor,
Iranian Journal of Nuclear Medicine
Editor,
3.
Editorial Board Member,
Asia Oceania Journal of Nuclear Medicine and Biology
Editorial Board Member,
4.
Editorial Board Member,
Open Cardiovascular Imaging Journal
Editorial Board Member,
5.
Referee,
Iranian Journal of Basic Medical Sciences
Referee,
6.
Referee,
The Journal of Nuclear Medicine Technology
Referee,
7.
Referee,
Iranian Journal of Pharmaceutical Research
Referee,
8.
Referee,
Tehran University Medical Journal
Referee,
9.
Editorial Board Member,
DARU Journal of Pharmaceutical Sciences
Editorial Board Member,
10.
Editorial Board Member,
Journal of Nuclear Sciences and Technology
Editorial Board Member,
11.
Referee,
Mazandaran University of Medical Sciences Journal
Referee,
12.
Referee,
Applied Radiation and Isotopes
Referee,
1.
Computer Knowledge
Microsoft Word - Powerpoint - SPSS - EndNote - Reference Manager
1.
Activity Type:Member
European Association of Nuclear Medicine
Activity Type:Member
2.
Activity Type:Member Of Board
National Center of Excellence in Nuclear Medicine
Activity Type:Member Of Board
3.
Activity Type:Member Of Board
National Center of Excellence in Radiopharmaceuticals
Activity Type:Member Of Board
4.
Activity Type:Member
Cancer Research Network
Activity Type:Member
5.
Activity Type:Member Of Board
Nuclear Medicine National Board of Examination
Activity Type:Member Of Board
6.
Activity Type:Member Of Board
Radiopharmacy National Board of Examination
Activity Type:Member Of Board
7.
Activity Type:Member
European Association of Nuclear Medicine
Activity Type:Member
8.
Activity Type:Member
Iranian Society of Nuclear Medicine
Activity Type:Member
9.
Activity Type:Member
Iranian Association of Pharmacists
Activity Type:Member
10.
Activity Type:Member
Iranian Medical Council
Activity Type:Member
1. Therapeutic Radiopharmaceuticals
2. Hospital radiopharmacy
3. Gammascintigraphy in the evaluation of pharmaceuticals dosage forms
4. Quality control in radiopharmacy
5. Synthesis of radiosensitizers and radioprotectors
Top